<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet type="text/xsl" href="annotation.xsl"?>
<?oxygen NVDLSchema="annotation.nvdl"?>
<fulltext-document system="ops.epo.org" fulltext-format="text-only" xmlns="http://www.epo.org/fulltext"><bibliographic-data><publication-reference data-format="docdb"><document-id><country>WO</country><doc-number>03054142</doc-number><kind>A2</kind></document-id></publication-reference></bibliographic-data><description lang="EN"><p>&lt;Desc/Clms Page number 1&gt;
 </p><p> NOVEL SULFURYLASE-LUCIFERASE FUSION PROTEINS AND 
THERMOSTABLE &lt;RTI ID=0.0&gt;SULFURYLASE&lt;/RTI&gt; 
FIELD OF THE INVENTION 
The invention relates generally to fusion proteins that are useful as reporter proteins, in particular to fusion proteins &lt;RTI ID=0.0&gt;of ATP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; which are utilized to achieve an efficient conversion of pyrophosphate &lt;RTI ID=0.0&gt;(PPi)&lt;/RTI&gt; to light. This invention also relates to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; novel thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; which can be used in the detection of inorganic pyrophosphate, particularly in the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; of nucleic acid. </p><p> BACKGROUND OF THE INVENTION 
ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; has been identified as being involved in sulfur metabolism. It catalyzes the initial reaction in &lt;RTI ID=0.0&gt;the&lt;/RTI&gt; metabolism of inorganic sulfate &lt;RTI ID=0.0&gt;(So4~2)&lt;/RTI&gt; ; see e. g, <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Robbins &lt;RTI ID=0.0&gt;and Lipmann,&lt;/RTI&gt; 1958. J. Biol. Chem. 233 : 686-690</bibl> ; <bibl next="bibl80" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Hawes and Nicholas, 1973. Biochem. J.</bibl> </p><p><bibl xml:id="bibl80" xmlns="http://www.tei-c.org/ns/1.0">133 : 541-550</bibl>). In this reaction &lt;RTI ID=0.0&gt;So4~2&lt;/RTI&gt; is activated to adenosine &lt;RTI ID=0.0&gt;5'-phosphosulfate&lt;/RTI&gt; (APS). </p><p>ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is also commonly used in pyrophosphate &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; methods. In order to convert pyrophosphate &lt;RTI ID=0.0&gt;(PPi)&lt;/RTI&gt; generated from the addition &lt;RTI ID=0.0&gt;of dNMP&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; growing DNA chain to light, PPi must first be converted to ATP by ATP sulfurylase. </p><p> ATP produced by an ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; can also be &lt;RTI ID=0.0&gt;hydrolyzed&lt;/RTI&gt; using &lt;RTI ID=0.0&gt;enzymatic&lt;/RTI&gt; reactions to generate light. Light-emitting chemical reactions &lt;RTI ID=0.0&gt;(i. e.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;chemiluminescence)&lt;/RTI&gt; and biological reactions &lt;RTI ID=0.0&gt;(i.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.,&lt;/RTI&gt; bioluminescence) are widely used in analytical biochemistry for sensitive measurements of various &lt;RTI ID=0.0&gt;metabolites.&lt;/RTI&gt; In &lt;RTI ID=0.0&gt;bioluminescent&lt;/RTI&gt; reactions, the chemical reaction that leads to the emission of light is enzyme-catalyzed. For example, the &lt;RTI ID=0.0&gt;luciferin-&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; system allows for specific assay of &lt;RTI ID=0.0&gt;ATP.&lt;/RTI&gt; Thus, both ATP generating enzymes, such as ATP &lt;RTI ID=0.0&gt;sulfurylase,&lt;/RTI&gt; and light emitting enzymes, such as &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; could be useful in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; number of different assays for the detection &lt;RTI ID=0.0&gt;and/or&lt;/RTI&gt; concentration of specific substances in fluids and gases. Since high physical and chemical stability is sometimes required for enzymes involved in &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reactions, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable enzyme is desirable. </p><p> Because the product of the &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; reaction is consumed by &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; proximity between these two enzymes by &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linking the two enzymes in the form of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein would provide for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; more efficient use of the substrate. Substrate channeling is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 2&gt;</p><p> phenomenon in which substrates are efficiently delivered from enzyme to enzyme without equilibration with other pools of the same substrates. In effect, this creates local pools of &lt;RTI ID=0.0&gt;metabolites&lt;/RTI&gt; at high concentrations relative to those &lt;RTI ID=0.0&gt;found&lt;/RTI&gt; in other areas of the cell. </p><p>Therefore, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion &lt;RTI ID=0.0&gt;of an ATP&lt;/RTI&gt; generating polypeptide and an ATP converting peptide could benefit from the phenomenon of substrate channeling and would reduce production costs and increase the number of &lt;RTI ID=0.0&gt;enzymatic&lt;/RTI&gt; reactions that occur during &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; given time period. </p><p> All patents and publications cited throughout the specification are hereby incorporated by reference into this specification in their entirety in order to more fully describe the state of the art to which this invention pertains. </p><p> SUMMARY OF THE INVENTION 
The invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein comprising an ATP generating polypeptide bound to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide which converts ATP into an entity which is detectable. In one aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptide bound to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; polypeptide. This invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid that comprises an open reading frame that encodes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; novel thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptide. In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; further aspect, the invention provides for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; joined to at least one affinity tag. </p><p> In another aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; recombinant &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; that comprises &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein having &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;poylpeptide&lt;/RTI&gt; sequence joined to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; polypeptide sequence. In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; further aspect, the invention provides an expression vector for expressing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein. The expression vector comprises &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein having : &lt;RTI ID=0.0&gt;(i)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; regulator sequence, (ii) &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; first polypeptide sequence of an ATP generating polypeptide and &lt;RTI ID=0.0&gt;(iii)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second polypeptide sequence that converts ATP to an entity which is detectable. In an additional embodiment, the fusion protein comprises &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptide and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; polypeptide. In another aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; transformed host cell which comprises the expression &lt;RTI ID=0.0&gt;vector. In&lt;/RTI&gt; an additional aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein bound to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mobile support. The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; kit comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion protein expression vector. </p><p>&lt;Desc/Clms Page number 3&gt;</p><p> The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for determining the nucleic acid sequence in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template nucleic acid polymer, comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; introducing the template nucleic acid polymer into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerization environment in which the nucleic acid polymer will act as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template polymer &lt;RTI ID=0.0&gt;for&lt;/RTI&gt; the synthesis of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary nucleic acid polymer when nucleotides are added ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; successively providing to the polymerization environment &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; series of feedstocks, each &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; separately recovering each of the &lt;RTI ID=0.0&gt;feedstocks&lt;/RTI&gt; from the polymerization environment ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; measuring the amount &lt;RTI ID=0.0&gt;of PPi&lt;/RTI&gt; with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein in each of the recovered &lt;RTI ID=0.0&gt;feedstocks&lt;/RTI&gt; to determine the identity of each nucleotide in the complementary polymer and thus the sequence of the template polymer. In one embodiment, the amount of inorganic pyrophosphate is measured by the steps of : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; adding &lt;RTI ID=0.0&gt;adenosine-5'-phosphosulfate&lt;/RTI&gt; to the &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; combining the recovered &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; containing &lt;RTI ID=0.0&gt;adenosine-5'-phosphosulfate&lt;/RTI&gt; with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein such that any inorganic pyrophosphate in the recovered &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; and the adenosine-5'-phosphosulfate will react to the form ATP and sulfate ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; combining the ATP and sulfate-containing &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; with &lt;RTI ID=0.0&gt;luciferin&lt;/RTI&gt; in the presence of oxygen such that the ATP is consumed to produced AMP, inorganic pyrophosphate, carbon dioxide and light ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; measuring the amount of light produced. </p><p> In another aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method wherein each &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; comprises &lt;RTI ID=0.0&gt;adenosine-5'-phosphosulfate&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;luciferin&lt;/RTI&gt; in addition to the selected nucleotide base, and the amount of inorganic pyrophosphate is determined by reacting the inorganic pyrophosphate &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein thereby producing light in an amount proportional to the amount of inorganic pyrophosphate, and measuring the amount of light produced. </p><p> In another aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing one or more nucleic acid anchor primers ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the </p><p>&lt;Desc/Clms Page number 4&gt;</p><p> reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200, um&lt;/RTI&gt; ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; annealing an effective amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed anchor primer-circular template complex ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; combining the primed anchor primer-circular template complex with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase to form an extended anchor primer &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid complementary to the circular nucleic acid template &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; annealing an effective amount of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to one or more copies of said &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked complementary nucleic acid ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; extending the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product and, if the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3"end&lt;/RTI&gt; of said &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; ; and &lt;RTI ID=0.0&gt;(g)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with the use of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein, thereby determining the sequence of the nucleic acid. </p><p> In one aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing at least one nucleic acid anchor primer ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates in an array having at least 400, 000 discrete reaction sites ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; annealing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; first amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed anchor primer-circular template complex ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; combining the primed anchor primer-circular template complex with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase to form an extended anchor primer &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid complementary to the circular nucleic acid template ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; annealing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second amount of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to one or more copies of the &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked complementary nucleic acid ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; extending the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product and, when the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; of the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; ; and &lt;RTI ID=0.0&gt;(g)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with the use of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein, thereby determining the sequence of the nucleic acid at each reaction site that contains &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid template. </p><p> In another aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of determining the base sequence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of nucleotides on an array, the method comprising the steps of &lt;RTI ID=0.0&gt;: (a)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of sample DNAs, each disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;llm,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; adding an activated nucleotide 5'-triphosphate </p><p>&lt;Desc/Clms Page number 5&gt;</p><p> precursor of one known nitrogenous base to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; reaction mixture in each reaction chamber, each reaction mixture comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template-directed nucleotide polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single-stranded &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; template hybridized to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; primer strand at least one nucleotide residue shorter than the templates to form at least one unaired nucleotide residue in each template at the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unaired nucleotide residue of the templates ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; determining whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands through detection of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein, thus indicating that the unaired nucleotide residue of the template has &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; sequentially repeating steps &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(c),&lt;/RTI&gt; wherein each sequential repetition adds and, detects the incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition ; and &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; determining the base sequence of the unaired nucleotide residue of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors. </p><p> In one aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for determining the nucleic acid sequence in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template nucleic acid polymer, comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; introducing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of template nucleic acid polymers into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analytic&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200, um,&lt;/RTI&gt; each reaction chamber having &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerization environment in which the nucleic acid polymer will act as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template polymer for the synthesis of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary nucleic acid polymer when nucleotides are added ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; successively providing to the polymerization environment &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; series of &lt;RTI ID=0.0&gt;feedstocks,&lt;/RTI&gt; each &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; detecting the formation of inorganic pyrophosphate with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 6&gt;</p><p> converting polypeptide fusion protein to determine the identify of each nucleotide in the complementary polymer and thus the sequence of the template polymer. </p><p> In one aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of identifying the base in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; target position in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; DNA sequence of sample DNA including the steps comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; disposing sample DNA within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;u. m,&lt;/RTI&gt; said DNA being rendered single stranded either before or after being disposed in the reaction chambers, &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing an extension primer which hybridizes to said immobilized single-stranded DNA at &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; position immediately adjacent to said target position ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; subjecting said immobilized single-stranded DNA to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase reaction in the presence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate, wherein if the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3"end&lt;/RTI&gt; of said &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer then &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; is formed &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein, thereby determining the nucleotide complementary to the base at said target position. </p><p> The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of identifying &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; base at &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; target position in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sample DNA sequence comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing sample DNA disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;u. m,&lt;/RTI&gt; said DNA being rendered single stranded either before or after being disposed in the reaction chambers &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing an extension primer which hybridizes to the sample DNA immediately adjacent to the target position &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; subjecting the sample DNA sequence and the extension primer to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase reaction in the presence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide triphosphate whereby the nucleotide triphosphate will only become incorporated and release pyrophosphate &lt;RTI ID=0.0&gt;(PPi)&lt;/RTI&gt; if it is complementary to the base in the target position, said nucleotide triphosphate being added either to separate &lt;RTI ID=0.0&gt;aliquots&lt;/RTI&gt; of sample-primer mixture or successively to the same sample- primer mixture &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; detecting the release of &lt;RTI ID=0.0&gt;PPi&lt;/RTI&gt; with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein to indicate which nucleotide is incorporated. </p><p> In one aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of identifying &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; base at &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; target position in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single-stranded sample DNA sequence, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing an extension primer which hybridizes to sample DNA immediately adjacent to the target position, said sample DNA disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each </p><p>&lt;Desc/Clms Page number 7&gt;</p><p> cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;um,&lt;/RTI&gt; said DNA being rendered single stranded either before or after being disposed in the reaction chambers ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; subjecting the sample DNA and extension primer to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase reaction in the presence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined &lt;RTI ID=0.0&gt;deoxynucleotide&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;dideoxynucleotide&lt;/RTI&gt; whereby the &lt;RTI ID=0.0&gt;deoxynucleotide&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;dideoxynucleotide&lt;/RTI&gt; will only become incorporated and release pyrophosphate &lt;RTI ID=0.0&gt;(PPi)&lt;/RTI&gt; if it is complementary to the base in the target position, said predetermined &lt;RTI ID=0.0&gt;deoxynucleotides&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;dideoxynucleotides&lt;/RTI&gt; being added either to separate &lt;RTI ID=0.0&gt;aliquots&lt;/RTI&gt; of sample-primer mixture or successively to the same sample-primer mixture, &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; detecting any release of &lt;RTI ID=0.0&gt;PPi&lt;/RTI&gt; with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein to indicate which &lt;RTI ID=0.0&gt;deoxynucleotide&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;dideoxynucleotide&lt;/RTI&gt; is incorporated ; characterized in that, the &lt;RTI ID=0.0&gt;PPi-detection&lt;/RTI&gt; enzyme &lt;RTI ID=0.0&gt;(s)&lt;/RTI&gt; are included in the polymerase reaction step and in that in place &lt;RTI ID=0.0&gt;of deoxy-or&lt;/RTI&gt; &lt;RTI ID=0.0&gt;dideoxy&lt;/RTI&gt; adenosine triphosphate &lt;RTI ID=0.0&gt;(ATP)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; dATP or &lt;RTI ID=0.0&gt;ddATP&lt;/RTI&gt; analogue is used which is capable of acting as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; substrate for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase but incapable of acting as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; substrate for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; said PPi-detection enzyme. </p><p> In another aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of determining the base sequence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of nucleotides on an array, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of sample DNAs, each disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200, um,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; converting &lt;RTI ID=0.0&gt;PPi&lt;/RTI&gt; into light with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; detecting the light level emitted from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of reaction sites on respective portions of an &lt;RTI ID=0.0&gt;optically&lt;/RTI&gt; sensitive device &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; converting the light impinging upon each of said portions of said &lt;RTI ID=0.0&gt;optically&lt;/RTI&gt; sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; determining &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; light intensity for each of said discrete regions from the corresponding electrical signal ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; recording the variations of said electrical signals with time. </p><p> In one aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing one or more nucleic acid anchor primers ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;llm&lt;/RTI&gt; ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; converting &lt;RTI ID=0.0&gt;PPi&lt;/RTI&gt; into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; detectable entity with the use of an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting </p><p>&lt;Desc/Clms Page number 8&gt;</p><p> polypeptide fusion protein &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; detecting the light level emitted from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of reaction sites on respective portions of an &lt;RTI ID=0.0&gt;optically&lt;/RTI&gt; sensitive device ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; converting the light impinging upon each of said portions of said &lt;RTI ID=0.0&gt;optically&lt;/RTI&gt; sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; determining &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; light intensity for each of said discrete regions from the corresponding electrical signal ; (g) recording the variations of said electrical signals with time. </p><p> In another aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing at least one nucleic acid anchor primer ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates in an array having at least 400, 000 discrete reaction sites &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; converting &lt;RTI ID=0.0&gt;PPi&lt;/RTI&gt; into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; detectable entity with an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; detecting the light level emitted from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of reaction sites on respective portions of an &lt;RTI ID=0.0&gt;optically&lt;/RTI&gt; sensitive device &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; converting the light impinging upon each of said portions of said &lt;RTI ID=0.0&gt;optically&lt;/RTI&gt; sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; determining &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; light intensity for each of said discrete regions from the corresponding electrical signal ; (g) recording the variations of said electrical signals with time. </p><p> &lt;RTI ID=0.0&gt;In&lt;/RTI&gt; another aspect, the invention includes an isolated polypeptide comprising an amino acid sequence selected from the group consisting of : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature form of an amino acid sequence of SEQ ID NO : 2 ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; variant of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature form of an amino acid sequence of SEQ ID NO : 2 ; an amino acid sequence of SEQ ID NO : 2 ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; variant of an amino acid sequence of SEQ ID NO : &lt;RTI ID=0.0&gt;2,&lt;/RTI&gt; wherein one or more amino acid residue in said variant differs from the amino acid sequence of said mature form, provided that said variant differs in no more than &lt;RTI ID=0.0&gt;5%&lt;/RTI&gt; of amino acid residue from said amino acid sequence ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; and at least one conservative amino acid substitution to the amino acid sequences in &lt;RTI ID=0.0&gt;(a),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;(d).&lt;/RTI&gt; The invention also includes an antibody that binds &lt;RTI ID=0.0&gt;immunospecifically&lt;/RTI&gt; to the polypeptide of &lt;RTI ID=0.0&gt;(a),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;(d).&lt;/RTI&gt; </p><p> &lt;RTI ID=0.0&gt;In&lt;/RTI&gt; another aspect, the invention includes an isolated nucleic acid molecule comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid sequence encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide comprising an amino acid sequence selected from the group consisting of &lt;RTI ID=0.0&gt;: (a)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature form of an amino acid sequence of SEQ ID NO : 2 ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; variant of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature form of an amino acid sequence of SEQ &lt;RTI ID=0.0&gt;ID&lt;/RTI&gt; NO : 2, wherein one or more amino acid residue in said variant differs from the amino acid sequence of said mature form, provided that said variant differs in no more than &lt;RTI ID=0.0&gt;5%&lt;/RTI&gt; of the amino acid residue from </p><p>&lt;Desc/Clms Page number 9&gt;</p><p> the amino acid sequence of said mature &lt;RTI ID=0.0&gt;form ;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; an &lt;RTI ID=0.0&gt;amino&lt;/RTI&gt; acid sequence &lt;RTI ID=0.0&gt;of SEQ&lt;/RTI&gt; ID NO : 2 ; (d) &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; variant of an amino acid sequence of SEQ ID NO : 2, wherein one or more amino acid residue in said variant differs from the amino acid sequence of said mature &lt;RTI ID=0.0&gt;form,&lt;/RTI&gt; provided that said variant differs in no more than 15% of amino acid residue from said amino acid sequence ; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid fragment encoding at least &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; portion &lt;RTI ID=0.0&gt;of a polypeptide&lt;/RTI&gt; comprising an amino acid sequence of SEQ ID NO : &lt;RTI ID=0.0&gt;2,&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; variant of said polypeptide, wherein one or more amino acid residue in said variant differs from the amino acid sequence of said mature form, provided that said variant differs in no more than &lt;RTI ID=0.0&gt;5%&lt;/RTI&gt; of amino acid residue from said amino acid sequence ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid molecule comprising the complement of &lt;RTI ID=0.0&gt;(a),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;(e).&lt;/RTI&gt; In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; further aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid molecule wherein the nucleic acid molecule comprises nucleotide sequence selected from the group consisting of : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; first nucleotide sequence comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence differing by one or more nucleotide sequences from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence encoding said amino acid sequence, provided that no more than 20% of the nucleotides in the coding sequence in said first nucleotide sequence differ from said coding sequence ; an isolated second &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; that is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complement of the first &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid fragment of &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;(b).&lt;/RTI&gt; The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; vector comprising the nucleic acid molecule of &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;(b).&lt;/RTI&gt; In another aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; cell comprising the vector. </p><p> In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; further aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for determining the nucleic acid sequence in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template nucleic acid polymer, comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; introducing the template nucleic acid polymer into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerization environment in which the nucleic acid polymer will act as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template polymer for the synthesis of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary nucleic acid polymer when nucleotides are added ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; successively providing to the polymerization environment &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; series of &lt;RTI ID=0.0&gt;feedstocks,&lt;/RTI&gt; each &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; separately recovering each of the feedstocks from the polymerization environment ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; measuring the amount &lt;RTI ID=0.0&gt;of PPi&lt;/RTI&gt; with an ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; in each of the recovered &lt;RTI ID=0.0&gt;feedstocks&lt;/RTI&gt; to determine the identity of each nucleotide in the complementary polymer and thus the sequence of the template polymer. </p><p>&lt;Desc/Clms Page number 10&gt;</p><p> In another aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing one or more nucleic acid anchor primers ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities in an array on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;llm&lt;/RTI&gt; and at least 400, 000 discrete sites ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; annealing an effective amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed anchor primer-circular template complex ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; combining the primed anchor primer-circular template complex with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase to form an extended anchor primer &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid complementary to the circular nucleic acid template ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; annealing an effective amount of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to one or more copies of said &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked complementary nucleic acid ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; extending the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product and, if the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; of said &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; ; and &lt;RTI ID=0.0&gt;(g)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with the use &lt;RTI ID=0.0&gt;of an ATP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; thereby determining the sequence of the nucleic acid. </p><p> In another aspect, the invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing at least one nucleic acid anchor primer &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates in an array having at least 400, 000 discrete reaction sites ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; annealing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; first amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed anchor primer-circular template complex &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; combining the primed anchor primer-circular template complex with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase to form an extended anchor primer &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid complementary to the circular nucleic acid template ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; annealing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second amount of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to one or more copies of the &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked complementary nucleic acid ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; extending the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product and, when the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; of the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(g)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with the use of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; thereby determining the sequence of the nucleic acid at each reaction site that contains &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid template. </p><p>&lt;Desc/Clms Page number 11&gt;</p><p> In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; further aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of determining the base sequence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of nucleotides on an array, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of sample DNAs, each disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;p, m,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; adding an activated nucleotide 5'-triphosphate precursor of one known nitrogenous base to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; reaction mixture in each reaction chamber, each reaction mixture comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template-directed nucleotide polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single-stranded &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; template hybridized to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; primer strand at least one nucleotide residue shorter than the templates to form at least one unaired nucleotide residue in each template at the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unaired nucleotide residue of the templates ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; detecting whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands through detection of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; thus indicating that the unaired nucleotide residue of the template has &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; sequentially repeating steps &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(c),&lt;/RTI&gt; wherein each sequential repetition adds and, detects the incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; determining the base sequence of the unaired nucleotide residue of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors. </p><p> BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is one embodiment for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; cloning strategy for obtaining the &lt;RTI ID=0.0&gt;luciferase-sulfurylase&lt;/RTI&gt; sequence. </p><p>FIG. 2A and &lt;RTI ID=0.0&gt;2B&lt;/RTI&gt; show the &lt;RTI ID=0.0&gt;preparative&lt;/RTI&gt; &lt;RTI ID=0.0&gt;agarose&lt;/RTI&gt; gel of &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; as well as &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion genes. </p><p>FIG. 3 shows the results of experiments to determine the activity of the &lt;RTI ID=0.0&gt;luciferase-sulfurylase&lt;/RTI&gt; fusion protein on &lt;RTI ID=0.0&gt;NTA-agarose&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;MPG-SA&lt;/RTI&gt; solid supports. </p><p>&lt;Desc/Clms Page number 12&gt;</p><p> DETAILED DESCRIPTION OF THE INVENTION 
This invention provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein containing an ATP generating polypeptide bound to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide which converts ATP into an entity which is detectable. As used herein, the &lt;RTI ID=0.0&gt;term"fusion&lt;/RTI&gt; &lt;RTI ID=0.0&gt;protein"refers&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;chimeric&lt;/RTI&gt; protein containing an exogenous protein fragment joined to another exogenous protein fragment. The fusion protein could include an affinity tag to allow attachment of the protein to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid support or to allow for purification of the recombinant fusion protein from the host cell or culture &lt;RTI ID=0.0&gt;supernatant,&lt;/RTI&gt; or both. </p><p> In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the ATP generating polypeptide and ATP converting polypeptide are from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;eukaryote&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;prokaryote.&lt;/RTI&gt; The &lt;RTI ID=0.0&gt;eukaryote&lt;/RTI&gt; could be an animal, plant, fungus or yeast. In some embodiments, the animal is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mammal, rodent, insect, worm, mollusk, reptile, bird and amphibian. Plant sources of the polypeptides include but are not limited to Arabidopsis thaiana, Brassica napus, Allium sativum, Amaranthus caudatus, Hevea brasiliensis, Hordeum vulgare, Lycopersicon esculentum, Nicotiana tabacum, Oryza sativum, Pisum sativum, Populus trichocarpa, Solanum tuberosum, Secale cereale, Sambucus nigra, Ulmus americana or Triticum aestivum. Examples of fungi include but are not limited to Penicillum chrysogenum, Stachybotrys chartarum, Aspergillus fumigatus, Podospora &lt;RTI ID=0.0&gt;anserina&lt;/RTI&gt; and Trichoderma reesei. Examples of sources of yeast include but are not limited to Saccharomyces cerevisiae, Candida tropicalis, Candida lypolitica, Candida utilis, Kluyveromyces lactis, Schizosaccharomyces pombe, Yarrowia lipolytica, Candida spp., Pichia spp. and Hansenula spp.. </p><p> The &lt;RTI ID=0.0&gt;prokaryote&lt;/RTI&gt; source could be bacteria or &lt;RTI ID=0.0&gt;archaea.&lt;/RTI&gt; In some embodiments, the bacteria is E. coli, B. subtilis, Streptococcus gordonii, &lt;RTI ID=0.0&gt;flavobacteria&lt;/RTI&gt; or green sulfur bacteria. </p><p>In other embodiments, the &lt;RTI ID=0.0&gt;archaea&lt;/RTI&gt; is Sulfolobus, Thermococcus, Methanobacterium, Halococcus, Halobacterium or Methanococcus jannaschii. </p><p> The ATP generating polypeptide can be &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; ATP &lt;RTI ID=0.0&gt;sulfurylase,&lt;/RTI&gt; hydrolase or an ATP &lt;RTI ID=0.0&gt;synthase.&lt;/RTI&gt; In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the ATP generating polypeptide is ATP &lt;RTI ID=0.0&gt;sulfurylase.&lt;/RTI&gt; In one embodiment, the ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; cloned from &lt;RTI ID=0.0&gt;Bacillus&lt;/RTI&gt; stearothermophilus &lt;RTI ID=0.0&gt;(Bst)&lt;/RTI&gt; and comprising the nucleotide sequence of SEQ ID NO : 1. This putative gene was cloned using genomic DNA acquired from ATCC &lt;RTI ID=0.0&gt;(Cat.&lt;/RTI&gt; No. 12980D). The gene is shown to code for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; functional ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; that can be expressed as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion </p><p>&lt;Desc/Clms Page number 13&gt;</p><p> protein with an affinity tag. The disclosed &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleic acid &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;1)&lt;/RTI&gt; includes the 1247 nucleotide sequence. An open reading frame &lt;RTI ID=0.0&gt;(ORF)&lt;/RTI&gt; for the mature protein was identified beginning with an ATG codon at nucleotides &lt;RTI ID=0.0&gt;1-3&lt;/RTI&gt; and ending with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; TAA codon at nucleotides &lt;RTI ID=0.0&gt;1159-1161.&lt;/RTI&gt; The start and stop codons of the open reading frame are highlighted in bold type. The putative untranslated regions are underlined and found upstream of the initiation codon and downstream from the termination codon. </p><p>&lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; Thermostable &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; Nucleotide Sequence &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;1)&lt;/RTI&gt; 
EMI13.1
 
The &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptide &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;2)&lt;/RTI&gt; is &lt;RTI ID=0.0&gt;386&lt;/RTI&gt; &lt;RTI ID=0.0&gt;amino&lt;/RTI&gt; acid residue in length and is presented using the three letter amino acid code. </p><p>&lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; Amino Acid Sequence &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;2)&lt;/RTI&gt; Met Ser Leu Ser &lt;RTI ID=0.0&gt;Ile&lt;/RTI&gt; Pro His &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Leu Ile Asn Arg &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Asn 
5 &lt;RTI ID=0.0&gt;10&lt;/RTI&gt; &lt;RTI ID=0.0&gt;15&lt;/RTI&gt; Pro Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Pro Ile Asp Glu Ala Thr Lys Thr Ile Glu Leu Ser Lys &lt;RTI ID=0.0&gt; 20 25 30&lt;/RTI&gt; Ala Glu Leu Ser Asp Leu Glu Leu Ile &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ala &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ser Pro &lt;RTI ID=0.0&gt; 35 40 45&lt;/RTI&gt; Leu Thr Gly Phe Leu Thr Lys Ala Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp Ala Val Val Glu &lt;RTI ID=0.0&gt;Thr&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 14&gt;</p><p> &lt;RTI ID=0.0&gt; 50 55 60&lt;/RTI&gt; Met Arg Leu Ala Asp &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Val &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Ser &lt;RTI ID=0.0&gt;Ile&lt;/RTI&gt; Pro Ile Thr Leu Ala &lt;RTI ID=0.0&gt; 65 70 75&lt;/RTI&gt; Val Thr Glu Glu Lys Ala Ser Glu Leu Thr Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Lys Ala Lys &lt;RTI ID=0.0&gt;80 85 90 95&lt;/RTI&gt; Leu Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Ile Glu Ile Ala Asp Ile &lt;RTI ID=0.0&gt; 100 105 110&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Arg Pro Asp Lys Thr Lys Glu Ala Lys Leu Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Lys Thr Asp &lt;RTI ID=0.0&gt; 115 120 125&lt;/RTI&gt; Glu Leu Ala His Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Arg Lys Leu Phe Glu Lys Pro Asp Val &lt;RTI ID=0.0&gt; 130 135 140&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ala Val Thr Leu Val Lys Arg Thr Asp Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Gin &lt;RTI ID=0.0&gt; 145 150 155&lt;/RTI&gt; Phe Ala Pro Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Phe Asp Pro Ala Glu Thr Arg Lys Arg Phe Ala &lt;RTI ID=0.0&gt;160 165 170 175&lt;/RTI&gt; Glu Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Asn Thr Val Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe Gin Thr Arg Asn Pro Val &lt;RTI ID=0.0&gt; 180 185 190&lt;/RTI&gt; His Arg Ala His Glu &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ile Gln Lys &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Ala Leu Glu Ile Val Asp &lt;RTI ID=0.0&gt; 195 200 205&lt;/RTI&gt; Gly Leu Phe Leu Asn Pro Leu Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Glu Thr Lys Ala Asp Asp Ile &lt;RTI ID=0.0&gt; 210 215 220&lt;/RTI&gt; Pro Ala Asp Ile Arg Met Glu Ser &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Gin Val Leu Leu Glu Asn &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 225 230 235&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Pro Lys Asp Arg Val Phe Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Phe Gin Ala Ala Met Arg &lt;RTI ID=0.0&gt; 240 245 250 255&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ala Gly Pro Arg Glu Ala Ile Phe His Ala Met Val Arg Lys Asn &lt;RTI ID=0.0&gt; 260 265 270&lt;/RTI&gt; Phe &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Thr&lt;/RTI&gt; His &lt;RTI ID=0.0&gt;Phe&lt;/RTI&gt; He Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Arg Asp His Ala &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 275 280 285&lt;/RTI&gt; Asn &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp Ala Gin Lys Ile Phe Ser Asn Phe Thr &lt;RTI ID=0.0&gt; 290 295 300&lt;/RTI&gt; Ala Glu Glu Leu Gly Ile Thr Pro Leu Phe Phe Glu His Ser Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 305 310 315&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 15&gt;</p><p> &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Thr Lys &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Glu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Met Ala Ser Thr Lys &lt;RTI ID=0.0&gt;Thr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Pro His Asp &lt;RTI ID=0.0&gt;320 325 330 335&lt;/RTI&gt; Ala Gin &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; His Val Val Leu Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Lys Val Arg Glu Met Leu &lt;RTI ID=0.0&gt; 340 345 350&lt;/RTI&gt; Arg Asn Gly Gin Val Pro Pro Ser Thr Phe Ser Arg Pro Glu Val Ala &lt;RTI ID=0.0&gt; 355 360 365&lt;/RTI&gt; Ala Val Leu &lt;RTI ID=0.0&gt;Ile&lt;/RTI&gt; Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Gin Glu Arg Glu Thr Val Thr Pro Ser &lt;RTI ID=0.0&gt; 370 375 380&lt;/RTI&gt; Thr Arg &lt;RTI ID=0.0&gt; 385&lt;/RTI&gt; 
In one embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is active at temperatures above ambient to at least &lt;RTI ID=0.0&gt;50 C.&lt;/RTI&gt; This property is beneficial so that the &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; will not be denatured at higher temperatures commonly utilized in polymerase chain reaction &lt;RTI ID=0.0&gt;(PCR)&lt;/RTI&gt; reactions or &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reactions. In one embodiment, the ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermophile. The thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; can come from &lt;RTI ID=0.0&gt;thermophilic&lt;/RTI&gt; bacteria, including but not limited &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; Bacillus stearothermophilus, Thermus thermophilus, Bacillus caldolyticus, Bacillus subtilis, Bacillus thermoleovorans, Pyrococcus furiosus, Sulfolobus acidocaldarius, Rhodothermus obamensis, Aquifex aeolicus, Archaeoglobs fulgidus, Aeropyrum pernix, Pyrobaculum aerophilum, Pyrococcus abyssi, Penicillium chrysogenum, Sulfolobus solfataricus and Thermomonospora fusca. </p><p> The homology of twelve ATP &lt;RTI ID=0.0&gt;sulfurylases&lt;/RTI&gt; can be shown graphically in the &lt;RTI ID=0.0&gt;ClustalW&lt;/RTI&gt; analysis in Tablet. The alignment is of ATP &lt;RTI ID=0.0&gt;sulfurylases&lt;/RTI&gt; from the following species : Bacillus stearothermophilus &lt;RTI ID=0.0&gt;(Bst),&lt;/RTI&gt; University of Oklahoma-Strain &lt;RTI ID=0.0&gt;10&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(Univ&lt;/RTI&gt; of &lt;RTI ID=0.0&gt;OK),&lt;/RTI&gt; Aquifex &lt;RTI ID=0.0&gt;aeolicus&lt;/RTI&gt; (Aae), Pyrococcus furiosus (Pfu), SUlfolobus solfataricus &lt;RTI ID=0.0&gt;(Sso),&lt;/RTI&gt; Pyrobaculum aerophilum (Pae), Archaeoglobus fulgidus (Afu), Penicillium chrysogenum (Pch), Aeropyrum &lt;RTI ID=0.0&gt;pernix&lt;/RTI&gt; (Ape), Saccharomyces cerevisiae (Sce), and Thermomonospora fusca (Tfu). </p><p>&lt;Desc/Clms Page number 16&gt;</p><p>Table &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; : ClustalW Analysis &lt;RTI ID=0.0&gt;of ATP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; Amino Acid Sequence 
EMI16.1
 
10 20 30 40 50 Bst-Sulf-----MSLSI a TltNRWNPDYP-----IDEATK---------TIESS 31 Univ of OK-----MSVSI-TINEWNPDYP-----LDEATK---------TIEXS 31 Aae-Sulf--------------MEKIKYLKS-----IQS 13 Pfu-Sulf------MVSE EtIRRIAAPRTgERILSEQHEYP--------RVQID 36 Sso-Sulf------MNLIG---KVEIVERIKTISDFKELHRIEVK----------30 Pae-Sulf--MPMPAPZE'YNIEDRDAAAMIQGLPSIEIEPTLGPDGSPI 48 Afu-Sulf--MPLIKTPP-E VERVVKKRDIAEKMIAGCPTYELKPTTLPDGTPI 48 Pch-Sulf-----MAN-KDLARDAPRQAEZAAEAES--LP-----AVTT 37 Ape-Sulf MGCSVGZVS'RRULSGRRREIFESQYREMP--------RLEP 42 Sce-Sulf-----MP--A = I QDLXARDALSKNELLSEAQSSDIL-----VWNT 38 Tfu-Sulf----------------MSQVSDAVGR----YQLSQLDF----------LE 20 
60 70 80 90 100 Bst-Sulf KAELS LgL GA At T&amp;commat;¦hTX YDS VÉT&amp;commat;MN0iTN S 33T Au 81 Univ of OK KAELS T. L GT X'T TTICT YD 'iT'W T. S T 81 Aae-Sulf QRSVLLKLA  FT'D GEYRN S'KS TT : iFP'T PM 63 Pfu-Sulf HGRAILN H ; X'TrTRE FES LDY'SDTP T' : 86 Sso-Sulf RQLAHSVS Y FL'NYEVDG N'P7 TaBP LtVFY 80 Pae-Sulf RNPYRETNlS Y E"E''E TRNVSTKE L1 PF LIYn 98 Afu-Sulf RHVYRTMSVCY FE'E SMV3NLE TFNE'LSEWTFPY'LF T 98 Pch-Sulf ERQLCLEZNIN GE''E N YD CDN' VSM'T n 87 Ape-Sulf LERAI DTsA F''E VED W.'LS I. S NDLP T'92 Sce-Sulf PRQLC IRLILN G, F = T = SNgN YSc VTDS TLXTI gTI ¦ 88 Tfu-Sulf AEAIFIgREMAAEFERIVLLNSGGE-S--VVMLgIREKAFP. EPFPy 6 7 
110 120 130 140 150 Bst-Sulf TE KAS--ELTV E KAE V-YGGDVY--GgtEtAD g P-S TKE&amp;commat;Ev Y 125 Univ of OK TEaKAK--EltAV ! gKAKjV-YRGDVY--GVJ : EIADs ! RP-TKEaKLNY 125 Aae-Sulf E IAK--DDtiEiEWtV R--DPKNV LPIMRVEEV SW-MLEYEEKN L 108 Pfu-Sulf G-----EPTFEG !'Al ! LJY---YENPalHVEDn ! TY-'SKEFaV 127 Sso-Sulf SuN--EK--tE&amp;commat;¦3TI G T---YLG LUIMIKVEi E KLY-Z9LKI Ë Y 12 2 Pae-Sulf D--KIKGS El33SUL K---LKG LIVLiNEVEE RiLPlF KEL D F 143 Afu-Sulf SEaDYKALDEiEjRItL M--LKGQgFaTltDJEEV'KI-'PVDVaTST 144 Pch-Sulf S VIDEKKL&amp;commat;ASRIT RDFRDDRN LIILTEDD RP-=TKE 9Eu E7 135 Ape-Sulf NRNVLNEGSAggDII T--YHGLiaVETLEDEsw-jSGLHaE'KNF 138 Sce-Sulf DEAFAN-QKPDTRTA-FQDDElSiaiLTivQDvJKP-NSTIEaEKNF 133 Tfu-Sulf MH-------DTEHNFPEV-IEFRDKRgEGRLEvASVQDLIDgGK 109 
160 170 180 190 200 Bst-Sulf] D-----------tLS 3RKLF-EKPDVYG AVTtRTDKG-QtA 162 Univ of OK K ! D--------EIjA agVRKLE-EKPDVYVGeElTLVKRTDKG-QEA 162 Aae-Sulf G ! T------'PR aVAEMH-TWGYYSISeEpRVIQLPKYY-DFP 145 Pfu-Sulf K ! D-------'PN'EARVY-SMGKYL'V'GeGI'ELLNELPN-PiFA163 Sso-Sulf-K---------I'KRTL-SYADAF, D ; VW, LVREPQFNKPXS 160 Pae-Sulf GPERNKEWKKRFE LIYR-SMRPMAI ITTNPPRFKEP''S 192 Afu-Sulf G PEKNPEWREPFD YVIYK-MHNPII 'KYT, VNEPKFKEPxD 193 Pch-Sulf GG-------'PE IYLNNTVK&amp;commat;FYI. GeKIiEAVNK] jNHY-D'YV 172 Ape-Sulf KSR--------'PN V'EATS-KRGDiLLGtRLEMQGPPN-PLE 174 Sce-Sulf RG------------PE &gt; SYLFNVAGpYYV ; G SLEÀQLPQHY-D9P 170 Tfu-Sulf EP------------------KGR-WASRNRLQTAALLEAI2KYGFDAARiG 140 
210 220 230 240 250 </p><p>&lt;Desc/Clms Page number 17&gt;</p><p> 
EMI17.1
 Bst-Sulf PFYFD''T'K-EL NT G NP YQ CEIVD--209 Univ of OK AFYFD T'KIA-F NT G NPV YQ CiLEIVD--209 Aae-Sulf EXRKT BQV EEIS-SL r D NPi RV EgJTgRaMEKVGeG-193 Pfu-Sulf KYTZ T'IZK- KTT''IIVP LG YQ TFVD--210 Sso-Sulf EFWLT RMH TV t-RKMKRS SiRVP TGllY M FAWFAAN NQ 209 Pae-Sulf RFWMP RVS EYVS-hK = RI = NVP IG FVAGO--239 Afu-Sulf R'WFP'SKC'EVIKNEK RT T'H'NUP G MC YTG-D--240 Pch-Sulf ALRYT'L'H D-L S PM RE TV RSRQAN-220 Ape-Sulf RYTL V0 V-gK g RT-ENVP LG B Y QS LTFVD3--221 Sce-Sulf GLRK AQL L Q-SR Q DR-&amp;commat;NPM R ç EITVF  REANAK-218 Tfu-Sulf GARRD EKS AK R----~~~ H B EF QWDPKNQRP LWNLYN--179 
260 270 280 290 300 Bst-Sulf--------FLN'L ET D. IPAI) IRMES. Q LN-YPKDRVFGV 250 Bst-Sulf--------iI ; F ; LiN L E ADsIPAD, IRMES QR LEN-YPKDRVF GV 250 Univ of OK----FLNSLVeETSSD IPAIRMEScQV LEN-MYPKDRVFJGV 250 Aae-Sulf----- [LgLEaVVeLTSP VDVYTRMRIEKV YEK-MYDKKKTISAF 234 Pfu-Sulf--------TiFIN'Z R YKDVI Y-IMK-CSN-------243 Sso-Sulf KVDEPRTG VN VI E : VSYIDEAIBLT DS SKYG ISPKVHLiSF 259 Pae-Sulf--ERPGDA ViNAI AKAPSYVDgAIkEGWE, N% G FH PDRHVMTM 287 Afu-Sulf-IEPCHGJ ; ! VNAII AtR'YPDIEGpEAMYGmKPERHMTF 288 Pch-Sulf-------T LT P IDHFTR' Q L, PR- PNG-MA GL 260 Ape-Sulf--------! xL W ? iYRDgVItiR t STH-YPRGVV'SV 262 Sce-Sulf-------. TLT P IDHHTRU, R QETTIR-PNG-IAF SL 258 Tfu-Sulf---------TR------VH ENIRVFPSNGITEDVWH IRRE------208 
310 320 330 340 350 .... </p><p>Bst-Sulf FQ'Y.. T : F . 'INF C ET'. G. --N--GT 294 Univ of OK FQ Y' F , V'FNF C EU' GV---N---GT 294 Aae-Sulf ZPLA'MA~'LW G T RNY FIV' SPKDSKGKP"DP 284 Pfu-Sulf------------TTH TSTSQT----------------------259 , Sso-Sulf TLWD Y 'TsL T'SNL C H'TF' G-----N SP 303 Pae-Sulf TLWD'YGN L STiL G T QNM HMF T------D DP 331 Afu-Sulf TLWD¦YGN IStL GtI tN : CHMiFR'------EmDI 332 Pch-Sulf LGLAsMG sÍ,) sI KjN AZF ; ; V=GP SNSKGEDsGP 310 Ape-Sulf LRMN NY"U : H 'KNF E''GV------S GP 306 Sce-Sulf LPLAuMS I KN AsFjI=GP KNSKGVDjGP 308 Tù-Sulf---G'LP--STYFHRRUFERDGIZIaP---DS--------P TRD 240 
360 370 380 390 400 Bst-Sulf bKIB'SNFT-------AEEMGaTPSFFEHSFBCTKCEGMASTK-331 Bst-Sulf iDsiKÍFSNFT------------AEESG TPjLFFEHSF CTKCEGMASTK-331 Univ of OK BKIBJLNFT-------AEESGNTp ! dFFEHSFMCTKCEGMASTK- 331 Aae-Sulf ! EEsLiEiKKY-------EDEI'GaKMPFEELvEvPELDQYVEIN- 320 Pfu Sulf 259 Sso-Sulf EEHEISDS--------INEED-L KPmFLRENYBCPRCGSIENE-339 Pae-Sulf ATYHTRGLPSYGLNEPPHMTDKG R KPMLGEFAHCPKCGEYTYLGM 381 Afu-Sulf AT ITSQGIPSFGFEAPPNEVDYG IPQNMAEFW CPICQEIAYS--380 Pch-Sulf D H VEKY-------------KDEZGNEVVEFQMVTILPDTDEYRPVD-346 Ape-Sulf EEIE'REF---------PD G TPFVREAYMCRRCGGMVNEK-341 Sce-Sulf DggEI &lt; VESY--------KHE D EVMPFRMVTSLPDEDRYAPID-344 Tfu-Sulf EDEEVEEAS---------------------tRYRTVGDMTCTGAVLST--267 
410 420 430 440 450 Bst-Sulf-----TCPHDAQYHVVHtw3E-MERNeQVP3STFSAAm 372 Univ of OK----TCPHDAKYHVVaE-MI, RNeQVPaSTFSAAJVBI 372 Univ of OK--------TCPHDAKYHVVL is E-MLRNIQVPISTFS-I 372 Aae-Sulf--------EAKKRNLKYINI EENF. iKQ RKL EWFT''E'TTA 362 Pfu Sulf 259 Sso-Sulf--------ILCDHKDEKQEF SL' S ITLDEVKPTKMVM'YDVIaM 380 Pae-Sulf SYEGYKEVALCGHT--PERS E SLLIG-IXIEILRPS &lt; YD H V 428 </p><p>&lt;Desc/Clms Page number 18&gt;</p><p> 
EMI18.1
 Afu-Sulf--------ENCGHTDAKQKF ESF ; G-MVA VFP R W M YKQIV 421 v Pch-Sulf--------QVPAG-VKTLNS D ES R-R*LR AHI EWFS 3 VKSBR 386 Ape-Sulf--------VCPHGDEYRVR RL'E-MG ERP'EYM'DA", I 382 Sce-Sulf--------QIDTTKTRTZNT E R-RLR GEIEWFSY'R 385 Tfu-Sulf--------AT-TLDEVIAEI RTE---RGQTRADDRGSEAAEERKR 305 
460 470 480 490 500 Bst-Sulf EGLQER-----------------ETMT----------------PSTR---386 Univ of OK KGLQER-----------------ETMA----------------PSAR---386 Aae-Sulf STYVPKHKQGFCVWLTGLPCAGKSTtA-EILATMLQARGRKVTLLDGDVV 411 Pfu Sulf 259 Sso-Sulf WRAEQYGFGS--------PFVTEEYkE--------------KRQSILG--406 Pae-Sulf iWRVYGY-----PYVTDKYR--------IKEQELEVE 454 Afu-Sulf SWWKVYNY----------PFVNRKYSE--------------LKNKELEID 447 Pch-Sulf ESNPPRATQGFTIFLTGYMNSGKDAIARALQVTLNQQGGRSVSLLLGDTV 436 Ape-Sulf SHPDPFI----------------------389 Sce-Sulf ESNPPRPKQGFSIVLGNSLTVSREQSSIALLSTFLQFGGGRYYKIFEHNN 435 Tfu-Sulf EGYF-------------------------------309 
510 520 530 540 550 .... </p><p>Bst-Sul ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 Univ of OK---------------------------386 Aae-Sulf RTHLSRGLGFSKEDRITNILRVGFVASEIVKHNGVVICALVSPYRSARN-460 Pfu Sulf 259 Sso Sulf 406 Pae-Sulf L-----------------------------455 Afu-Sulf LPAMEVPKA-----------------------456 Pch-Sulf RHELSSELGFTREDRHTNIQRIAFVATELTRAGAAVIAAPIAPYEESRKF 486 Ape-Sulf-----------------------------389 Sce-Sulf KTELLSLI------------------QDFIGSGSGLIIP--NQWEDD---462 Tfu-Sulf---------------------------309 
560 570 580 590 600 Bst-Sulf--------------------------------386 Univ of OK--------------------------386 Aae-Sulf QVRNMMEEGKFIEVFVDAPVEVCEERDVKGLYKKAKEGLIKGFTGVDDPY 510 Pfu Sulf 259 Sso Sulf 406 Pae-Sulf-----------------------------455 Afu-Sulf------------------------------456 Pch-Sulf ARDAVSQAGSFFLVHVATPLEHCEQSDKRGIYAAARRGEIKGFTGVDDPY 536 Ape-Sulf-----------------------------389 Sce-Sulf-KDSWGKQNVYLLDTSS--------------------------------479 Tfu-Sulf----------------------------309 
610 620 630 Bst-Sulf----------------------386 (SEQ ID NO : 2) Univ of OK-------------------------------------386 (SEQ ID NO : 22) Aae-Sulf EPPVAPEVRVDTTKLTPEESALKILEFLKKEGFIKD-546 (SEQ ID NO : 23) Pfu-Sulf-------------------------------------259 (SEQ ID NO : 24) Sso-Sulf-------------------------------------406 (SEQ ID NO : 25) Pae-Sulf-------------------------------------455 (SEQ ID NO : 26) Afu-Sulf-------------------------------------456 (SEQ ID NO : 27) Pch-Sulf ETPEKADL W DFSKQSVRSIVHEIILVLESQGFLERQ 573 (SEQ ID NO : 28) Ape-Sulf---------------------389 (SEQ ID NO : 29) Sce-Sulf----SADIQLESADEPISHIVQKVVLFLEDNGFFVF-511 (SEQ ID NO : 30) Tfu-Sulf-------------------------------------309 (SEQ ID NO : 31) </p><p>&lt;Desc/Clms Page number 19&gt;</p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptide is encoded by the open reading frame &lt;RTI ID=0.0&gt;("ORF")&lt;/RTI&gt; of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleic acid. An ORF corresponds to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide sequence that could potentially be translated into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide. &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; stretch of nucleic acids comprising an ORF is uninterrupted by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; stop codon. An ORF that represents the coding sequence for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; full protein begins with an &lt;RTI ID=0.0&gt;ATG"start"codon&lt;/RTI&gt; and terminates with one of the three"stop"codons, namely, TAA, TAG, or &lt;RTI ID=0.0&gt;TGA.&lt;/RTI&gt; For the purposes of this invention, an ORF may be any part of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence, with or without &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; start codon, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; stop codon, or both. For an ORF to be considered as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; good candidate for coding for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;bonafìde&lt;/RTI&gt; cellular protein, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; minimum size requirement is often set, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; stretch of DNA that would encode &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein of &lt;RTI ID=0.0&gt;50&lt;/RTI&gt; amino acids or more. </p><p> The invention further encompasses nucleic acid molecules that differ from the nucleotide sequences shown in SEQ ID NO : 1 due to degeneracy of the genetic code and thus encode the same thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; proteins as that encoded by the nucleotide sequences shown in SEQ ID NO : &lt;RTI ID=0.0&gt;1.&lt;/RTI&gt; In another embodiment, an isolated nucleic acid molecule of the invention has &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide sequence encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein having an amino acid sequence shown in SEQ ID NO : &lt;RTI ID=0.0&gt;2.&lt;/RTI&gt; In addition to the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleotide sequence shown in SEQ ID NO : 1 it will be appreciated by those skilled in the art that DNA sequence &lt;RTI ID=0.0&gt;polymorphisms&lt;/RTI&gt; that lead to changes in the amino acid sequences of the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptides may exist within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; population &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., the bacterial population). Such genetic polymorphism in the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; genes may exist among individuals within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; population due to natural &lt;RTI ID=0.0&gt;allelic&lt;/RTI&gt; variation. As used herein, the &lt;RTI ID=0.0&gt;terms"gene"and&lt;/RTI&gt; "recombinant &lt;RTI ID=0.0&gt;gene"refer&lt;/RTI&gt; to nucleic acid molecules comprising an open reading frame encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; protein. Such natural &lt;RTI ID=0.0&gt;allelic&lt;/RTI&gt; variations can typically result in 1-5% variance in the nucleotide sequence of the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; genes. Any and all such nucleotide variations and resulting amino acid &lt;RTI ID=0.0&gt;polymorphisms&lt;/RTI&gt; in the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptides, which are the result of natural &lt;RTI ID=0.0&gt;allelic&lt;/RTI&gt; variation and that do not alter the functional activity of the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptides, are intended to be within the scope of the invention. </p><p> Moreover, nucleic acid molecules encoding thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; proteins from other species, and thus that have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide sequence that differs from the sequence SEQ ID </p><p>&lt;Desc/Clms Page number 20&gt;</p><p> NO : 1 are intended to be within the scope of the invention. Nucleic acid molecules corresponding to natural &lt;RTI ID=0.0&gt;allelic&lt;/RTI&gt; variants and homologues of the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;cDNAs&lt;/RTI&gt; of the invention can be isolated based on their homology to the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleic acids disclosed herein using the human &lt;RTI ID=0.0&gt;cDNAs,&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; portion thereof, as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; hybridization probe according to standard hybridization techniques under stringent hybridization conditions. The invention further includes the nucleic acid sequence of SEQ ID NO : 1 and mature and variant forms thereof, wherein &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; first nucleotide sequence comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence differing by one or more nucleotide sequences from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence encoding said amino acid sequence, provided that no more than &lt;RTI ID=0.0&gt;11%&lt;/RTI&gt; of the nucleotides in the coding sequence differ from the coding sequence. </p><p> Another aspect of the invention pertains to nucleic acid molecules encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; protein that contains changes in amino acid residue that are not essential for activity. Such thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; proteins differ in amino acid sequence from SEQ ID NO : 2 yet retain biological activity. In separate embodiments, the isolated nucleic acid molecule comprises &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide sequence encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein, wherein the protein comprises an amino acid sequence at least about 96%, 97%, &lt;RTI ID=0.0&gt;98%&lt;/RTI&gt; or 99% homologous to the amino acid sequence of SEQ ID NO : &lt;RTI ID=0.0&gt;2.&lt;/RTI&gt; An isolated nucleic acid molecule encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; protein homologous to the protein of SEQ ID NO : 2 can be created by introducing one or more nucleotide substitutions, additions or deletions into the nucleotide sequence of SEQ ID NO : 1 such that one or more amino acid substitutions, additions or deletions are introduced into the encoded protein. </p><p> Mutations can be introduced into SEQ ID NO : 2 by standard techniques, such as site-directed &lt;RTI ID=0.0&gt;mutagenesis&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;PCR-mediated&lt;/RTI&gt; &lt;RTI ID=0.0&gt;mutagenesis.&lt;/RTI&gt; Preferably, conservative amino acid substitutions are made at one or more predicted, non-essential amino acid residue. &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; "conservative amino acid &lt;RTI ID=0.0&gt;substitution"is&lt;/RTI&gt; one in which the amino acid residue is replaced with an amino acid residue having &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; similar side chain. Families of amino acid residue having similar side chains have been defined within the art. These families include amino acids with basic side chains &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., lysine, arginin, histidine), &lt;RTI ID=0.0&gt;acidic&lt;/RTI&gt; side chains &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;aspartic&lt;/RTI&gt; acid, glutamic &lt;RTI ID=0.0&gt;acid),&lt;/RTI&gt; uncharged polar side chains &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., glycine, asparagine, glutamin, serine, threonin, tyrosine, cystine), &lt;RTI ID=0.0&gt;nonpolar&lt;/RTI&gt; side chains &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., alanine, valine, leucine, isoleucine, &lt;RTI ID=0.0&gt;proline,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;phenylalanine,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;methionine,&lt;/RTI&gt; tryptophan), beta-branched side chains &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., threonin, valine, isoleucine) and aromatic side chains &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., tyrosine, &lt;RTI ID=0.0&gt;phenylalanine,&lt;/RTI&gt; tryptophan, </p><p>&lt;Desc/Clms Page number 21&gt;</p><p> histidine). Thus, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predicted non-essential &lt;RTI ID=0.0&gt;amino&lt;/RTI&gt; acid residue in the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; protein is replaced with another amino acid residue from the same side chain family. </p><p>Alternatively, in another embodiment, mutations can be introduced randomly along all or part of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; coding sequence, such as by saturation &lt;RTI ID=0.0&gt;mutagenesis,&lt;/RTI&gt; and the resultant mutants can be screened for thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; biological activity to identify mutants that retain activity. Following &lt;RTI ID=0.0&gt;mutagenesis&lt;/RTI&gt; of SEQ ID NO : &lt;RTI ID=0.0&gt;1,&lt;/RTI&gt; the encoded protein can be expressed by any recombinant technology known in the art and the activity of the protein can be determined. </p><p> The &lt;RTI ID=0.0&gt;relatedness&lt;/RTI&gt; of amino acid families may also be determined based on side chain interactions. Substituted amino acids may be fully &lt;RTI ID=0.0&gt;conserved"strong"residues&lt;/RTI&gt; or fully &lt;RTI ID=0.0&gt;conserved"weak"residues.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;The"strong"group&lt;/RTI&gt; of conserved amino acid residue may be any one of the following groups : STA, &lt;RTI ID=0.0&gt;NEQK,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;NHQK,&lt;/RTI&gt; NDEQ, QHRK, MILV, MILF, &lt;RTI ID=0.0&gt;HY,&lt;/RTI&gt; FYW, wherein the single letter amino acid codes are grouped by those amino acids that may be substituted for each other. Likewise, &lt;RTI ID=0.0&gt;the"weak"group&lt;/RTI&gt; of conserved residue may be any one of the following : CSA, ATV, SAG, &lt;RTI ID=0.0&gt;STNK,&lt;/RTI&gt; STPA, SGND, SNDEQK, NDEQHK, NEQHRK, VLIM, &lt;RTI ID=0.0&gt;HFY,&lt;/RTI&gt; wherein the letters within each group represent the single letter amino acid code. </p><p> The thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleic acid of the invention includes the nucleic acid whose sequence is provided herein, or fragments &lt;RTI ID=0.0&gt;thereof.&lt;/RTI&gt; The invention also includes mutant or variant nucleic acids any of whose bases may be changed from the corresponding base shown herein while still encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein that maintains its &lt;RTI ID=0.0&gt;sulfurylase-like&lt;/RTI&gt; activities and physiological functions, or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fragment of such &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid. The invention further includes nucleic acids whose sequences are complementary to those just described, including nucleic acid fragments that are complementary to any of the nucleic acids just described. The invention additionally includes nucleic acids or nucleic acid fragments, or complements thereto, whose structures include chemical modifications. Such modifications include, by way &lt;RTI ID=0.0&gt;of nonlimiting&lt;/RTI&gt; example, modified bases, and nucleic acids whose sugar phosphate backbones are modified or &lt;RTI ID=0.0&gt;derivatized.&lt;/RTI&gt; These modifications are carried out at least in part to enhance the chemical stability of the modified nucleic acid, such that they may be used, for example, as &lt;RTI ID=0.0&gt;antisense&lt;/RTI&gt; binding nucleic acids in therapeutic applications in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; subject. </p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleic acid can encode &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptide. As used herein, &lt;RTI ID=0.0&gt;a"mature"form&lt;/RTI&gt; &lt;RTI ID=0.0&gt;of a polypeptide&lt;/RTI&gt; or protein disclosed in the </p><p>&lt;Desc/Clms Page number 22&gt;</p><p> present invention is the product of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; naturally occurring polypeptide or precursor &lt;RTI ID=0.0&gt;form&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;proprotein.&lt;/RTI&gt; The naturally occurring polypeptide, precursor or &lt;RTI ID=0.0&gt;proprotein&lt;/RTI&gt; includes, by way of &lt;RTI ID=0.0&gt;nonlimiting&lt;/RTI&gt; example, the full-length gene product, encoded by the corresponding gene. </p><p>Alternatively, it may be defined as the polypeptide, precursor or &lt;RTI ID=0.0&gt;proprotein&lt;/RTI&gt; encoded by an ORF described herein. The &lt;RTI ID=0.0&gt;product"mature"form&lt;/RTI&gt; arises, again by way of &lt;RTI ID=0.0&gt;nonlimiting&lt;/RTI&gt; example, as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; result of one or more naturally occurring processing steps as they may take place within the cell, or host cell, in which the gene product arises. Examples of such processing steps leading to &lt;RTI ID=0.0&gt;a"mature"form&lt;/RTI&gt; of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide or protein include the cleavage of the N-terminal methionin residue encoded by the initiation codon of an &lt;RTI ID=0.0&gt;ORF,&lt;/RTI&gt; or the &lt;RTI ID=0.0&gt;proteolytic&lt;/RTI&gt; cleavage of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; signal peptide or leader sequence. Thus &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature form arising from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; precursor polypeptide or protein that has residue &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;N,&lt;/RTI&gt; where residue &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; is the N-terminal &lt;RTI ID=0.0&gt;methionine,&lt;/RTI&gt; would have residue &lt;RTI ID=0.0&gt;2&lt;/RTI&gt; through &lt;RTI ID=0.0&gt;N&lt;/RTI&gt; remaining after removal of the N-terminal &lt;RTI ID=0.0&gt;methionine.&lt;/RTI&gt; Alternatively, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature form arising from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; precursor polypeptide or protein having residue &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;N,&lt;/RTI&gt; in which an N-terminal signal sequence from residue &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; to residue &lt;RTI ID=0.0&gt;M&lt;/RTI&gt; is cleaved, would have the residue from residue &lt;RTI ID=0.0&gt;M+1&lt;/RTI&gt; to residue &lt;RTI ID=0.0&gt;N&lt;/RTI&gt; remaining. &lt;RTI ID=0.0&gt;Further&lt;/RTI&gt; as used herein, &lt;RTI ID=0.0&gt;a"mature"form&lt;/RTI&gt; of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide or protein may arise from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; step &lt;RTI ID=0.0&gt;of post-translational&lt;/RTI&gt; modification other than &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;proteolytic&lt;/RTI&gt; cleavage event. Such additional processes include, by way of non-limiting example, &lt;RTI ID=0.0&gt;glycosylation,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;myristoylation&lt;/RTI&gt; or phosphorylation. &lt;RTI ID=0.0&gt;In&lt;/RTI&gt; general, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature polypeptide or protein may result from the operation of only one of these processes, or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; combination of any of them. </p><p> The &lt;RTI ID=0.0&gt;term"isolated"nucleic&lt;/RTI&gt; acid molecule, as utilized herein, is one, which is separated &lt;RTI ID=0.0&gt;f om&lt;/RTI&gt; other nucleic acid molecules which are present in the natural source of the nucleic acid. Preferably, &lt;RTI ID=0.0&gt;an"isolated"nucleic&lt;/RTI&gt; acid is free of sequences which naturally flank the nucleic acid &lt;RTI ID=0.0&gt;(i. e.,&lt;/RTI&gt; sequences located at the 5'-and 3'-termini of the nucleic acid) in the genomic DNA of the organism from which the nucleic acid is derived. For example, in various embodiments, the isolated thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleic acid molecules can contain less than about &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; &lt;RTI ID=0.0&gt;kb,&lt;/RTI&gt; 4 &lt;RTI ID=0.0&gt;kb,&lt;/RTI&gt; 3 &lt;RTI ID=0.0&gt;kb,&lt;/RTI&gt; 2 &lt;RTI ID=0.0&gt;kb,&lt;/RTI&gt; 1 &lt;RTI ID=0.0&gt;kb,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;0.&lt;/RTI&gt; 5 kb or &lt;RTI ID=0.0&gt;0.&lt;/RTI&gt; 1 kb of nucleotide sequences which naturally flank the nucleic acid molecule in genomic DNA of the &lt;RTI ID=0.0&gt;cell/tissue&lt;/RTI&gt; from which the nucleic acid is derived &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., brain, heart, liver, spleen, &lt;RTI ID=0.0&gt;etc.).&lt;/RTI&gt; Moreover, an &lt;RTI ID=0.0&gt;"isolated"nucleic&lt;/RTI&gt; acid molecule, such as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; cDNA molecule, can be substantially free of other cellular material or culture medium when produced by recombinant techniques, or of chemical precursors or other chemicals when chemically synthesized. </p><p>&lt;Desc/Clms Page number 23&gt;</p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; nucleic acid molecule of the invention, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid molecule having the nucleotide sequence of SEQ ID NO : 1 or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complement of this aforementioned nucleotide sequence, can be isolated using standard molecular biology techniques and the sequence information provided herein. Using all or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; portion of the nucleic acid sequence of SEQ ID NO : 1 as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; hybridization probe, &lt;RTI ID=0.0&gt;thermostable sulfurylase&lt;/RTI&gt; molecules can be isolated using standard hybridization and cloning techniques &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., as described in &lt;RTI ID=0.0&gt;<bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Sambrook,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;et al.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(eds.),&lt;/RTI&gt; MOLECULAR CLONING : A LABORATORY MANUAL &lt;RTI ID=0.0&gt;2nd&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Ed.,&lt;/RTI&gt; Cold Spring Harbor Laboratory Press, Cold Spring Harbor, &lt;RTI ID=0.0&gt;NY,&lt;/RTI&gt; 1989</bibl> ; and &lt;RTI ID=0.0&gt;<bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Ausubel,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;et al.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(eds.),&lt;/RTI&gt; CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley &lt;RTI ID=0.0&gt; &amp; &lt;/RTI&gt; Sons, New York, &lt;RTI ID=0.0&gt;NY,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1993</bibl>.)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; nucleic acid of the invention can be amplified using cDNA, &lt;RTI ID=0.0&gt;mRNA&lt;/RTI&gt; or alternatively, genomic DNA, as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template and appropriate &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; primers according to standard PCR amplification techniques. The nucleic acid so amplified can be cloned into an appropriate vector and characterized by DNA sequence analysis. Furthermore, &lt;RTI ID=0.0&gt;oligonucleotides&lt;/RTI&gt; corresponding to thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; nucleotide sequences can be prepared by standard synthetic techniques, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., using an automated DNA synthesizer. </p><p> As used herein, the &lt;RTI ID=0.0&gt;term"complementary"refers&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;Watson-Crick&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;Hoogsteen&lt;/RTI&gt; base pairing between nucleotides units of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid molecule, and the &lt;RTI ID=0.0&gt;term"binding"means&lt;/RTI&gt; the physical or chemical interaction between two polypeptides or compounds or associated polypeptides or compounds or combinations thereof. Binding includes ionic, non-ionic, van der &lt;RTI ID=0.0&gt;Waals,&lt;/RTI&gt; hydrophobic interactions, and the like. &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; physical interaction can be either direct or indirect. Indirect interactions may be through or due to the effects of another polypeptide or compound. Direct binding refers to interactions that do not take place through, or due &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; the effect of another polypeptide or compound, but instead are without other substantial chemical intermediates. </p><p> Fragments provided herein are defined as sequences of at least &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; (contiguous) nucleic acids or at least &lt;RTI ID=0.0&gt;4&lt;/RTI&gt; (contiguous) amino acids, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; length sufficient to allow for specific hybridization in the case of nucleic acids or for specific recognition &lt;RTI ID=0.0&gt;of an epitope&lt;/RTI&gt; in the case of amino acids, respectively, and are at most some portion less than &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;full&lt;/RTI&gt; length sequence. </p><p>Fragments may be derived from any contiguous portion of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid or amino acid sequence of choice. Derivatives are nucleic acid sequences or amino acid sequences &lt;RTI ID=0.0&gt;formed&lt;/RTI&gt; from the native compounds either directly or by modification or partial substitution. Analogs are nucleic acid sequences or amino acid sequences that have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; structure similar &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; but not </p><p>&lt;Desc/Clms Page number 24&gt;</p><p> identical to, the native compound but differs from it in respect to certain components or side chains. Analogs may be synthetic or from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; different evolutionary origin and may have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; similar or opposite metabolic activity compared to wild type. Homologs are nucleic acid sequences or &lt;RTI ID=0.0&gt;amino&lt;/RTI&gt; acid sequences of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; particular gene that are derived from different species. </p><p> Derivatives and analogs may be full length or other than full length, if the derivative or analog contains &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; modified nucleic acid or amino acid, as described below. Derivatives or analogs of the nucleic acids or proteins of the invention include, but are not limited &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; molecules comprising regions that are substantially homologous to the nucleic acids or proteins of the invention, in various embodiments, by at least about 89% identity over &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid or amino acid sequence of identical size or when compared to an aligned sequence in which the alignment is done by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; computer homology program known in the art, or whose encoding nucleic acid is capable of hybridizing to the complement of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence encoding the aforementioned proteins under stringent, moderately stringent, or low stringent conditions. See &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g. &lt;RTI ID=0.0&gt;<bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Ausubel,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;et al.,&lt;/RTI&gt; CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley &lt;RTI ID=0.0&gt; &amp; &lt;/RTI&gt; Sons, New York, &lt;RTI ID=0.0&gt;NY,&lt;/RTI&gt; 1993</bibl>, and below. </p><p> &lt;RTI ID=0.0&gt;A"homologous&lt;/RTI&gt; nucleic acid &lt;RTI ID=0.0&gt;sequence"or"homologous&lt;/RTI&gt; amino acid &lt;RTI ID=0.0&gt;sequence,"or&lt;/RTI&gt; variations thereof, refer to sequences characterized by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; homology at the nucleotide level or amino acid level as discussed above. Homologous nucleotide sequences encode those sequences coding for &lt;RTI ID=0.0&gt;isoforms&lt;/RTI&gt; of thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptides. &lt;RTI ID=0.0&gt;Isoforms&lt;/RTI&gt; can be expressed in different tissues of the same organism as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; result &lt;RTI ID=0.0&gt;of,&lt;/RTI&gt; for example, alternative splicing of &lt;RTI ID=0.0&gt;RNA.&lt;/RTI&gt; Alternatively, &lt;RTI ID=0.0&gt;isoforms&lt;/RTI&gt; can be encoded by different genes. In the invention, homologous nucleotide sequences include nucleotide sequences encoding for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; polypeptide of species other than humans, including, but not limited to : vertebrates, and thus can include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., frog, mouse, rat, rabbit, dog, cat cow, horse, and other &lt;RTI ID=0.0&gt;organisms.&lt;/RTI&gt; Homologous nucleotide sequences also include, but are not limited &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; naturally occurring &lt;RTI ID=0.0&gt;allelic&lt;/RTI&gt; variations and mutations of the nucleotide sequences set forth herein. Homologous nucleic acid sequences include those nucleic acid sequences that encode conservative amino acid substitutions in SEQ ID NO : &lt;RTI ID=0.0&gt;1,&lt;/RTI&gt; as well as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide possessing thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; biological activity. Various biological activities of the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; proteins are described below. </p><p>&lt;Desc/Clms Page number 25&gt;</p><p> The thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; proteins of the invention include the &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; protein whose sequence is provided herein. The invention also includes mutant or variant proteins any of whose residue may be changed &lt;RTI ID=0.0&gt;from&lt;/RTI&gt; the corresponding residue shown herein while still encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein that maintains its &lt;RTI ID=0.0&gt;sulfurylase-like&lt;/RTI&gt; activities and physiological functions, or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; functional fragment thereof. The invention further encompasses antibodies and antibody fragments, such as &lt;RTI ID=0.0&gt;Fab&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;(Fab)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;2,&lt;/RTI&gt; that bind &lt;RTI ID=0.0&gt;immunospecifically&lt;/RTI&gt; to any of the proteins of the invention. This invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; variant or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mature form of the amino acid sequence &lt;RTI ID=0.0&gt;of SEQ&lt;/RTI&gt; ID NO : 2, wherein one or more amino acid residue in the variant differs in no more than &lt;RTI ID=0.0&gt;4%&lt;/RTI&gt; of the amino &lt;RTI ID=0.0&gt;acic&lt;/RTI&gt; residue from the amino acid sequence of the mature form. </p><p> Several assays have been developed for detection of the forward ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; reaction. The colorimetric &lt;RTI ID=0.0&gt;molybdolysis&lt;/RTI&gt; assay is based on phosphate detection (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Wilson and Bandurski, &lt;RTI ID=0.0&gt;1958.&lt;/RTI&gt; J. Biol. Chem. 233 : 975-981</bibl>), whereas the continuous spectrophotometric &lt;RTI ID=0.0&gt;molybdolysis&lt;/RTI&gt; assay is based upon the detection &lt;RTI ID=0.0&gt;of NADH&lt;/RTI&gt; oxidation (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Seubert, et al., &lt;RTI ID=0.0&gt;1983.&lt;/RTI&gt; Arch. Biochem. Biophys. 225 : 679-691</bibl> ; <bibl next="bibl81" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Seubert, et al., &lt;RTI ID=0.0&gt;1985.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Arch.&lt;/RTI&gt;</bibl> </p><p><bibl xml:id="bibl81" xmlns="http://www.tei-c.org/ns/1.0">Biochem. Biophys. 240 : &lt;RTI ID=0.0&gt;509-523</bibl>).&lt;/RTI&gt; The later assay requires the presence of several detection enzymes. </p><p> Suitable enzymes for converting ATP into light include &lt;RTI ID=0.0&gt;luciferases,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., insect &lt;RTI ID=0.0&gt;luciferases.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Luciferases&lt;/RTI&gt; produce light as an end-product of catalysis. The best known light- emitting enzyme is that of the firefly, Photinus pyralis (Coleoptera). The corresponding gene has been cloned and expressed in bacteria (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g.,<bibl next="bibl82" type="journal" xmlns="http://www.tei-c.org/ns/1.0"> de Wet, &lt;RTI ID=0.0&gt;et al.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1985.&lt;/RTI&gt; Proc. Natl. Acad.</bibl> </p><p><bibl xml:id="bibl82" xmlns="http://www.tei-c.org/ns/1.0">Sci. USA &lt;RTI ID=0.0&gt;80&lt;/RTI&gt; : 7870-7873</bibl>) and plants (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Ow,&lt;/RTI&gt; et al., &lt;RTI ID=0.0&gt;1986.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Science&lt;/RTI&gt; &lt;RTI ID=0.0&gt;234&lt;/RTI&gt; : 856-859</bibl>), as well as in insect (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Jha, et al., &lt;RTI ID=0.0&gt;1990.&lt;/RTI&gt; FEBS Lett. 274 : 24-26</bibl>) and mammalian cells (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">de Wet, et al., &lt;RTI ID=0.0&gt;1987.&lt;/RTI&gt; Mol. Cell. Biol. 7 : 725-7373</bibl> ; <bibl next="bibl83" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Keller, et al., &lt;RTI ID=0.0&gt;1987.&lt;/RTI&gt; Proc. Natl. Acad. Sci.</bibl> </p><p><bibl xml:id="bibl83" xmlns="http://www.tei-c.org/ns/1.0">&lt;RTI ID=0.0&gt;USA&lt;/RTI&gt; &lt;RTI ID=0.0&gt;82&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;3264-3268</bibl>).&lt;/RTI&gt; In addition, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; number &lt;RTI ID=0.0&gt;of luciferase&lt;/RTI&gt; genes from the Jamaican click beetle, Pyroplorus plagiophilhalamus (Coleoptera), have recently been cloned and partially characterized (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Wood, et al., &lt;RTI ID=0.0&gt;1989.&lt;/RTI&gt; J. Biolumin. Chemilumin. 4 : &lt;RTI ID=0.0&gt;289-301</bibl>&lt;/RTI&gt; &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Wood, &lt;RTI ID=0.0&gt;et&lt;/RTI&gt; &lt;RTI ID=0.0&gt;al.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1989.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Science&lt;/RTI&gt; &lt;RTI ID=0.0&gt;244&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;700-702)</bibl>.&lt;/RTI&gt; Distinct luciferases can sometimes produce light of different wavelengths, which may enable simultaneous monitoring of light emissions at different wavelengths. Accordingly, these aforementioned characteristics are unique, and add new dimensions with respect to the utilization of current reporter systems. </p><p>&lt;Desc/Clms Page number 26&gt;</p><p> Firefly &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; catalyzes bioluminescence in the presence &lt;RTI ID=0.0&gt;of luciferin,&lt;/RTI&gt; adenosine &lt;RTI ID=0.0&gt;5'-&lt;/RTI&gt; triphosphate &lt;RTI ID=0.0&gt;(ATP),&lt;/RTI&gt; magnesium ions, and oxygen, resulting in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; quantum yield of &lt;RTI ID=0.0&gt;0.&lt;/RTI&gt; 88 (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">McElroy and&lt;/RTI&gt; Selinger, &lt;RTI ID=0.0&gt;1960.&lt;/RTI&gt; Arch. Biochem. Biophys. 88 : &lt;RTI ID=0.0&gt;136-145)</bibl>.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;The firefly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;bioluminescent&lt;/RTI&gt; reaction can be utilized as an assay for the detection of ATP with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; detection limit of approximately &lt;RTI ID=0.0&gt;lx10-l3&lt;/RTI&gt; &lt;RTI ID=0.0&gt;M&lt;/RTI&gt; (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Leach, &lt;RTI ID=0.0&gt;1981.&lt;/RTI&gt; J. Appl. Biochem. 3 : 473- &lt;RTI ID=0.0&gt;517</bibl>).&lt;/RTI&gt; In addition, the overall degree of sensitivity and convenience of the &lt;RTI ID=0.0&gt;luciferase-mediated&lt;/RTI&gt; detection systems have created considerable interest in the development of firefly &lt;RTI ID=0.0&gt;luciferase-&lt;/RTI&gt; based biosensors (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g.,<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0"> Green and Kricka, &lt;RTI ID=0.0&gt;1984.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Talanta&lt;/RTI&gt; &lt;RTI ID=0.0&gt;31&lt;/RTI&gt; : 173-176</bibl> ; <bibl next="bibl84" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Blum, et al., &lt;RTI ID=0.0&gt;1989.&lt;/RTI&gt;</bibl> </p><p><bibl xml:id="bibl84" xmlns="http://www.tei-c.org/ns/1.0">&lt;RTI ID=0.0&gt;J.&lt;/RTI&gt; Biolumin. Chemilumin. 4 : &lt;RTI ID=0.0&gt;543-550</bibl>).&lt;/RTI&gt; </p><p> The development of new reagents have made it possible to obtain stable light emission proportional to the concentrations of ATP (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Lundin, &lt;RTI ID=0.0&gt;1982.&lt;/RTI&gt; Applications of firefly &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; In &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; Luminescent Assays (Raven Press, New &lt;RTI ID=0.0&gt;York</bibl>).&lt;/RTI&gt; With such stable light emission reagents, it is possible to make &lt;RTI ID=0.0&gt;endpoint&lt;/RTI&gt; assays and to calibrate each individual assay by addition of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; known amount of &lt;RTI ID=0.0&gt;ATP.&lt;/RTI&gt; In addition, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; stable light-emitting system also allows continuous monitoring of ATP-converting systems. </p><p> In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the ATP &lt;RTI ID=0.0&gt;generating-ATP&lt;/RTI&gt; converting fusion protein is attached to an affinity tag. The &lt;RTI ID=0.0&gt;term"affinity&lt;/RTI&gt; &lt;RTI ID=0.0&gt;tag"is&lt;/RTI&gt; used herein to denote &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; peptide segment that can be attached to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide to provide for purification or detection of the polypeptide or provide sites for attachment of the polypeptide to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; substrate. In principal, any peptide or protein for which an antibody or other specific binding agent is available can be used as an affinity tag. Affinity tags include &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; poly-histidine tract or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; carboxyl carrier protein &lt;RTI ID=0.0&gt;(BCCP)&lt;/RTI&gt; domain, protein &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Nilsson&lt;/RTI&gt; et al., &lt;RTI ID=0.0&gt;EMBO&lt;/RTI&gt; &lt;RTI ID=0.0&gt;J.&lt;/RTI&gt; 4 : 1075, 1985</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Nilsson et al., Methods &lt;RTI ID=0.0&gt;Enzymol.&lt;/RTI&gt; 198 : 3, 1991</bibl>), &lt;RTI ID=0.0&gt;glutathione&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S&lt;/RTI&gt; transferase (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Smith and Johnson, Gene &lt;RTI ID=0.0&gt;67&lt;/RTI&gt; : 31, 1988</bibl>), substance P, Flag. &lt;RTI ID=0.0&gt;.&lt;/RTI&gt; peptide &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Hopp&lt;/RTI&gt; et &lt;RTI ID=0.0&gt;al.,&lt;/RTI&gt; Biotechnology &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; : 1204-1210, 1988</bibl> ; available from &lt;RTI ID=0.0&gt;Eastman&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Kodak&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Co.,&lt;/RTI&gt; New Haven, &lt;RTI ID=0.0&gt;Conn.),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;streptavidin&lt;/RTI&gt; binding peptide, or other &lt;RTI ID=0.0&gt;antigenic epitope&lt;/RTI&gt; or binding domain. See, in general <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Ford et &lt;RTI ID=0.0&gt;al.,&lt;/RTI&gt; Protein Expression and Purification &lt;RTI ID=0.0&gt;2&lt;/RTI&gt; : 95-107, &lt;RTI ID=0.0&gt;1991</bibl>.&lt;/RTI&gt; DNAs encoding affinity tags are available from commercial suppliers &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; Pharmacia Biotech, Piscataway, &lt;RTI ID=0.0&gt;N.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;J.).&lt;/RTI&gt; </p><p> As used herein, the &lt;RTI ID=0.0&gt;term"poly-histidine&lt;/RTI&gt; &lt;RTI ID=0.0&gt;tag,"when&lt;/RTI&gt; used in reference to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein refers to the presence of two to ten histidine residue at either the amino-or carboy- terminus of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein of interest. &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; poly-histidine tract of six to ten residue is preferred. The poly-histidine tract is also &lt;RTI ID=0.0&gt;defined&lt;/RTI&gt; functionally as being &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; number of consecutive histidine </p><p>&lt;Desc/Clms Page number 27&gt;</p><p> residue added to the protein of interest which allows the affinity purification of the resulting fusion protein on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nickel-chelate or IDA column. </p><p> In some embodiments, the fusion protein has an orientation such that the sulfurylase polypeptide is N-terminal to the &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; polypeptide. In other embodiments, the &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; polypeptide is N-terminal to the sulfurylase polypeptide. As used herein, the term sulfurylase-luciferase fusion protein refers to either of these orientations. The &lt;RTI ID=0.0&gt;terms"amino-&lt;/RTI&gt; &lt;RTI ID=0.0&gt;terminal" (N-terminal) and''carboxyl-terminal''&lt;/RTI&gt; (C-terminal) are used herein to denote positions within polypeptides and proteins. Where the context allows, these terms are used with reference to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; particular sequence or portion of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polypeptide or protein to denote proximity or relative position. For example, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; certain sequence positioned carboxyl-terminal to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; reference sequence within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein is located proximal to the carboxyl terminus of the reference sequence, but is not necessarily at the carboxyl terminus of the complete protein. </p><p> The fusion protein of this invention can be produced by standard recombinant DNA techniques. For example, DNA fragments coding for the different polypeptide sequences are &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; together in-frame in accordance with conventional techniques, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; by employing blunt-ended &lt;RTI ID=0.0&gt;or"sticky"-ended&lt;/RTI&gt; termini for &lt;RTI ID=0.0&gt;ligation,&lt;/RTI&gt; restriction enzyme digestion to provide for appropriate termini, filling-in of cohesive ends as appropriate, alkaline phosphatase treatment to avoid undesirable joining, and &lt;RTI ID=0.0&gt;enzymatic&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ligation.&lt;/RTI&gt; In another embodiment, the fusion gene can be synthesized by conventional techniques including automated DNA synthesizers. </p><p>Alternatively, PCR amplification of gene fragments can be carried out using anchor primers that give rise to complementary overhangs between two consecutive gene fragments that can subsequently be annealed and &lt;RTI ID=0.0&gt;reamplified&lt;/RTI&gt; to generate &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;chimeric&lt;/RTI&gt; gene sequence (see, for example, <bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Ausubel et al. &lt;RTI ID=0.0&gt;(eds.)&lt;/RTI&gt; CURRENT PROTOCOLS &lt;RTI ID=0.0&gt;1N MOLECULAR&lt;/RTI&gt; BIOLOGY, John Wiley &lt;RTI ID=0.0&gt; &amp; &lt;/RTI&gt; Sons, &lt;RTI ID=0.0&gt;1992</bibl>).&lt;/RTI&gt; The two polypeptides of the fusion protein can also be joined by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; linker, such as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; unique restriction site, which is engineered with specific primers during the cloning procedure. In one embodiment, the sulfurylase and &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; polypeptides are joined by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; linker, for example an &lt;RTI ID=0.0&gt;ala-ala-ala&lt;/RTI&gt; linker which is encoded by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Notl restriction&lt;/RTI&gt; site. </p><p> In one embodiment, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; recombinant &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; that comprises &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; coding sequence for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein having an ATP generating polypeptide sequence and an ATP converting polypeptide sequence. In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the recombinant &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; encodes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion protein. The term "recombinant DNA &lt;RTI ID=0.0&gt;molecule"or"recombinant&lt;/RTI&gt; &lt;RTI ID=0.0&gt;polynucleotide"as&lt;/RTI&gt; used herein refers to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 28&gt;</p><p> DNA molecule which is comprised of segments of DNA joined together by means of molecular biological techniques. The &lt;RTI ID=0.0&gt;term"recombinant&lt;/RTI&gt; &lt;RTI ID=0.0&gt;protein"or"recombinant&lt;/RTI&gt; &lt;RTI ID=0.0&gt;polypeptide"as&lt;/RTI&gt; used herein refers to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein molecule which is expressed from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; recombinant DNA molecule. </p><p> In one aspect, this invention discloses &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion protein with an N-terminal &lt;RTI ID=0.0&gt;hexahistidine&lt;/RTI&gt; tag and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; BCCP tag. The nucleic acid sequence of the disclosed &lt;RTI ID=0.0&gt;N-&lt;/RTI&gt; terminal &lt;RTI ID=0.0&gt;hexahistidine-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase-sulfurylase&lt;/RTI&gt; gene &lt;RTI ID=0.0&gt;(His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;L-S)&lt;/RTI&gt; gene is shown below : &lt;RTI ID=0.0&gt;His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;L-S&lt;/RTI&gt; Nucleotide Sequence &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;3)&lt;/RTI&gt; : 
EMI28.1
 </p><p>&lt;Desc/Clms Page number 29&gt;</p><p> 
EMI29.1
 
The amino acid sequence of the disclosed &lt;RTI ID=0.0&gt;His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;L-S&lt;/RTI&gt; polypeptide is presented using the three letter amino acid code &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;4).&lt;/RTI&gt; </p><p>&lt;RTI ID=0.0&gt;His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;L-S&lt;/RTI&gt; Amino Acid Sequence &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;4)&lt;/RTI&gt; Met Arg &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ser His His His His His His &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Met Ala Ser Met Glu 
1 5 &lt;RTI ID=0.0&gt;10&lt;/RTI&gt; &lt;RTI ID=0.0&gt;15&lt;/RTI&gt; Ala Pro Ala Ala Ala Glu Ile Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; His Ile Val Arg Ser Pro Met &lt;RTI ID=0.0&gt; 20 25 30&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Arg Thr Pro Ser Pro Asp Ala Lys Ala Phe Ile &lt;RTI ID=0.0&gt; 35 40 45&lt;/RTI&gt; Glu Val Gly Gin Lys Val Asn Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Thr Leu &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Ile Val Glu &lt;RTI ID=0.0&gt; 50 55 60&lt;/RTI&gt; Ala Met Lys Met Met Asn Gln Ile Glu Ala Asp Lys Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Val &lt;RTI ID=0.0&gt; 65 70 75 80&lt;/RTI&gt; Lys Ala Ile Leu Val Glu Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Gin Pro Val Glu Phe Asp Glu Pro &lt;RTI ID=0.0&gt; 85 90 95&lt;/RTI&gt; Leu Val Val Ile Glu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ser Glu Leu Glu Ile Gln Met Glu Asp Ala &lt;RTI ID=0.0&gt; 100 105 110&lt;/RTI&gt; Lys Asn Ile Lys Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Pro Ala Pro Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Pro Leu Glu Asp &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 30&gt;</p><p> &lt;RTI ID=0.0&gt; 115 120 125&lt;/RTI&gt; Thr Ala Gly Glu Gin Leu His Lys Ala Met Lys Arg &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ala Leu Val &lt;RTI ID=0.0&gt; 130 135 140&lt;/RTI&gt; Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Ile Ala Phe Thr Asp Ala His Ile Glu Val Asn Ile Thr &lt;RTI ID=0.0&gt;145 150 155 160&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ala Glu Tyr Phe Glu Met Ser Val Arg Leu Ala Glu Ala Met Lys &lt;RTI ID=0.0&gt; 165 170 175&lt;/RTI&gt; Arg &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Asn Thr Asn His Arg Ile Val Val &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Ser Glu Asn &lt;RTI ID=0.0&gt; 180 185 190&lt;/RTI&gt; Ser Leu Gin Phe Phe Met Pro Val Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ala Leu Phe Ile &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt; 195 200 205&lt;/RTI&gt; Ala Val Ala Pro Ala Asn Asp Ile &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asn Glu Arg Glu Leu Leu Asn &lt;RTI ID=0.0&gt; 210 215 220&lt;/RTI&gt; Ser Met Asn Ile Ser Gin Pro Thr Val Val Phe Val Ser Lys Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;225 230 235 240&lt;/RTI&gt; Leu Gin Lys Ile Leu Asn Val Gin Lys Lys Leu Pro &lt;RTI ID=0.0&gt;Ile Ile Gln&lt;/RTI&gt; Lys &lt;RTI ID=0.0&gt; 245 250 255&lt;/RTI&gt; Ile Ile Ile Met Asp Ser Lys Thr Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Gin &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe Gin Ser Met &lt;RTI ID=0.0&gt; 260 265 270&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Thr Phe Val Thr Ser His Leu Pro Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe Asn Glu &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp &lt;RTI ID=0.0&gt; 275 280 285&lt;/RTI&gt; Phe Val Pro Glu Ser Phe Asp Arg Asp Lys Thr Ile Ala Leu Ile Met &lt;RTI ID=0.0&gt; 290 295 300&lt;/RTI&gt; Asn Ser Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ser Thr &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Pro Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Ala Leu Pro His &lt;RTI ID=0.0&gt;305 310 315 320&lt;/RTI&gt; Arg Thr Ala &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Val Arg Phe Ser His Ala Arg Asp Pro Ile Phe &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 325 330 335&lt;/RTI&gt; Asn Gln Ile Ile Pro Asp Thr Ala Ile Leu Ser Val Val Pro Phe His &lt;RTI ID=0.0&gt; 340 345 350&lt;/RTI&gt; His &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe Gly Met Phe Thr Thr Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Leu Ile &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe &lt;RTI ID=0.0&gt; 355 360 365&lt;/RTI&gt; Arg Val Val Leu Met &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Arg Phe Glu Glu Glu Leu Phe Leu Arg Ser </p><p>&lt;Desc/Clms Page number 31&gt;</p><p> &lt;RTI ID=0.0&gt; 370 375 380&lt;/RTI&gt; Leu Gin Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Lys Ile Gln Ser Ala Leu Leu Val Pro Thr Leu Phe &lt;RTI ID=0.0&gt;385 390 395 400&lt;/RTI&gt; Ser Phe Phe Ala Lys Ser Thr Leu Ile Asp Lys &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp Leu Ser Asn &lt;RTI ID=0.0&gt; 405 410 415&lt;/RTI&gt; Leu His Glu Ile Ala Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ala Pro Leu Ser Lys Glu Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 420 425 430&lt;/RTI&gt; Glu Ala Val Ala Lys Arg Phe His Leu Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ile Arg Gin &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 435 440 445&lt;/RTI&gt; Gly Leu Thr Glu Thr Thr Ser Ala Ile Leu Ile Thr Pro Glu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp &lt;RTI ID=0.0&gt; 450 455 460&lt;/RTI&gt; Asp Lys Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ala Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Lys Val Val Pro Phe Phe Glu Ala Lys &lt;RTI ID=0.0&gt;465 470 475 480&lt;/RTI&gt; Val Val Asp Leu Asp Thr &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Lys Thr Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Asn Gin Arg &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 485 490 495&lt;/RTI&gt; Glu Leu &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Val Arg &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Pro Met Ile Met Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Val Asn Asn &lt;RTI ID=0.0&gt; 500 505 510&lt;/RTI&gt; Pro Glu Ala Thr Asn Ala Leu Ile Asp Lys Asp &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Leu His Ser &lt;RTI ID=0.0&gt; 515 520 525&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Ile Ala &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Asp Glu Asp Glu His Phe Phe Ile Val Asp &lt;RTI ID=0.0&gt; 530 535 540&lt;/RTI&gt; Arg Leu Lys Ser Leu Ile Lys &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Gin Val Ala Pro Ala &lt;RTI ID=0.0&gt;545 550 555 560&lt;/RTI&gt; Glu Leu Glu Ser Ile Leu Leu Gin His Pro Asn Ile Phe Asp Ala &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 565 570 575&lt;/RTI&gt; Val Ala Gly Leu Pro Asp Asp Asp Ala Gly Glu Leu Pro Ala Ala Val&lt;RTI ID=0.0&gt; 580 585 590&lt;/RTI&gt; Val Val Leu Glu His &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Lys Thr Met Thr Glu Lys Glu Ile Val Asp &lt;RTI ID=0.0&gt; 595 600 605&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Val Ala Ser Gin Val Thr Thr Ala Lys Lys Leu Arg &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt; 610 615 620&lt;/RTI&gt; Val Phe Val Asp Glu Val Pro Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Thr &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Lys Leu Asp Ala </p><p>&lt;Desc/Clms Page number 32&gt;</p><p> &lt;RTI ID=0.0&gt;625 630 635 640&lt;/RTI&gt; Arg Lys Ile Arg Glu Ile Leu Ile Lys Ala Lys Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Lys Ser &lt;RTI ID=0.0&gt; 645 650 655&lt;/RTI&gt; Lys Leu Ala Ala Ala Met Pro Ala Pro His &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ile Leu Gin Asp &lt;RTI ID=0.0&gt; 660 665 670&lt;/RTI&gt; Leu Ile Ala Arg Asp Ala Leu Lys Lys Asn Glu Leu Leu Ser Glu Ala &lt;RTI ID=0.0&gt; 675 680 685&lt;/RTI&gt; Gin Ser Ser Asp Ile Leu Val &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Asn Leu Thr Pro Arg Gin Leu &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 690 695 700&lt;/RTI&gt; Asp Ile Glu Leu Ile Leu Asn &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe Ser Pro Leu Thr &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe &lt;RTI ID=0.0&gt; 705 710 715&lt;/RTI&gt; Leu Asn Glu Asn Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ser Ser Val Val Thr Asp Ser Arg Leu Ala &lt;RTI ID=0.0&gt;720 725 730 735&lt;/RTI&gt; Asp &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Leu &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Thr Ile Pro Ile Thr Leu Asp Val Asp Glu Ala &lt;RTI ID=0.0&gt; 740 745 750&lt;/RTI&gt; Phe Ala Asn Gln Ile Lys Pro Asp Thr Arg Ile Ala Leu Phe Gin Asp &lt;RTI ID=0.0&gt; 755 760 765&lt;/RTI&gt; 
Asp Glu Ile Pro Ile Ala Ile Leu Thr Val Gin Asp Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Lys Pro &lt;RTI ID=0.0&gt; 770 775 780&lt;/RTI&gt; Asn Lys Thr Ile Glu Ala Glu Lys Val Phe Arg &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Pro Glu His &lt;RTI ID=0.0&gt; 785 790 795&lt;/RTI&gt; Pro Ala Ile Ser &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Leu Phe Asn Val Ala &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;800 805 810 815&lt;/RTI&gt; Gly Ser Leu Glu Ala Ile Gln Leu Pro Gin His &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 820 825 830&lt;/RTI&gt; Leu Arg Lys Thr Pro Ala Gin Leu Arg Leu Glu Phe Gin Ser Arg Gln &lt;RTI ID=0.0&gt; 835 840 845&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Asp Arg Val Val Ala Phe Gln Thr Arg Asn Pro Met His Arg Ala &lt;RTI ID=0.0&gt; 850 855 860&lt;/RTI&gt; His Arg Glu Leu Thr Val Arg Ala Ala Arg Glu Ala Asn Ala Lys Val &lt;RTI ID=0.0&gt; 865 870 875&lt;/RTI&gt; Leu Ile His Pro Val Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Thr Lys Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Ile Asp His </p><p>&lt;Desc/Clms Page number 33&gt;</p><p> &lt;RTI ID=0.0&gt;880 885 890 895&lt;/RTI&gt; His Thr Arg Val Arg Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Gin Glu Ile Ile Lys Arg &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Pro Asn &lt;RTI ID=0.0&gt; 900 905 910&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ile Ala Phe Leu Ser Leu Leu Pro Leu Ala Met Arg Met Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 915 920 925&lt;/RTI&gt; Asp Arg Glu Ala Val &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; His Ala Ile Ile Arg Lys Asn &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ala
930 &lt;RTI ID=0.0&gt;935&lt;/RTI&gt; &lt;RTI ID=0.0&gt;940&lt;/RTI&gt; Ser His Phe Ile Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Arg Asp His Ala &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Lys Asn Ser &lt;RTI ID=0.0&gt; 945 950 955&lt;/RTI&gt; Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Asp Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Pro &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp Ala Gin Glu Leu Val Glu &lt;RTI ID=0.0&gt;960 965 970 975&lt;/RTI&gt; Ser &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Lys His Glu Leu Asp Ile Glu Val Val Pro Phe Arg Met Val &lt;RTI ID=0.0&gt; 980 985 990&lt;/RTI&gt; Thr &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Leu Pro Asp Glu Asp Arg &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ala Pro Ile Asp Gln Ile Asp &lt;RTI ID=0.0&gt; 995 1000 1005&lt;/RTI&gt; Thr Thr Lys Thr Arg Thr Leu Asn Ile Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Glu Leu Arg Arg &lt;RTI ID=0.0&gt; 1010 1015 1020&lt;/RTI&gt; Arg Leu Arg Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Glu Ile Pro Glu &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Phe Ser &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Pro Glu &lt;RTI ID=0.0&gt; 1025 1030 1035&lt;/RTI&gt; Val Val Lys Ile Leu Arg Glu Ser Asn Pro Pro Arg Pro Lys Gin &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1040 1045 1050 1055&lt;/RTI&gt; Phe Ser Ile Val Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asn Ser Leu Thr Val Ser Arg Glu Gin Leu &lt;RTI ID=0.0&gt; 1060 1065 1070&lt;/RTI&gt; Ser Ile Ala Leu Leu Ser Thr Phe Leu Gin Phe &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Arg &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 1075 1080 1085&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Lys Ile Phe Glu His Asn Asn Lys Thr Glu Leu Leu Ser Leu Ile &lt;RTI ID=0.0&gt; 1090 1095 1100&lt;/RTI&gt; Gin Asp Phe Ile &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Ile Ile Pro Asn Gin &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 1105 1110 1115&lt;/RTI&gt; Glu Asp Asp Lys Asp Ser Val Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Lys Gin Asn Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Leu Leu &lt;RTI ID=0.0&gt;1120 1125 1130 1135&lt;/RTI&gt; Asp Thr Ser Ser Ser Ala Asp Ile Gln Leu Glu Ser Ala Asp Glu Pro </p><p>&lt;Desc/Clms Page number 34&gt;</p><p> &lt;RTI ID=0.0&gt; 1140 1145 1150&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Ile&lt;/RTI&gt; Ser His Ile Val Gin Lys Val Val Leu Phe Leu Glu Asp Asn &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 1155 1160 1165&lt;/RTI&gt; Phe Phe Val Phe &lt;RTI ID=0.0&gt; 1170&lt;/RTI&gt; 
Accordingly, in one aspect, the invention provides for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; joined to at least one &lt;RTI ID=0.0&gt;affinity&lt;/RTI&gt; tag. The nucleic acid sequence of the disclosed N-terminal &lt;RTI ID=0.0&gt;hexahistidine-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; ATP &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Sulfurylase)&lt;/RTI&gt; gene is shown below : His6-BCCP &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; Nucleotide Sequence &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;5)&lt;/RTI&gt; 
EMI34.1
 
The amino acid sequence of the &lt;RTI ID=0.0&gt;His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; polypeptide is presented using the three letter amino acid code in Table &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;6).&lt;/RTI&gt; </p><p>&lt;RTI ID=0.0&gt;His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; Amino Acid Sequence &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;6)&lt;/RTI&gt; Met Arg &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ser His His His His His His &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Met Ala Ser Met Glu 
5 &lt;RTI ID=0.0&gt;10&lt;/RTI&gt; &lt;RTI ID=0.0&gt;15&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 35&gt;</p><p> Ala Pro Ala Ala Ala Glu &lt;RTI ID=0.0&gt;Ile&lt;/RTI&gt; Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; His &lt;RTI ID=0.0&gt;Ile&lt;/RTI&gt; Val Arg Ser Pro Met &lt;RTI ID=0.0&gt; 20 25 30&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Arg Thr Pro Ser Pro Asp Ala Lys Ala Phe Ile &lt;RTI ID=0.0&gt; 35 40 45&lt;/RTI&gt; Glu Val Gly Gin Lys Val Asn Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Thr Leu &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Ile Val Glu &lt;RTI ID=0.0&gt; 50 55 60&lt;/RTI&gt; Ala Met Lys Met Met Asn Gln Ile Glu Ala Asp Lys Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Val &lt;RTI ID=0.0&gt; 65 70 75 80&lt;/RTI&gt; Lys Ala Ile Leu Val Glu Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Gin Pro Val Glu Phe Asp Glu Pro &lt;RTI ID=0.0&gt; 85 90 95&lt;/RTI&gt; Leu Val Val Ile Glu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ser Glu Leu Glu Ile &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Ser Met Ser Val &lt;RTI ID=0.0&gt; 100 105 110&lt;/RTI&gt; Ser Ile Pro His &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Leu Ile Asn Arg &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Asn Pro Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 115 120 125&lt;/RTI&gt; Pro ILe Asp Glu Ala Thr Lys Thr Ile Glu Leu Ser Lys Ala Glu Leu &lt;RTI ID=0.0&gt; 130 135 140&lt;/RTI&gt; Ser Asp Leu Glu Leu Ile &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ala &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ser Pro Leu Thr &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;145 150 155 160&lt;/RTI&gt; Phe Leu Thr Lys Ala Asp &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp Ala Val Val Glu Thr Met Arg Leu &lt;RTI ID=0.0&gt; 165 170 175&lt;/RTI&gt; Ala Asp &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Val &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Ser Ile Pro Ile Thr Leu Ala Val &lt;RTI ID=0.0&gt;Thr&lt;/RTI&gt; Glu &lt;RTI ID=0.0&gt; 180 185 190&lt;/RTI&gt; Glu Lys Ala Ser Glu Leu Thr Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Lys Ala Lys Leu Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 195 200 205&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asp Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Ile Glu Ile Ala Asp Ile &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Arg Pro &lt;RTI ID=0.0&gt; 210 215 220&lt;/RTI&gt; Asp Lys Thr Lys Glu Ala Lys Leu Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Lys Thr Asp Glu Leu Ala &lt;RTI ID=0.0&gt;225 230 235 240&lt;/RTI&gt; His Pro &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Arg Lys Leu Phe Glu Lys Pro Asp Val &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Val Gly &lt;RTI ID=0.0&gt; 245 250 255&lt;/RTI&gt; Gly &lt;RTI ID=0.0&gt;Ala&lt;/RTI&gt; Val Thr Leu Val Lys Arg Thr Asp Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Gin Phe Ala Pro &lt;RTI ID=0.0&gt; 260 265 270&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 36&gt;</p><p> Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Phe Asp Pro Ala Glu Thr Arg Lys Arg Phe Ala Glu Leu Gly &lt;RTI ID=0.0&gt; 275 280 285&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Trp&lt;/RTI&gt; Asn Thr Val Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Phe Gin Thr Arg Asn Pro Val His Arg Ala &lt;RTI ID=0.0&gt; 290 295 300&lt;/RTI&gt; His Glu &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;He Gin&lt;/RTI&gt; Lys &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Ala Leu Glu Ile Val Asp &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Phe &lt;RTI ID=0.0&gt;305 310 315 320&lt;/RTI&gt; Leu Asn Pro Leu Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Glu Thr Lys Ala Asp Asp Ile Pro Ala Asp &lt;RTI ID=0.0&gt; 325 330 335&lt;/RTI&gt; Ile Arg Met Glu Ser &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Gin Val Leu Leu Glu Asn &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Pro Lys &lt;RTI ID=0.0&gt; 340 345 350&lt;/RTI&gt; Asp Arg Val Phe Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val Phe Gin Ala Ala Met Arg &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Ala &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 355 360 365&lt;/RTI&gt; Pro Arg Glu Ala Ile Phe His Ala Met Val Arg Lys Asn Phe &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 370 375 380&lt;/RTI&gt; Thr His Phe Ile Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Arg Asp His Ala &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Val &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Asn &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;385 390 395 400&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; Asp Ala Gin Lys Ile Phe Ser Asn Phe &lt;RTI ID=0.0&gt;Thr&lt;/RTI&gt; Ala Glu Glu &lt;RTI ID=0.0&gt; 405 410 415&lt;/RTI&gt; Leu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Ile Thr Pro Leu Phe Phe Glu His Ser Phe &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Thr Lys &lt;RTI ID=0.0&gt; 420 425 430&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Glu &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Met Ala Ser Thr Lys Thr &lt;RTI ID=0.0&gt;Cys&lt;/RTI&gt; Pro His Asp Ala Gin &lt;RTI ID=0.0&gt;Tyr&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 435 440 445&lt;/RTI&gt; His Val Val Leu Ser &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Thr Lys Val Arg Glu Met Leu Arg Asn &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; &lt;RTI ID=0.0&gt; 450 455 460&lt;/RTI&gt; Gin Val Pro Pro Ser Thr Phe Ser Arg Pro Glu Val Ala Ala Val Leu &lt;RTI ID=0.0&gt;465 470 475 480&lt;/RTI&gt; Ile Lys &lt;RTI ID=0.0&gt;Gly&lt;/RTI&gt; Leu Gin Glu Arg Glu Thr Val Ala Pro Ser Ala Arg &lt;RTI ID=0.0&gt; 485 490 495&lt;/RTI&gt; 
Another aspect of the invention pertains to vectors, preferably expression vectors, containing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid encoding an ATP generating polypeptide and an ATP converting </p><p>&lt;Desc/Clms Page number 37&gt;</p><p> polypeptide, or derivatives, fragments, analogs or homologs thereof. As used herein, the term &lt;RTI ID=0.0&gt;"vector"refers&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. One type of vector is &lt;RTI ID=0.0&gt;a"plasmid",&lt;/RTI&gt; which refers to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; circular double stranded DNA loop into which additional DNA segments can be &lt;RTI ID=0.0&gt;ligated.&lt;/RTI&gt; Another type of vector is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; viral vector, wherein additional DNA segments can be &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; into the viral &lt;RTI ID=0.0&gt;genome.&lt;/RTI&gt; Certain vectors are capable of autonomous replication in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; host cell into which they are introduced &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., bacterial vectors having &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; bacterial origin of replication and &lt;RTI ID=0.0&gt;episomal&lt;/RTI&gt; mammalian vectors). Other vectors &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;non-episomal&lt;/RTI&gt; mammalian vectors) are integrated into the genome of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; host cell upon introduction into the host cell, and thereby are replicated along with the host &lt;RTI ID=0.0&gt;genome.&lt;/RTI&gt; Moreover, certain vectors are capable of directing the expression of genes to which they are operatively linked. Such vectors are referred to herein &lt;RTI ID=0.0&gt;as"expression&lt;/RTI&gt; vectors". In general, expression vectors of utility in recombinant DNA techniques are often in the &lt;RTI ID=0.0&gt;form of plasmids.&lt;/RTI&gt; In the present &lt;RTI ID=0.0&gt;specification,"plasmid"and&lt;/RTI&gt; &lt;RTI ID=0.0&gt;"vector"can&lt;/RTI&gt; be used &lt;RTI ID=0.0&gt;interchangeably&lt;/RTI&gt; as the plasmid is the most commonly used form of vector. However, the invention is intended to include such other forms of expression vectors, such as viral vectors &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., replication defective retroviruses, &lt;RTI ID=0.0&gt;adenoviruses&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;adeno-associated&lt;/RTI&gt; viruses), which serve equivalent functions. </p><p> The recombinant expression vectors of the invention comprise &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; form suitable for expression of the nucleic acid in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; host cell, which means that the recombinant expression vectors include one or more regulator sequences, selected on the basis of the host cells to be used for expression, that is operatively linked to the nucleic acid sequence to be expressed. Within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; recombinant expression &lt;RTI ID=0.0&gt;vector,"operably&lt;/RTI&gt; &lt;RTI ID=0.0&gt;linked"is&lt;/RTI&gt; intended to mean that the nucleotide sequence of interest is linked to the &lt;RTI ID=0.0&gt;regulatory sequence&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(s)&lt;/RTI&gt; in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; manner that allows for expression of the nucleotide sequence &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., in an &lt;RTI ID=0.0&gt;in vitro&lt;/RTI&gt; transcription/translation system or in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; host cell when the vector is introduced into the host &lt;RTI ID=0.0&gt;cell).&lt;/RTI&gt; The &lt;RTI ID=0.0&gt;term"regulatory&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequence"is&lt;/RTI&gt; intended to includes promoters, enhances and other expression control elements &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;polyadenylation&lt;/RTI&gt; signals). Such regulator sequences are described, for example, in &lt;RTI ID=0.0&gt;<bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Goeddel&lt;/RTI&gt; &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; GENE EXPRESSION TECHNOLOGY : METHODS IN &lt;RTI ID=0.0&gt;ENZYMOLOGY&lt;/RTI&gt; 185, Academic Press, San Diego, &lt;RTI ID=0.0&gt;Calif.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(1990)</bibl>.&lt;/RTI&gt; Regulator sequences include those that direct constitutive expression of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide sequence in many types of host cell and those that direct expression of the nucleotide sequence only in certain host cells &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., tissue-specific regulator sequences). It will be appreciated by those skilled in the art that the </p><p>&lt;Desc/Clms Page number 38&gt;</p><p> design of the expression vector can depend on such factors as the choice of the host cell to be transformed, the level of expression of protein desired, etc. The expression vectors of the invention can be introduced into host cells to thereby produce &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein. </p><p> The recombinant expression vectors of the invention can be designed for expression of the fusion protein in &lt;RTI ID=0.0&gt;prokaryotic&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;eukaryotic&lt;/RTI&gt; cells. For example, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion protein can be expressed in bacterial cells such as &lt;RTI ID=0.0&gt;E.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;coli,&lt;/RTI&gt; insect cells (using &lt;RTI ID=0.0&gt;baculovirus&lt;/RTI&gt; expression vectors) yeast cells or mammalian cells. Suitable host cells are discussed further in <bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Goeddel, GENE EXPRESSION TECHNOLOGY : METHODS IN &lt;RTI ID=0.0&gt;ENZYMOLOGY&lt;/RTI&gt; 185, Academic Press, San Diego, &lt;RTI ID=0.0&gt;Calif.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(1990)</bibl>.&lt;/RTI&gt; Alternatively, the recombinant expression vector can be transcribed and translated &lt;RTI ID=0.0&gt;in vitro,&lt;/RTI&gt; for example using &lt;RTI ID=0.0&gt;T7&lt;/RTI&gt; promoter regulator sequences and &lt;RTI ID=0.0&gt;T7&lt;/RTI&gt; polymerase. </p><p> Expression of proteins in &lt;RTI ID=0.0&gt;prokaryotes&lt;/RTI&gt; is most often carried out in &lt;RTI ID=0.0&gt;E.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;coli&lt;/RTI&gt; with vectors containing constitutive or &lt;RTI ID=0.0&gt;inducible&lt;/RTI&gt; promoters directing the expression. Fusion vectors add &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; number of amino acids to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; protein encoded therein, usually to the amino terminus of the recombinant protein. Such fusion vectors typically serve three purposes : &lt;RTI ID=0.0&gt;(1)&lt;/RTI&gt; to increase expression of recombinant protein ; &lt;RTI ID=0.0&gt;(2)&lt;/RTI&gt; to increase the solubility of the recombinant protein ; and &lt;RTI ID=0.0&gt;(3)&lt;/RTI&gt; to aid in the purification of the recombinant protein by acting as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; ligand in affinity purification. Often, in fusion expression vectors, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;proteolytic&lt;/RTI&gt; cleavage site is introduced at the junction of the fusion &lt;RTI ID=0.0&gt;moiety&lt;/RTI&gt; and the recombinant protein to enable separation of the recombinant protein from the fusion &lt;RTI ID=0.0&gt;moiety&lt;/RTI&gt; subsequent to purification of the fusion protein. </p><p> In another embodiment, the ATP &lt;RTI ID=0.0&gt;generating-ATP&lt;/RTI&gt; converting fusion protein expression vector is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; yeast expression vector. Examples of vectors for expression in yeast S. &lt;RTI ID=0.0&gt;cerivisae&lt;/RTI&gt; include &lt;RTI ID=0.0&gt;pYepSecl&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Baldari,&lt;/RTI&gt; et al., (1987) &lt;RTI ID=0.0&gt;EMBU J&lt;/RTI&gt; &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; : 229-234)</bibl>, &lt;RTI ID=0.0&gt;pMFa&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Kurjan&lt;/RTI&gt; and Herskowitz, (1982) Cell &lt;RTI ID=0.0&gt;30&lt;/RTI&gt; : 933-943</bibl>), &lt;RTI ID=0.0&gt;pJRY88&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Schultz&lt;/RTI&gt; et al., (10987) Gene &lt;RTI ID=0.0&gt;54&lt;/RTI&gt; : 113-123</bibl>), &lt;RTI ID=0.0&gt;pYES2&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(Invitrogen&lt;/RTI&gt; Corporation, San Diego, &lt;RTI ID=0.0&gt;Calif.),&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;picZ&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(InVitrogen&lt;/RTI&gt; Corp, San Diego, Calcif). </p><p> Alternatively, the fusion protein can be expressed in insect cells using &lt;RTI ID=0.0&gt;baculovirus&lt;/RTI&gt; expression vectors. &lt;RTI ID=0.0&gt;Baculovirus&lt;/RTI&gt; vectors available for expression of proteins in cultured insect cells &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;SF9&lt;/RTI&gt; cells) include the &lt;RTI ID=0.0&gt;pAc&lt;/RTI&gt; series (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Smith &lt;RTI ID=0.0&gt;et al.&lt;/RTI&gt; (1983) Mol Cell Biol 3 : 2156-2165</bibl>) and the &lt;RTI ID=0.0&gt;pVL&lt;/RTI&gt; series &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Lucklow&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;Summers&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(1989)&lt;/RTI&gt; Virology &lt;RTI ID=0.0&gt;170&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;31-39</bibl>).&lt;/RTI&gt; </p><p> In yet another embodiment, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid of the invention is expressed in mammalian cells using &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mammalian expression vector. Examples of mammalian expression vectors </p><p>&lt;Desc/Clms Page number 39&gt;</p><p> include &lt;RTI ID=0.0&gt;pCDM8&lt;/RTI&gt; (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Seed (1987) Nature &lt;RTI ID=0.0&gt;329&lt;/RTI&gt; : 840</bibl>) and &lt;RTI ID=0.0&gt;pMT2PC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Kaufman et al.&lt;/RTI&gt; (1987) &lt;RTI ID=0.0&gt;EMBU J&lt;/RTI&gt; &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;187-195</bibl>).&lt;/RTI&gt; When used in mammalian cells, the expression vector's control functions are often provided by viral regulator elements. For example, commonly used promoters are derived from polyoma, Adenovirus &lt;RTI ID=0.0&gt;2,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;cytomegalovirus&lt;/RTI&gt; and Simian Virus &lt;RTI ID=0.0&gt;40.&lt;/RTI&gt; For other suitable expression systems for both &lt;RTI ID=0.0&gt;prokaryotic&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;eukaryotic&lt;/RTI&gt; cells. See, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., Chapters &lt;RTI ID=0.0&gt;16&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;17&lt;/RTI&gt; of <bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Sambrook et al., MOLECULAR CLONING : A LABORATORY MANUAL. &lt;RTI ID=0.0&gt;2nd&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ed.,&lt;/RTI&gt; Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, &lt;RTI ID=0.0&gt;N.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Y.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1989</bibl>.&lt;/RTI&gt; </p><p> In another embodiment, the recombinant mammalian expression vector is capable of directing expression of the nucleic acid preferentially in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; particular cell type &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., tissue-specific regulator elements are used to express the nucleic acid). Tissue-specific regulator elements are known in the art. Non-limiting examples of suitable tissue-specific promoters include the albumin promoter (liver-specific ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Pinkert &lt;RTI ID=0.0&gt;et al.&lt;/RTI&gt; (1987) Genes Dev &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; : 268-277</bibl>), lymphoid-specific promoters (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Calame and Baton &lt;RTI ID=0.0&gt;(1988)&lt;/RTI&gt; Adv Immunol &lt;RTI ID=0.0&gt;43&lt;/RTI&gt; : 235-275</bibl>), in particular promoters &lt;RTI ID=0.0&gt;of T&lt;/RTI&gt; cell receptors &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Winoto&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;Baltimore&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(1989)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;EMBO&lt;/RTI&gt; &lt;RTI ID=0.0&gt;J8&lt;/RTI&gt; : 729-733</bibl>) and immunoglobulins &lt;RTI ID=0.0&gt;(<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Banerji&lt;/RTI&gt; &lt;RTI ID=0.0&gt;et al.&lt;/RTI&gt; (1983) &lt;RTI ID=0.0&gt;Cell 33&lt;/RTI&gt; : 729-740</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Queen and &lt;RTI ID=0.0&gt;Baltimore&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(1983)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Cell 33&lt;/RTI&gt; : 741-748</bibl>), neuron-specific promoters &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., the &lt;RTI ID=0.0&gt;neurofilament&lt;/RTI&gt; promoter ; &lt;RTI ID=0.0&gt;<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Byrne&lt;/RTI&gt; and Ruddle &lt;RTI ID=0.0&gt;(1989)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;PNAS 86&lt;/RTI&gt; : 5473-5477</bibl>), pancreas-specific promoters (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Edlund et al. (1985) Science &lt;RTI ID=0.0&gt;230&lt;/RTI&gt; : 912-916</bibl>), and mammary gland-specific promoters &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., milk whey promoter ; &lt;RTI ID=0.0&gt;<bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">U.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S.&lt;/RTI&gt; Pat. &lt;RTI ID=0.0&gt;No.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;4,&lt;/RTI&gt; 873, 316</bibl> and <bibl next="bibl85" type="patent" xmlns="http://www.tei-c.org/ns/1.0">European Application Publication &lt;RTI ID=0.0&gt;No.&lt;/RTI&gt;</bibl> </p><p><bibl xml:id="bibl85" xmlns="http://www.tei-c.org/ns/1.0">264, &lt;RTI ID=0.0&gt;166</bibl>).&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Developmentally-regulated&lt;/RTI&gt; promoters are also encompassed, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; the murine box promoters (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Kessel and Gruss &lt;RTI ID=0.0&gt;(1990)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Science&lt;/RTI&gt; &lt;RTI ID=0.0&gt;249&lt;/RTI&gt; : 374-379</bibl>) and the a-fetoprotein promoter (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Campes and &lt;RTI ID=0.0&gt;Tilghman&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(1989)&lt;/RTI&gt; Genes Dev &lt;RTI ID=0.0&gt;3&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;537-546</bibl>).&lt;/RTI&gt; </p><p> Another aspect of the invention pertains to host cells into which &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; recombinant expression vector of the invention has been introduced. The &lt;RTI ID=0.0&gt;terms"host&lt;/RTI&gt; &lt;RTI ID=0.0&gt;cell"and&lt;/RTI&gt; "recombinant host cell" are used &lt;RTI ID=0.0&gt;interchangeably&lt;/RTI&gt; herein. It is understood that such terms refer not only to the particular subject cell but to the progeny or potential progeny of such &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein. The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; kit comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion protein expression vector. </p><p>&lt;Desc/Clms Page number 40&gt;</p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; host cell can be any &lt;RTI ID=0.0&gt;prokaryotic&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;eukaryotic&lt;/RTI&gt; cell. For example, the &lt;RTI ID=0.0&gt;sulfurylase-&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; fusion protein can be expressed in bacterial cells such as &lt;RTI ID=0.0&gt;E. coli,&lt;/RTI&gt; insect cells, yeast or mammalian cells (such as Chinese hamster ovary cells (CHO) or COS cells). Other suitable host cells are known to those skilled in the art. </p><p> Vector DNA can be introduced into &lt;RTI ID=0.0&gt;prokaryotic&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;eukaryotic&lt;/RTI&gt; cells via conventional transformation or transfection techniques. As used herein, the &lt;RTI ID=0.0&gt;terms"transformation"and&lt;/RTI&gt; &lt;RTI ID=0.0&gt;"transfection"are&lt;/RTI&gt; intended to refer to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; variety of art-recognized techniques for introducing foreign nucleic acid &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., DNA) into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; host cell, including calcium phosphate or calcium chloride &lt;RTI ID=0.0&gt;co-precipitation,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;DEAE-dextran-mediated&lt;/RTI&gt; &lt;RTI ID=0.0&gt;transfection,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;lipofection,&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;electroporation.&lt;/RTI&gt; Suitable methods for transforming or &lt;RTI ID=0.0&gt;transfecting&lt;/RTI&gt; host cells can be found in &lt;RTI ID=0.0&gt;<bibl type="book" xmlns="http://www.tei-c.org/ns/1.0">Sambrook,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;et al.&lt;/RTI&gt; (MOLECULAR CLONING : A LABORATORY MANUAL. &lt;RTI ID=0.0&gt;2nd&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ed.,&lt;/RTI&gt; Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, &lt;RTI ID=0.0&gt;N.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Y.,&lt;/RTI&gt; 1989)</bibl>, and other laboratory manual. </p><p> For stable &lt;RTI ID=0.0&gt;transfection&lt;/RTI&gt; of mammalian cells, it is known that, depending upon the expression vector and &lt;RTI ID=0.0&gt;transfection&lt;/RTI&gt; technique used, only &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; small fraction of cells may integrate the foreign DNA into their &lt;RTI ID=0.0&gt;genome.&lt;/RTI&gt; In order to identify and select these &lt;RTI ID=0.0&gt;integrants,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; gene that encodes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;selectable&lt;/RTI&gt; marker &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., resistance to antibiotics) is generally introduced into the host cells along with the gene of interest. Various &lt;RTI ID=0.0&gt;selectable&lt;/RTI&gt; markers include those that confer resistance to drugs, such as &lt;RTI ID=0.0&gt;G418,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;hygromycin&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;methotrexate.&lt;/RTI&gt; Nucleic acid encoding &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;selectable&lt;/RTI&gt; marker can be introduced into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; host cell on the same vector as that encoding ORFX or can be introduced on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; separate vector. Cells stably &lt;RTI ID=0.0&gt;transfected&lt;/RTI&gt; with the introduced nucleic acid can be identified by drug selection &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; cells that have incorporated the &lt;RTI ID=0.0&gt;selectable&lt;/RTI&gt; marker gene will survive, while the other cells die). </p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; host cell of the invention, such as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;prokaryotic&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;eukaryotic&lt;/RTI&gt; host cell in culture, can be used to produce &lt;RTI ID=0.0&gt;(i.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.,&lt;/RTI&gt; express) the fusion protein. Accordingly, the invention further provides methods for producing the fusion protein using the host cells of the invention. In one embodiment, the method comprises culturing the host cell of invention (into which &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; recombinant expression vector encoding the fusion protein has been introduced) in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; suitable medium such that the fusion protein is produced. In another embodiment, the method further comprises isolating the fusion protein from the medium or the host cell. </p><p> The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein bound to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mobile support. In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the fusion gene is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion gene. In another embodiment, </p><p>&lt;Desc/Clms Page number 41&gt;</p><p> the mobile support is bound to &lt;RTI ID=0.0&gt;strepavidin.&lt;/RTI&gt; The mobile support could be &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; bead or optical fiber. In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the bead is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;nickel-agarose&lt;/RTI&gt; bead or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; MPG-Streptavidin bead. In one embodiment, the &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion protein is bound to the beads in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; : 3 ratio of protein to bead. It can be attached to the solid support via &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; covalent or non-covalent interaction. In general, any linkage recognized in the art can be used. Examples of such linkages common in the art include any suitable metal &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Co2+, Ni29)-hexahistidine&lt;/RTI&gt; complex, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; binding protein, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., NEUTRAVIDINTM modified &lt;RTI ID=0.0&gt;avidin&lt;/RTI&gt; (Pierce Chemicals, &lt;RTI ID=0.0&gt;Rockford,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;IL),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;streptavidin/biotin,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;avidin/biotin,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;glutathione&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S-transferase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(GST)/glutathione,&lt;/RTI&gt; monoclonal &lt;RTI ID=0.0&gt;antibody/antigen,&lt;/RTI&gt; and maltose binding &lt;RTI ID=0.0&gt;protein/maltose,&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;pluronic&lt;/RTI&gt; coupling technologies. Samples containing the appropriate tag arc incubated with the sensitized substrate so that zero, one, or multiple molecules attach at each sensitized site. </p><p> &lt;RTI ID=0.0&gt;Acetyl-CoA&lt;/RTI&gt; carboxylase &lt;RTI ID=0.0&gt;(ACCase)&lt;/RTI&gt; catalyzes the first committed step in de novo fatty acid biosynthesis. It belongs to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; group of carboxylases that use &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; as &lt;RTI ID=0.0&gt;cofactor&lt;/RTI&gt; and bicarbonate as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; source of the carboxyl group. There are two types of ACCase : &lt;RTI ID=0.0&gt;prokaryotic&lt;/RTI&gt; ACCase &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; E. coli, &lt;RTI ID=0.0&gt;P.&lt;/RTI&gt; aeruginosa, Anabaena, Synechococcus and probably pea &lt;RTI ID=0.0&gt;chloroplast)&lt;/RTI&gt; in which the three functional domains : &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; carboxylase &lt;RTI ID=0.0&gt;(BC),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; carboxyl carrier protein &lt;RTI ID=0.0&gt;(BCCP)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;carboxyltransferase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(CT)&lt;/RTI&gt; are located on separable &lt;RTI ID=0.0&gt;subunits&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;eukaryotic&lt;/RTI&gt; ACCase &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; rat, chicken, yeast, &lt;RTI ID=0.0&gt;diatom&lt;/RTI&gt; and wheat) in which all the domains are located on one large polypeptide. It is known that &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; BCCP as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;subunit&lt;/RTI&gt; of acetyl &lt;RTI ID=0.0&gt;CoA&lt;/RTI&gt; carboxylase from &lt;RTI ID=0.0&gt;E. coli&lt;/RTI&gt; is &lt;RTI ID=0.0&gt;biotinated&lt;/RTI&gt; at the Lys residue at the 122-position by the action of &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; &lt;RTI ID=0.0&gt;holoenzyme&lt;/RTI&gt; &lt;RTI ID=0.0&gt;synthetase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;in E. eoli&lt;/RTI&gt; (<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Journal of Biological Chemistry, 263, 6461 &lt;RTI ID=0.0&gt;(1988)</bibl>).&lt;/RTI&gt; </p><p>In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment of this invention, the fusion protein is bound to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; BCCP domain which is then utilized for binding &lt;RTI ID=0.0&gt;avidins&lt;/RTI&gt; ; therefore, it can bind to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;streptavidin&lt;/RTI&gt; mobile support. One &lt;RTI ID=0.0&gt;biotin- (strept-)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;avidin-based&lt;/RTI&gt; anchoring method uses &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thin layer of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;photoactivatable&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; analog dried onto &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid surface. (<bibl next="bibl86" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Hengsakul and Cass, &lt;RTI ID=0.0&gt;1996.&lt;/RTI&gt;</bibl> </p><p><bibl xml:id="bibl86" xmlns="http://www.tei-c.org/ns/1.0">Bioconjugate Chem. 7 : &lt;RTI ID=0.0&gt;249-254</bibl>).&lt;/RTI&gt; The &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; analog is then exposed to white light through &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; mask, so as to create defined areas of activated &lt;RTI ID=0.0&gt;biotin.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Avidin&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(or&lt;/RTI&gt; &lt;RTI ID=0.0&gt;streptavidin)&lt;/RTI&gt; is then added and allowed to bind to the activated &lt;RTI ID=0.0&gt;biotin.&lt;/RTI&gt; The &lt;RTI ID=0.0&gt;avidin&lt;/RTI&gt; possesses free &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; binding sites which can be utilized &lt;RTI ID=0.0&gt;to"anchor"the&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotinylated&lt;/RTI&gt; proteins through &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin- (strept-)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;avidin&lt;/RTI&gt; linkage. </p><p> Alternatively, the fusion protein can be attached to the solid support with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; derivative possessing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; photo-removable protecting group. This &lt;RTI ID=0.0&gt;moiety&lt;/RTI&gt; is covalently bound </p><p>&lt;Desc/Clms Page number 42&gt;</p><p> to bovine serum albumin &lt;RTI ID=0.0&gt;(BSA),&lt;/RTI&gt; which is attached to the solid support, e. g, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; glass surface. </p><p>See &lt;RTI ID=0.0&gt;<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Pirrung&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;Huang,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1996.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Bioconjugate Chem.&lt;/RTI&gt; 7 : &lt;RTI ID=0.0&gt;317-321</bibl>.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; mask is then used to create activated &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; within the defined irradiated areas. &lt;RTI ID=0.0&gt;Avidin&lt;/RTI&gt; may then be localized to the irradiated area, with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotinylated&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase-luciferase&lt;/RTI&gt; fusion protein subsequently attached through &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;BSA-biotin-avidin-biotin&lt;/RTI&gt; link. </p><p> Another method of attachment is with the use &lt;RTI ID=0.0&gt;of a pluronics&lt;/RTI&gt; based attachment. </p><p>&lt;RTI ID=0.0&gt;Pluronics&lt;/RTI&gt; attach to hydrophobic surfaces by virtue of the reaction between the hydrophobic surface and the polypropylene oxide. The remaining polyethylene oxide groups extend off the surface, thereby creating &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; hydrophilic environment. &lt;RTI ID=0.0&gt;Nitrilotriacetic&lt;/RTI&gt; acid &lt;RTI ID=0.0&gt;(NTA)&lt;/RTI&gt; can be conjugated to the terminal ends of the polyethylene oxide chains to allow for &lt;RTI ID=0.0&gt;hexahistidine&lt;/RTI&gt; tagged proteins to be attached. </p><p> This invention provides methods of &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; which utilize and ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein for detection. In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the nucleotide sequence of the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product is determined by measuring inorganic pyrophosphate &lt;RTI ID=0.0&gt;(PPi)&lt;/RTI&gt; liberated from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide triphosphate &lt;RTI ID=0.0&gt;(dNTP)&lt;/RTI&gt; as the dNMP is incorporated into an extended sequence primer. This method of &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; is termed &lt;RTI ID=0.0&gt;Pyrosequencing&lt;/RTI&gt; technology (PyroSequencing &lt;RTI ID=0.0&gt;AB,&lt;/RTI&gt; Stockholm, Sweden). It can be performed in solution (liquid phase) or as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid phase technique. Various &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; methods, including &lt;RTI ID=0.0&gt;PPi&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; methods, are described in, &lt;RTI ID=0.0&gt;e. g, <bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">WO9813523A1</bibl>,&lt;/RTI&gt; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Ronaghi, et al., 1996. Anal. Biochem. 242 : &lt;RTI ID=0.0&gt;84-89</bibl>,&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Ronaghi,&lt;/RTI&gt; et al., &lt;RTI ID=0.0&gt;1998.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Science&lt;/RTI&gt; &lt;RTI ID=0.0&gt;281&lt;/RTI&gt; : 363-365 (1998)</bibl>, <bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">US patent &lt;RTI ID=0.0&gt;6,&lt;/RTI&gt; 274, 320</bibl> and the patent application <bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">USSN 10/104, 280</bibl> which was filed on March 21, 2001 &lt;RTI ID=0.0&gt;(21465-501CIP3).&lt;/RTI&gt; These disclosures of &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; are incorporated herein in their entirety, by reference. </p><p> Pyrophosphate released under these conditions can be detected &lt;RTI ID=0.0&gt;enzymatically&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(e. g.,&lt;/RTI&gt; by the generation of light in the &lt;RTI ID=0.0&gt;luciferase-luciferin&lt;/RTI&gt; reaction). Such methods enable &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide to be identified in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; given target position, and the DNA to be sequenced simply and rapidly while avoiding the need for &lt;RTI ID=0.0&gt;electrophoresis&lt;/RTI&gt; and the use of potentially dangerous &lt;RTI ID=0.0&gt;radiolabels.&lt;/RTI&gt; </p><p> The invention also provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; nucleic acids which generally comprises &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing one or more nucleic acid anchor primers and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single- stranded circular nucleic acid templates disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of reaction chambers or cavities ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; annealing an effective amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed anchor primer-circular template </p><p>&lt;Desc/Clms Page number 43&gt;</p><p> complex ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; combining the primed anchor primer-circular template complex with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase to form an extended anchor primer &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid complementary to the circular nucleic acid template ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; annealing an effective amount of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to one or more copies of said &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked complementary nucleic acid ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; extending the sequencing primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product and, if the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; of said &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction byproduct ; and &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;PPi&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with the use of an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein, thereby determining the sequence of the nucleic acid. In one embodiment, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; dATP or &lt;RTI ID=0.0&gt;ddATP&lt;/RTI&gt; analogue is used in place &lt;RTI ID=0.0&gt;of deoxy-or dideoxy&lt;/RTI&gt; adenosine triphosphate. This analogue is capable of acting as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; substrate for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase but incapable of acting as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; substrate for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;PPi-detection&lt;/RTI&gt; enzyme. This method can be carried out in separate parallel common reactions in an aqueous environment. </p><p> In another aspect, the invention includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of determining the base sequence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of nucleotides on an array, which generally comprises &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of sample DNAs, each disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; adding an activated nucleotide 5'-triphosphate precursor of one known nitrogenous base to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; reaction mixture in each reaction chamber, each reaction mixture comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template-directed nucleotide polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single-stranded &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; template hybridized to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; primer strand at least one nucleotide residue shorter than the templates to form at least one unaired nucleotide residue in each template at the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unaired nucleotide residue of the templates ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; utilizing an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein to detect whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands in which incorporation of the nucleoside 5'-triphosphate precursor indicates that the unaired nucleotide residue of the template has &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; sequentially repeating steps &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(c),&lt;/RTI&gt; wherein each sequential repetition adds and, detects the </p><p>&lt;Desc/Clms Page number 44&gt;</p><p> incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition ; and &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; determining the base sequence of the unaired nucleotide residue of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors. </p><p> The anchor primers of the invention generally comprise &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; stalk region and at least one adaptor &lt;RTI ID=0.0&gt;region. In&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment the anchor primer contains at least two contiguous adapter regions. The stalk region is present at the &lt;RTI ID=0.0&gt;5'end&lt;/RTI&gt; of the anchor primer and includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region &lt;RTI ID=0.0&gt;of nucleotides for&lt;/RTI&gt; attaching the anchor primer to the solid substrate. </p><p> The adaptor region &lt;RTI ID=0.0&gt;(s)&lt;/RTI&gt; comprise nucleotide sequences that hybridize to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary sequence present in one or more members of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; population of nucleic acid sequences. In some embodiments, the anchor primer includes two adjoining adaptor regions, which hybridize to complementary regions &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; to separate ends of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; target nucleic acid &lt;RTI ID=0.0&gt;sequence. In&lt;/RTI&gt; additional embodiments, the adapter regions in the anchor primers are complementary to non-contiguous regions of sequence present in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second nucleic acid sequence. Each adapter region, for example, can be homologous to each terminus of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fragment produced by digestion with one or more restriction &lt;RTI ID=0.0&gt;endonucleases.&lt;/RTI&gt; The fragment can include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence known or suspected to contain &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence polymorphism. </p><p>Additionally, the anchor primer may contain two adapter regions that are homologous to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;gapped&lt;/RTI&gt; region of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; target nucleic acid sequence, &lt;RTI ID=0.0&gt;i.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.,&lt;/RTI&gt; one that is non-contiguous because of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; deletion of one or more nucleotides. When adapter regions having these sequences are used, an aligning &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; corresponding to the &lt;RTI ID=0.0&gt;gapped&lt;/RTI&gt; sequence may be annealed to the anchor primer along with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; population of template nucleic acid molecules. </p><p> The anchor primer may optionally contain additional elements such as one or more restriction enzyme recognition sites, RNA polymerase binding sites, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;T7&lt;/RTI&gt; promoter site, or sequences present in identified DNA sequences, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; sequences present &lt;RTI ID=0.0&gt;in known&lt;/RTI&gt; genes. </p><p>The adapter region &lt;RTI ID=0.0&gt;(s)&lt;/RTI&gt; may also include sequences known to flank sequence &lt;RTI ID=0.0&gt;polymorphisms.&lt;/RTI&gt; </p><p>Sequence &lt;RTI ID=0.0&gt;polymorphisms&lt;/RTI&gt; include nucleotide substitutions, insertions, deletions, or other rearrangements which result in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence difference between two otherwise identical nucleic acid sequences. An example of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence polymorphism is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single nucleotide polymorphism &lt;RTI ID=0.0&gt;(SNP).&lt;/RTI&gt; </p><p> In general, any nucleic acid capable of base-pairing can be used as an anchor primer. </p><p>In some embodiments, the anchor primer is an &lt;RTI ID=0.0&gt;oligonucleotide.&lt;/RTI&gt; As utilized herein the term </p><p>&lt;Desc/Clms Page number 45&gt;</p><p> &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; includes linear oligomers of natural or modified monomers or linkages, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;deoxyribonucleosides,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ribonucleosides,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;anomeric&lt;/RTI&gt; &lt;RTI ID=0.0&gt;forms&lt;/RTI&gt; thereof, peptide nucleic acids &lt;RTI ID=0.0&gt;(PNAs),&lt;/RTI&gt; and the like, that are capable of specifically binding to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; target &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; by way of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; regular pattern of monomer-to-monomer interactions. These types of interactions can include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., Watson-Crick type of base-pairing, base stacking, Hoogsteen or reverse- &lt;RTI ID=0.0&gt;Hoogsteen&lt;/RTI&gt; types of base-pairing, or the like. Generally, the monomers are linked by &lt;RTI ID=0.0&gt;phosphodiester&lt;/RTI&gt; bonds, or analogs thereof, to form &lt;RTI ID=0.0&gt;oligonucleotides&lt;/RTI&gt; ranging in size from, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., 3-200, 8-150, 10-100, &lt;RTI ID=0.0&gt;20-80,&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;25-50&lt;/RTI&gt; monomeric units. Whenever an &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; is represented by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence of letters, it is understood that the nucleotides are oriented in the &lt;RTI ID=0.0&gt;5'&lt;/RTI&gt; &lt;RTI ID=0.0&gt;,&lt;/RTI&gt; 3'direction, from left-to-right, and that the &lt;RTI ID=0.0&gt;letter"A"donates&lt;/RTI&gt; &lt;RTI ID=0.0&gt;deoxyadenosine,&lt;/RTI&gt; the letter &lt;RTI ID=0.0&gt;"T"denotes&lt;/RTI&gt; &lt;RTI ID=0.0&gt;thyrnidine,&lt;/RTI&gt; the &lt;RTI ID=0.0&gt;letter"C"denotes&lt;/RTI&gt; &lt;RTI ID=0.0&gt;deoxycytosine,&lt;/RTI&gt; and the &lt;RTI ID=0.0&gt;letter"G"denotes&lt;/RTI&gt; &lt;RTI ID=0.0&gt;deoxyguanosine,&lt;/RTI&gt; unless otherwise noted herein. The &lt;RTI ID=0.0&gt;oligonucleotides&lt;/RTI&gt; of the present invention can include non-natural nucleotide analogs. However, where, for example, processing by enzymes is required, or the like, &lt;RTI ID=0.0&gt;oligonucleotides&lt;/RTI&gt; comprising naturally occurring nucleotides are generally required &lt;RTI ID=0.0&gt;for&lt;/RTI&gt; maintenance of biological function. </p><p>* Anchor primers are linked to the solid substrate at the sensitized sites. They can be linked by the same method of linkage as described &lt;RTI ID=0.0&gt;for&lt;/RTI&gt; the fusion protein to the solid support. </p><p>&lt;RTI ID=0.0&gt;A&lt;/RTI&gt; region of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid substrate containing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; linked primer is referred to herein as an anchor pad. </p><p> Thus, by specifying the sensitized states on the solid support, it is possible to form an array or matrix of anchor pads. The anchor pads can &lt;RTI ID=0.0&gt;be,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., small diameter spots etched at evenly spaced intervals on the solid support. The anchor pads can be located at the bottoms of the cavitations or wells if the substrate has been &lt;RTI ID=0.0&gt;cavitated,&lt;/RTI&gt; etched, or otherwise &lt;RTI ID=0.0&gt;micromachined&lt;/RTI&gt; as discussed above. </p><p> In one embodiment, the anchor primer is linked to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; particle. The anchor primer can be linked to the particle prior to formation of the extended anchor primer or after formation of the extended anchor primer. </p><p> Each sensitized site on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid support is potentially capable of attaching multiple anchor primers. Thus, each anchor pad may include one or more anchor primers. It is preferable to maximize the number of pads that have only &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single productive reaction center &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., the number of pads that, after the extension reaction, have only &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single sequence extended from the anchor primer). This can be accomplished by techniques which include, but are not limited to : &lt;RTI ID=0.0&gt;(i)&lt;/RTI&gt; varying the dilution &lt;RTI ID=0.0&gt;of biotinylated&lt;/RTI&gt; anchor primers that are washed </p><p>&lt;Desc/Clms Page number 46&gt;</p><p> over the surface &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(ici)&lt;/RTI&gt; varying the incubation time that the &lt;RTI ID=0.0&gt;biotinylated&lt;/RTI&gt; primers are in contact with the &lt;RTI ID=0.0&gt;avidin&lt;/RTI&gt; surface ; &lt;RTI ID=0.0&gt;(ici)&lt;/RTI&gt; varying the concentration of open-or closed-circular template so that, on average, only one primer on each pad is extended to generate the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; template ; or &lt;RTI ID=0.0&gt;(iv)&lt;/RTI&gt; reducing the size of the anchor pad to approach single-molecule dimensions &lt;RTI ID=0.0&gt;( &lt; &lt;/RTI&gt; 1 &lt;RTI ID=0.0&gt;lem)&lt;/RTI&gt; such that binding of one anchor inhibits or blocks the binding of another anchor &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g. by &lt;RTI ID=0.0&gt;photoactivation&lt;/RTI&gt; of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; small &lt;RTI ID=0.0&gt;spot) ;&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;(v)&lt;/RTI&gt; reducing the size of the anchor pad such that binding of one circular template inhibits or blocks the binding of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second circular template. </p><p> In some embodiments, each individual pad contains just one linked anchor primer. </p><p>Pads having only one anchor primer can be made by performing limiting dilutions of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; selected anchor primer on to the solid support such that, on average, only one anchor primer is deposited on each pad. The concentration of anchor primer to be applied to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; pad can be calculated utilizing, for example, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; Poisson distribution model. </p><p> In order to maximize the number of reaction pads that contain &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single anchor primer, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; series of dilution experiments are performed in which &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; range of anchor primer concentrations or circular template concentrations are varied. For highly dilute concentrations of primers, primers and circular templates binding to the same pad will be independent of each other, and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; Poisson distribution will characterize the number of anchor primers extended on any one pad. Although there will be variability in the number of primers that are actually extended, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; maximum of 37% of the pads will have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single extended anchor primer (the number of pads with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single anchor &lt;RTI ID=0.0&gt;oligonucleotide).&lt;/RTI&gt; </p><p> In other embodiments multiple anchor primers are attached to any one individual pad in an array. Limiting dilutions of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of circular nucleic acid templates (described in more detail below) may be hybridized to the anchor primers so immobilized such that, on average, only one primer on each pad is hybridized to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid template. Library concentrations to be used may be calculated utilizing, for example, limiting dilutions and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; Poisson distribution model. </p><p> The nucleic acid templates that can be sequenced according to the invention, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid library, in general can include open circular or closed circular nucleic acid molecules. &lt;RTI ID=0.0&gt;A"closed&lt;/RTI&gt; &lt;RTI ID=0.0&gt;circle"is&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; closed circular nucleic acid molecule, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; circular DNA or RNA molecule. &lt;RTI ID=0.0&gt;An"open&lt;/RTI&gt; &lt;RTI ID=0.0&gt;circle"is&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; linear single-stranded nucleic acid molecule having &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; 5'phosphate group and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; 3'hydroxyl &lt;RTI ID=0.0&gt;group. In&lt;/RTI&gt; one embodiment, the single stranded nucleic acid contains at least &lt;RTI ID=0.0&gt;100&lt;/RTI&gt; copies of nucleic acid sequence, each copy </p><p>&lt;Desc/Clms Page number 47&gt;</p><p> &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked end to end. In some embodiments, the open circle is formed &lt;RTI ID=0.0&gt;in situ&lt;/RTI&gt; from &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; linear double-stranded nucleic acid molecule. The ends of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; given open circle nucleic acid molecule can be &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; by DNA ligase. Sequences at the 5'and 3'ends of the open circle molecule are complementary to two regions of adjacent nucleotides in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second nucleic acid molecule, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., an adapter region of an anchor primer, or to two regions that are nearly adjoining in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second DNA molecule. Thus, the ends of the open-circle molecule can be &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; using DNA ligase, or extended by DNA polymerase in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;gap-filling&lt;/RTI&gt; reaction. Open circles are described in detail in Lizard, &lt;RTI ID=0.0&gt;U.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S.&lt;/RTI&gt; Pat. &lt;RTI ID=0.0&gt;No.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5,&lt;/RTI&gt; 854, &lt;RTI ID=0.0&gt;033.&lt;/RTI&gt; An open circle can be converted to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; closed circle in the presence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; DNA ligase (for DNA) or RNA ligase following, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., annealing of the open circle to an anchor primer. </p><p> If desired, nucleic acid templates can be provided as padlock probes. Padlock probes are linear &lt;RTI ID=0.0&gt;oligonucleotides&lt;/RTI&gt; that include target-complementary sequences located at each end, and which are separated by &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; linker sequence. The linkers can be &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; to ends of members of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; library of nucleic acid sequences that have been, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., physically sheared or digested with restriction &lt;RTI ID=0.0&gt;endonucleases.&lt;/RTI&gt; Upon hybridization to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; target-sequence, the 5'-and 3'-terminal regions of these linear &lt;RTI ID=0.0&gt;oligonucleotides&lt;/RTI&gt; are brought in juxtaposition. This juxtaposition allows the two probe segments &lt;RTI ID=0.0&gt;(if&lt;/RTI&gt; properly hybridized) to be &lt;RTI ID=0.0&gt;covalently-bound&lt;/RTI&gt; by &lt;RTI ID=0.0&gt;enzymatic&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ligation&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; g., with &lt;RTI ID=0.0&gt;T4&lt;/RTI&gt; DNA ligase), thus converting the probes to circularly-closed molecules which are &lt;RTI ID=0.0&gt;catenated&lt;/RTI&gt; to the specific target sequences (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Nilsson, et al., &lt;RTI ID=0.0&gt;1994.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Science&lt;/RTI&gt; &lt;RTI ID=0.0&gt;265&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;2085-2088</bibl>).&lt;/RTI&gt; The resulting probes are suitable for the simultaneous analysis of many gene sequences both due to their &lt;RTI ID=0.0&gt;specificity&lt;/RTI&gt; and selectivity for gene sequence variants (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Lizard, et al., &lt;RTI ID=0.0&gt;1998.&lt;/RTI&gt; Nat Genet. 19 : 225-232</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Nilsson, et al., &lt;RTI ID=0.0&gt;1997.&lt;/RTI&gt; Nat. Genet. 16 : 252- &lt;RTI ID=0.0&gt;255</bibl>)&lt;/RTI&gt; and due to the fact that the resulting reaction products remain localized to the specific target sequences. Moreover, &lt;RTI ID=0.0&gt;intramolecular&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ligation&lt;/RTI&gt; of many different probes is expected to be less susceptible to non-specific &lt;RTI ID=0.0&gt;cross-reactivity&lt;/RTI&gt; than multiplex &lt;RTI ID=0.0&gt;PCR-based&lt;/RTI&gt; methodologies where non-cognate pairs of primers can give rise to irrelevant amplification products (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g.,<bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0"> Landegren and Nilsson, &lt;RTI ID=0.0&gt;1997.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Ann. Med.&lt;/RTI&gt; 29 : &lt;RTI ID=0.0&gt;585-590</bibl>).&lt;/RTI&gt; </p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; starting library can be constructed comprising either single-stranded or double- stranded nucleic acid molecules, provided that the nucleic acid sequence includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region that, if present in the library, is available for annealing, or can be made available for annealing, to an anchor primer sequence. For example, when used as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template for rolling </p><p>&lt;Desc/Clms Page number 48&gt;</p><p> circle amplification, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; double-stranded template needs to be at least &lt;RTI ID=0.0&gt;transiently&lt;/RTI&gt; single-stranded in order to act as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template for extension of the anchor primer. </p><p> Library templates can include multiple elements, including, but not limited &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; one or more regions that arc complementary to the anchor primer. For example, the template libraries may include &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region complementary to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; control nucleotide region, and an insert sequence comprised of the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; template to be subsequently characterized. As is explained in more detail below, the control nucleotide region is used to calibrate the relationship between the amount of &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; and the number of nucleotides incorporated. As utilized herein the &lt;RTI ID=0.0&gt;term"complement"refers&lt;/RTI&gt; to nucleotide sequences that are able to hybridize to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; specific nucleotide sequence to form &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; matched duplex. </p><p> In one embodiment, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; library template includes : &lt;RTI ID=0.0&gt;(i)&lt;/RTI&gt; two distinct regions that are complementary to the anchor primer, &lt;RTI ID=0.0&gt;(ici)&lt;/RTI&gt; one region homologous to the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, &lt;RTI ID=0.0&gt;(ici)&lt;/RTI&gt; one optional control nucleotide region, &lt;RTI ID=0.0&gt;(iv)&lt;/RTI&gt; an insert sequence &lt;RTI ID=0.0&gt;of,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; 30-500, 50-200, or &lt;RTI ID=0.0&gt;60-100&lt;/RTI&gt; nucleotides, that is to be &lt;RTI ID=0.0&gt;sequenced.&lt;/RTI&gt; The template can, of course, include two, three, or all four of these features. </p><p> The template nucleic acid can be constructed from any source of nucleic acid, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; any cell, tissue, or organism, and can be generated by any art-recognized method. Suitable methods include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;sonication&lt;/RTI&gt; &lt;RTI ID=0.0&gt;of genomic&lt;/RTI&gt; DNA and digestion with one or more restriction &lt;RTI ID=0.0&gt;endonucleases&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(RE)&lt;/RTI&gt; to generate fragments of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; desired range of lengths from an initial population of nucleic acid molecules. Preferably, one or more of the restriction enzymes have distinct four-base recognition sequences. Examples of such enzymes include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., Sau3Al, &lt;RTI ID=0.0&gt;MspI,&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;TaqI.&lt;/RTI&gt; Preferably, the enzymes are used in conjunction with anchor primers having regions containing recognition sequences for the corresponding restriction enzymes. In some embodiments, one or both of the adapter regions of the anchor primers contain additional sequences adjoining known restriction enzyme recognition sequences, thereby allowing for capture or annealing to the anchor primer of specific restriction fragments of interest to the anchor primer. In other embodiments, the restriction enzyme is used with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; type IIS restriction enzyme. </p><p> Alternatively, template libraries can be made by generating &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary DNA &lt;RTI ID=0.0&gt;(cDNA)&lt;/RTI&gt; library from &lt;RTI ID=0.0&gt;RNA,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., messenger RNA &lt;RTI ID=0.0&gt;(mRNA).&lt;/RTI&gt; The cDNA library can, if desired, be further processed with restriction &lt;RTI ID=0.0&gt;endonucleases&lt;/RTI&gt; to obtain &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; characteristic of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; specific &lt;RTI ID=0.0&gt;RNA,&lt;/RTI&gt; internal fragments, or fragments including the &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; of the isolated &lt;RTI ID=0.0&gt;RNA.&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 49&gt;</p><p> Adapter regions in the anchor primer may be complementary to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence of interest that is thought to occur in the template library, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; known or suspected sequence polymorphism within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fragment generated by &lt;RTI ID=0.0&gt;endonuclease&lt;/RTI&gt; digestion. </p><p> &lt;RTI ID=0.0&gt;In&lt;/RTI&gt; one embodiment, an indexing &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; can be attached to members of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template library to allow for subsequent correlation of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template nucleic acid with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; population of nucleic acids from which the template nucleic acid is derived. For example, one or more samples of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; starting DNA population can be fragmented separately using any of the previously disclosed methods &lt;RTI ID=0.0&gt;(e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; restriction digestion, &lt;RTI ID=0.0&gt;sonication).&lt;/RTI&gt; An indexing &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; sequence specific for each sample is attached &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g., ligated&lt;/RTI&gt; &lt;RTI ID=0.0&gt;to,&lt;/RTI&gt; the termini of members of the fragmented population. The indexing &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; can act as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region for &lt;RTI ID=0.0&gt;circularization,&lt;/RTI&gt; amplification and, optionally, &lt;RTI ID=0.0&gt;sequencing,&lt;/RTI&gt; which permits it to be used to index, or code, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid so as to identify the starting sample from which it is derived. </p><p> Distinct template libraries made with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of distinguishable indexing primers can be mixed together for subsequent reactions. Determining the sequence of the member of the library allows for the identification of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence corresponding to the indexing &lt;RTI ID=0.0&gt;oligonucleotide.&lt;/RTI&gt; Based on this information, the origin of any given fragment can be inferred. </p><p> Libraries of nucleic acids are annealed to anchor primer sequences using recognized techniques (see, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Hatch, &lt;RTI ID=0.0&gt;et al.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1999.&lt;/RTI&gt; Genet. Anal. Biomol. Engineer. 15 : 35-40</bibl> ; Kool, &lt;RTI ID=0.0&gt;<bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">U.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S.&lt;/RTI&gt; Patent &lt;RTI ID=0.0&gt;No.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5,&lt;/RTI&gt; 714, 320</bibl> and Lizard, &lt;RTI ID=0.0&gt;<bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">U.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S.&lt;/RTI&gt; Patent &lt;RTI ID=0.0&gt;No.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;854,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;033</bibl>).&lt;/RTI&gt; In general, any procedure for annealing the anchor primers to the template nucleic acid sequences is suitable as long as it results in formation of specific, &lt;RTI ID=0.0&gt;i.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.,&lt;/RTI&gt; perfect or nearly perfect, complementarity between the adapter region or regions in the anchor primer sequence and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence present in the template library. </p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; number of in vitro nucleic acid amplification techniques may be utilized to extend the anchor primer sequence. The size of the amplified DNA preferably is smaller than the size of the anchor pad and also smaller than the distance between anchor pads. </p><p> The amplification is typically performed in the presence &lt;RTI ID=0.0&gt;of a polymerase,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; DNA or &lt;RTI ID=0.0&gt;RNA-directed&lt;/RTI&gt; DNA polymerase, and one, two, three, or four types of nucleotide &lt;RTI ID=0.0&gt;triphosphates,&lt;/RTI&gt; and, optionally, &lt;RTI ID=0.0&gt;auxiliary&lt;/RTI&gt; binding proteins. In general, any polymerase capable of extending &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed &lt;RTI ID=0.0&gt;3'-OH&lt;/RTI&gt; group can be used &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; long as it lacks &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;3'to&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5'exonuclease&lt;/RTI&gt; activity. Suitable &lt;RTI ID=0.0&gt;polymerases&lt;/RTI&gt; include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., the DNA &lt;RTI ID=0.0&gt;polymerases&lt;/RTI&gt; from &lt;RTI ID=0.0&gt;Bacillus&lt;/RTI&gt; stearothermophilus, Thermus acquaticus, Pyrococcus furiosis, Thermococcus litoralis, and </p><p>&lt;Desc/Clms Page number 50&gt;</p><p> Thermus thermophilus, &lt;RTI ID=0.0&gt;bacteriophage&lt;/RTI&gt; &lt;RTI ID=0.0&gt;T4&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;T7,&lt;/RTI&gt; and the &lt;RTI ID=0.0&gt;E.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;coli&lt;/RTI&gt; DNA polymerase &lt;RTI ID=0.0&gt;I&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Klenow&lt;/RTI&gt; fragment. Suitable &lt;RTI ID=0.0&gt;RNA-directed&lt;/RTI&gt; DNA &lt;RTI ID=0.0&gt;polymerases&lt;/RTI&gt; include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., the reverse &lt;RTI ID=0.0&gt;transcriptase&lt;/RTI&gt; from the &lt;RTI ID=0.0&gt;Avian&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Myeloblastosis&lt;/RTI&gt; Virus, the reverse &lt;RTI ID=0.0&gt;transcriptase&lt;/RTI&gt; from the Moloney Murine Leukemia Virus, and the reverse &lt;RTI ID=0.0&gt;transcriptase&lt;/RTI&gt; from the Human Immunodeficiency &lt;RTI ID=0.0&gt;Virus-1.&lt;/RTI&gt; </p><p> &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; number of &lt;RTI ID=0.0&gt;in vitro&lt;/RTI&gt; nucleic acid amplification techniques have been described. </p><p>These amplification methodologies may be differentiated into those methods : (i) which require temperature cycling-polymerase chain reaction &lt;RTI ID=0.0&gt;(PCR)&lt;/RTI&gt; (see &lt;RTI ID=0.0&gt;e. g,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;<bibl next="bibl87" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Saiki,&lt;/RTI&gt; et al., &lt;RTI ID=0.0&gt;1995.&lt;/RTI&gt;</bibl> </p><p><bibl xml:id="bibl87" xmlns="http://www.tei-c.org/ns/1.0">&lt;RTI ID=0.0&gt;Science&lt;/RTI&gt; &lt;RTI ID=0.0&gt;230&lt;/RTI&gt; : 1350-1354</bibl>), ligase chain reaction (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl next="bibl88" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Barany, 1991. Proc. Natl. Acad. Sci.</bibl> </p><p><bibl xml:id="bibl88" xmlns="http://www.tei-c.org/ns/1.0">&lt;RTI ID=0.0&gt;USA&lt;/RTI&gt; &lt;RTI ID=0.0&gt;88&lt;/RTI&gt; : 189-193</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Barringer, et al., &lt;RTI ID=0.0&gt;1990.&lt;/RTI&gt; Gene &lt;RTI ID=0.0&gt;89&lt;/RTI&gt; : 117-122</bibl>) and transcription-based amplification (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Kwoh, et al., &lt;RTI ID=0.0&gt;1989.&lt;/RTI&gt; proc. Natl. Acad. Sci. USA &lt;RTI ID=0.0&gt;86&lt;/RTI&gt; : 1173-1177</bibl>) and &lt;RTI ID=0.0&gt;(ici)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;isothermal&lt;/RTI&gt; amplification systems-self-sustaining, sequence replication (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Guatelli, et al., &lt;RTI ID=0.0&gt;1990.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Proc.&lt;/RTI&gt; Natl. Acad. Sci. USA &lt;RTI ID=0.0&gt;87&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;1874-1878</bibl>)&lt;/RTI&gt; ; the &lt;RTI ID=0.0&gt;Q &lt;/RTI&gt; replicase system (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Lizard, et al., &lt;RTI ID=0.0&gt;1988.&lt;/RTI&gt; BioTechnolgoy &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; : 1197-1202</bibl>) &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; strand displacement amplification Nucleic Acids &lt;RTI ID=0.0&gt;Res.&lt;/RTI&gt; 1992 &lt;RTI ID=0.0&gt;Apr&lt;/RTI&gt; 11 ; 20 &lt;RTI ID=0.0&gt;(7)&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;1691-6.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; and the methods described in <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">PNAS 1992 Jan &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; ; 89 &lt;RTI ID=0.0&gt;(1)&lt;/RTI&gt; : 392-6</bibl> ; &lt;RTI ID=0.0&gt;and <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">NASBA J Virol Methods.&lt;/RTI&gt; 1991 Dec ; 35 &lt;RTI ID=0.0&gt;(3)&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;273-86</bibl>.&lt;/RTI&gt; </p><p> &lt;RTI ID=0.0&gt;Isothermal&lt;/RTI&gt; amplification also includes rolling circle-based amplification &lt;RTI ID=0.0&gt;(RCA).&lt;/RTI&gt; RCA is discussed in, e.g., Kool, &lt;RTI ID=0.0&gt;<bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">U.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S.&lt;/RTI&gt; Patent &lt;RTI ID=0.0&gt;No.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5,&lt;/RTI&gt; 714, 320</bibl> and Lizard, &lt;RTI ID=0.0&gt;<bibl type="patent" xmlns="http://www.tei-c.org/ns/1.0">U.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;S.&lt;/RTI&gt; Patent &lt;RTI ID=0.0&gt;No.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5,&lt;/RTI&gt; 854, 033</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Hatch, et al., &lt;RTI ID=0.0&gt;1999.&lt;/RTI&gt; Genet. Anal. Biomol. Engineer. 15 : &lt;RTI ID=0.0&gt;35-40</bibl>.&lt;/RTI&gt; The result of the RCA is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single DNA strand extended from the 3'terminus of the anchor primer (and thus is linked to the solid support matrix) and including &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;concatamer&lt;/RTI&gt; containing multiple copies of the circular template annealed to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primer sequence. Typically, 1, 000 to 10, 000 or more copies of circular templates, each having &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; size &lt;RTI ID=0.0&gt;of,&lt;/RTI&gt; e.g., approximately 30-500, 50-200, or &lt;RTI ID=0.0&gt;60-100&lt;/RTI&gt; nucleotides size range, can be obtained with &lt;RTI ID=0.0&gt;RCA.&lt;/RTI&gt; </p><p> &lt;RTI ID=0.0&gt;In vivo,&lt;/RTI&gt; RCR is utilized in several biological systems. For example, the genome of several &lt;RTI ID=0.0&gt;bacteriophage&lt;/RTI&gt; are single-stranded, circular DNA. During replication, the circular DNA is initially converted to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; duplex form, which is then replicated by the aforementioned rolling-circle replication mechanism. The displaced terminus generates &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; series &lt;RTI ID=0.0&gt;of genomic&lt;/RTI&gt; units that can be cleaved and inserted into the &lt;RTI ID=0.0&gt;phage&lt;/RTI&gt; particles. Additionally, the displaced single-strand of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; rolling-circle can be converted to duplex DNA by synthesis of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary DNA strand. This synthesis can be used to generate the &lt;RTI ID=0.0&gt;concatemeric&lt;/RTI&gt; duplex molecules required for the maturation of certain &lt;RTI ID=0.0&gt;phage&lt;/RTI&gt; &lt;RTI ID=0.0&gt;DNAs.&lt;/RTI&gt; For example, this provides the principle &lt;RTI ID=0.0&gt;pathway&lt;/RTI&gt; by which &lt;RTI ID=0.0&gt;X&lt;/RTI&gt; &lt;RTI ID=0.0&gt;bacteriophage&lt;/RTI&gt; matures. &lt;RTI ID=0.0&gt;RCR&lt;/RTI&gt; is also used &lt;RTI ID=0.0&gt;in vivo&lt;/RTI&gt; to generate </p><p>&lt;Desc/Clms Page number 51&gt;</p><p> amplified rDNA in &lt;RTI ID=0.0&gt;Xenopus&lt;/RTI&gt; oocytes, and this fact may help explain why the amplified rDNA is comprised of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; large number of identical repeating units. In this case, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single genomic repeating unit is converted into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; rolling-circle. The displaced terminus is then converted into duplex DNA which is subsequently cleaved from the circle so that the two termini can be &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; together so as to generate the amplified circle of &lt;RTI ID=0.0&gt;rDNA.&lt;/RTI&gt; </p><p> Through the use of the RCA reaction, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; strand may be generated which represents many tandem copies of the complement to the circularized molecule. For example, RCA has recently been utilized to obtain an &lt;RTI ID=0.0&gt;isothermal&lt;/RTI&gt; cascade amplification reaction of circularized padlock probes &lt;RTI ID=0.0&gt;in vitro&lt;/RTI&gt; in order to detect single-copy genes in human genomic DNA samples (see <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Lizard, et al., &lt;RTI ID=0.0&gt;1998.&lt;/RTI&gt; Nat. Genet. 19 : &lt;RTI ID=0.0&gt;225-232</bibl>).&lt;/RTI&gt; In addition, RCA has also been utilized to detect single DNA molecules in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid phase-based assay, although difficulties arose when this technique was applied to in situ hybridization (see <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Lizard, &lt;RTI ID=0.0&gt;et aZ.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1998.&lt;/RTI&gt; Nat. Genet. 19 : &lt;RTI ID=0.0&gt;225-232</bibl>).&lt;/RTI&gt; </p><p> If desired, RCA can be performed at elevated temperatures, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; at temperatures greater than &lt;RTI ID=0.0&gt;37 &lt;/RTI&gt; C, 42  C, 45  C, 50  C, 60  &lt;RTI ID=0.0&gt;C,&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;70 &lt;/RTI&gt; &lt;RTI ID=0.0&gt;C.&lt;/RTI&gt; In addition, RCA can be performed initially at &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; lower temperature, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; room temperature, and then shifted to an elevated temperature. Elevated temperature RCA is preferably performed with thermostable nucleic acid &lt;RTI ID=0.0&gt;polymerases&lt;/RTI&gt; and with primers that can anneal stably and with &lt;RTI ID=0.0&gt;specificity&lt;/RTI&gt; at elevated temperatures. </p><p>RCA can also be performed with non-naturally occurring &lt;RTI ID=0.0&gt;oligonucleotides,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., peptide nucleic acids. Further, RCA can be performed in the presence of auxiliary proteins such as single-stranded binding proteins. </p><p> The development of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of amplifying short DNA molecules which have been immobilized to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid support, termed RCA has been recently described in the literature (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;g.,&lt;/RTI&gt; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Hatch, et al., &lt;RTI ID=0.0&gt;1999.&lt;/RTI&gt; Genet. Anal. Biomol. Engineer. 15 : 35-40</bibl> &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Zhang, et al., &lt;RTI ID=0.0&gt;1998.&lt;/RTI&gt; Gene &lt;RTI ID=0.0&gt;211&lt;/RTI&gt; : 277-85</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Baner, &lt;RTI ID=0.0&gt;et al.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1998.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Nucl. AcidsRes.&lt;/RTI&gt; 26 : 5073-5078</bibl> ;<bibl next="bibl89" type="journal" xmlns="http://www.tei-c.org/ns/1.0"> Liu, et al., 1995. J. Am.</bibl> </p><p><bibl xml:id="bibl89" xmlns="http://www.tei-c.org/ns/1.0">Chem. Soc. 118 : 1587-1594</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Fire &lt;RTI ID=0.0&gt;andXu,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1995.&lt;/RTI&gt; Proc. Natl. Acad. Sci. USA &lt;RTI ID=0.0&gt;92&lt;/RTI&gt; : 4641-4645</bibl> ; <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Nilsson, et al., &lt;RTI ID=0.0&gt;1994.&lt;/RTI&gt; Science &lt;RTI ID=0.0&gt;265&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;2085-2088</bibl>).&lt;/RTI&gt; RCA targets specific DNA sequences through hybridization and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; DNA ligase reaction. The circular product is then subsequently used as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; rolling circle replication reaction. </p><p> RCA driven by DNA polymerase can replicate circularized &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; probes with either linear or geometric kinetics under &lt;RTI ID=0.0&gt;isothermal&lt;/RTI&gt; conditions. In the presence of two </p><p>&lt;Desc/Clms Page number 52&gt;</p><p> primers (one hybridizing to the &lt;RTI ID=0.0&gt;+&lt;/RTI&gt; strand, and the other, to the-strand &lt;RTI ID=0.0&gt;of DNA),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complex pattern of DNA strand displacement ensues which possesses the ability to generate &lt;RTI ID=0.0&gt;lux109&lt;/RTI&gt; or more copies of each circle in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; short period of time (i. &lt;RTI ID=0.0&gt;e.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;less-than&lt;/RTI&gt; &lt;RTI ID=0.0&gt;90&lt;/RTI&gt; minutes), enabling the detection of single-point mutations within the human &lt;RTI ID=0.0&gt;genome.&lt;/RTI&gt; Using &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single primer, RCA generates hundreds of randomly-linked copies &lt;RTI ID=0.0&gt;of a covalently&lt;/RTI&gt; closed circle in several minutes. </p><p> If solid support matrix-associated, the DNA product remains bound at the site of synthesis, where it may be labeled, condensed, and imaged as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; point light source. For example, linear &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; probes, which can generate RCA signals, have been bound &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; onto &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; glass surface. The color of the signal generated by these probes indicates the &lt;RTI ID=0.0&gt;allele&lt;/RTI&gt; status of the target, depending upon the outcome of specific, target-directed &lt;RTI ID=0.0&gt;ligation&lt;/RTI&gt; events. As RCA permits millions of individual probe molecules to be counted and sorted, it is particularly amenable for the analysis of rare somatic mutations. RCA also shows promise for the detection of padlock probes bound to single-copy genes in cytological preparations. </p><p> In addition, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid-phase RCA methodology has also been developed to provide an effective method of detecting constituents within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solution. Initially, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; recognition step is used to generate &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complex &lt;RTI ID=0.0&gt;h&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; circular template is bound to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; surface. &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; polymerase enzyme is then used to amplify the bound complex. RCA uses small DNA probes that are amplified to provide an intense signal using detection methods, including the methods described in more detail below. </p><p>Other examples of &lt;RTI ID=0.0&gt;isothermal&lt;/RTI&gt; amplification systems include, &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., (i) self-sustaining, sequence replication (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Guatelli, &lt;RTI ID=0.0&gt;et al.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1990.&lt;/RTI&gt; proc. Natl. Acad. Sci. USA 87 : 1874-1878</bibl>), &lt;RTI ID=0.0&gt;(ici)&lt;/RTI&gt; the &lt;RTI ID=0.0&gt;Q &lt;/RTI&gt; replicase system (see &lt;RTI ID=0.0&gt;e.&lt;/RTI&gt; g., <bibl type="journal" xmlns="http://www.tei-c.org/ns/1.0">Lizard, et al., 1988. BioTechnology &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; : 1197-1202</bibl>), and (iii) nucleic acid sequence-based amplification &lt;RTI ID=0.0&gt;(NASBA, see&lt;/RTI&gt; &lt;RTI ID=0.0&gt;<bibl next="bibl90" type="journal" xmlns="http://www.tei-c.org/ns/1.0">Kievits,&lt;/RTI&gt; et al., &lt;RTI ID=0.0&gt;1991.&lt;/RTI&gt; J. Virol.</bibl> </p><p><bibl xml:id="bibl90" xmlns="http://www.tei-c.org/ns/1.0">&lt;RTI ID=0.0&gt;Methods&lt;/RTI&gt; &lt;RTI ID=0.0&gt;35&lt;/RTI&gt; : &lt;RTI ID=0.0&gt;273-286</bibl>).&lt;/RTI&gt; </p><p> Amplification of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid template as described above results in multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template nucleic acid sequence &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to an anchor primer. In one embodiment, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region of the sequence product is determined by annealing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region of the template nucleic acid, and then contacting the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; DNA polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; known nucleotide &lt;RTI ID=0.0&gt;triphosphate, i.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;e.,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;dATP,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;dCTP,&lt;/RTI&gt; dGTP, &lt;RTI ID=0.0&gt;dTTP,&lt;/RTI&gt; or an analog of one of these nucleotides. The sequence can be determined by detecting &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence reaction &lt;RTI ID=0.0&gt;byproduct,&lt;/RTI&gt; as is described below. </p><p>&lt;Desc/Clms Page number 53&gt;</p><p> The sequence primer can be any length or base composition, as long as it is capable of specifically annealing to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region of the amplified nucleic acid template. No particular structure for the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer is required so long as it is able to specifically prime &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region on the amplified template nucleic acid. Preferably, the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer is complementary to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region of the template that is between the sequence to be characterized and the sequence &lt;RTI ID=0.0&gt;hybridizable&lt;/RTI&gt; to the anchor primer. The &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer is extended with the DNA polymerase to form &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence product. The extension is performed in the presence of one or more types of nucleotide &lt;RTI ID=0.0&gt;triphosphates,&lt;/RTI&gt; and if desired, auxiliary binding proteins. </p><p> The method comprises the steps of : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; introducing the template nucleic acid polymer into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerization environment in which the nucleic acid polymer will act as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template polymer for the synthesis of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary nucleic acid polymer when nucleotides are added &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; successively providing to the polymerization environment &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; series of feedstocks, each &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; separately recovering each of the &lt;RTI ID=0.0&gt;feedstocks&lt;/RTI&gt; from the polymerization environment ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; measuring the amount of inorganic pyrophosphate by utilizing an ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein in each of the recovered &lt;RTI ID=0.0&gt;feedstocks&lt;/RTI&gt; to determine the identity of each nucleotide in the complementary polymer and thus the sequence of the template polymer. </p><p> The sequence primer can be any length or base composition, as long as it is capable of specifically annealing to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region of the amplified nucleic acid template. No particular structure is required for the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer so long as it is able to specifically prime &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region on the amplified template nucleic acid. Preferably, the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer is complementary to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; region of the template that is between the sequence to be characterized and the sequence &lt;RTI ID=0.0&gt;hybridizable&lt;/RTI&gt; to the anchor primer. The &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer is extended with the DNA polymerase to form &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; sequence product. The extension is performed in the presence of one or more types of nucleotide &lt;RTI ID=0.0&gt;triphosphates,&lt;/RTI&gt; and if desired, auxiliary binding proteins. </p><p> This invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method wherein the amount of inorganic pyrophosphate is measured by &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; adding &lt;RTI ID=0.0&gt;adenosine-5'-phosphosulfate&lt;/RTI&gt; to the &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; combining the recovered &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; containing &lt;RTI ID=0.0&gt;adenosine-5'-phosphosulfate&lt;/RTI&gt; with an ATP generating </p><p>&lt;Desc/Clms Page number 54&gt;</p><p> &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein such that any inorganic pyrophosphate in the recovered &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; and the &lt;RTI ID=0.0&gt;adenosine-5'-phosphosulfate&lt;/RTI&gt; will first react to the form ATP and sulfate and then react with &lt;RTI ID=0.0&gt;luciferin&lt;/RTI&gt; in the presence of oxygen such that the ATP is consumed to produced AMP, inorganic pyrophosphate, carbon dioxide and light &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; measuring the amount of light produced. In &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; preferred embodiment, the template polymer and ATP generating &lt;RTI ID=0.0&gt;polypeptide-ATP&lt;/RTI&gt; converting polypeptide fusion protein are immobilized on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; solid support. </p><p> The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for determining the nucleic acid sequence in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template nucleic acid polymer, comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; introducing the template nucleic acid polymer into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerization environment in which the nucleic acid polymer will act as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template polymer for the synthesis of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary nucleic acid polymer when nucleotides are added ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; successively providing to the polymerization environment &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; series of feedstocks, each &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the &lt;RTI ID=0.0&gt;feedstock&lt;/RTI&gt; is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; separately recovering each of the &lt;RTI ID=0.0&gt;feedstocks&lt;/RTI&gt; from the polymerization environment ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; measuring the amount &lt;RTI ID=0.0&gt;of PPi&lt;/RTI&gt; with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; luciférase in each of the recovered &lt;RTI ID=0.0&gt;feedstocks&lt;/RTI&gt; to determine the identity of each nucleotide in the complementary polymer and thus the sequence of the template polymer. In one embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and the &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; are joined in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein. In another embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is joined to an affinity tag. </p><p> The invention further provides &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing one or more nucleic acid anchor primers ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200&lt;/RTI&gt; &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; annealing an effective amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed anchor primer-circular template complex ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; combining the primed anchor primer-circular template complex with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase to form an extended anchor primer &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid complementary to the </p><p>&lt;Desc/Clms Page number 55&gt;</p><p> circular nucleic acid template ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; annealing an effective amount of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to one or more copies of said &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked complementary nucleic acid &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; extending the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product and, if the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; of said &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; ; and &lt;RTI ID=0.0&gt;(g)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with the use of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; thereby determining the sequence of the nucleic acid. In one embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and the &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; are joined in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein. In another embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is joined to an affinity tag. </p><p> Also included in the invention is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method for &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing at least one nucleic acid anchor primer ; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of single-stranded circular nucleic acid templates in an array having at least 400, 000 discrete reaction sites ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; annealing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; first amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primed anchor primer-circular template complex ; &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; combining the primed anchor primer-circular template complex with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase to form an extended anchor primer &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked to multiple copies of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid complementary to the circular nucleic acid template ; &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; annealing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; second amount of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer to one or more copies of the &lt;RTI ID=0.0&gt;covalently&lt;/RTI&gt; linked complementary nucleic acid ; &lt;RTI ID=0.0&gt;(f)&lt;/RTI&gt; extending the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; predetermined nucleotide triphosphate to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; product and, when the predetermined nucleotide triphosphate is incorporated onto the &lt;RTI ID=0.0&gt;3'end&lt;/RTI&gt; of the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; primer, to yield &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; ; and &lt;RTI ID=0.0&gt;(g)&lt;/RTI&gt; identifying the &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; reaction &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with the use of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; thereby determining the sequence of the nucleic acid at each reaction site that contains &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nucleic acid template. In one embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and the &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; are joined in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein. In another embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is joined to an affinity tag. </p><p> The invention also includes &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; method of determining the base sequence of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of nucleotides on an array, the method comprising : &lt;RTI ID=0.0&gt;(a)&lt;/RTI&gt; providing &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of sample DNAs, each disposed within &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; plurality of cavities on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; planar surface, each cavity forming an &lt;RTI ID=0.0&gt;analyte&lt;/RTI&gt; reaction chamber, wherein the reaction chambers have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; center to center spacing of between &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;200, um,&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; adding an activated nucleotide 5'-triphosphate precursor of one known nitrogenous base to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; reaction mixture in each reaction chamber, each reaction </p><p>&lt;Desc/Clms Page number 56&gt;</p><p> mixture comprising &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; template-directed nucleotide polymerase and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single-stranded &lt;RTI ID=0.0&gt;polynucleotide&lt;/RTI&gt; template hybridized to &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; complementary &lt;RTI ID=0.0&gt;oligonucleotide&lt;/RTI&gt; primer strand at least one nucleotide residue shorter than the templates to form at least one unaired nucleotide residue in each template at the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the &lt;RTI ID=0.0&gt;3'-end&lt;/RTI&gt; of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unaired nucleotide residue of the templates ; &lt;RTI ID=0.0&gt;(c)&lt;/RTI&gt; detecting whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands through detection of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sequencing&lt;/RTI&gt; &lt;RTI ID=0.0&gt;byproduct&lt;/RTI&gt; with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; thus indicating that the unaired nucleotide residue of the template has &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor ; and &lt;RTI ID=0.0&gt;(d)&lt;/RTI&gt; sequentially repeating steps &lt;RTI ID=0.0&gt;(b)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;(c),&lt;/RTI&gt; wherein each sequential repetition adds and, detects the incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition ; and &lt;RTI ID=0.0&gt;(e)&lt;/RTI&gt; determining the base sequence of the unaired nucleotide residue of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors. In one embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and the &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; are joined in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; fusion protein. In another embodiment, the thermostable &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is joined to an affinity tag. </p><p> The invention will be further illustrated in the following non-limiting examples. </p><p>There are several abbreviations which will be used in the following examples : FUS stands for fusion gene, S stands for sulfurylase, L stands for luciferase, TL stands for thermostable luciferase, X stands for &lt;RTI ID=0.0&gt;XhoI,&lt;/RTI&gt; H stands for HindIII, N stands for &lt;RTI ID=0.0&gt;NotI&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;B&lt;/RTI&gt; stands for &lt;RTI ID=0.0&gt;BamHI.&lt;/RTI&gt; For example, FUS-L/S &lt;RTI ID=0.0&gt;X&lt;/RTI&gt; &lt;RTI ID=0.0&gt;F&lt;/RTI&gt; means &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; primer for the fusion gene, &lt;RTI ID=0.0&gt;luciferase-&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; Xho Forward and so forth. Primers &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; through &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; are for the &lt;RTI ID=0.0&gt;L&lt;/RTI&gt; or TL to &lt;RTI ID=0.0&gt;S&lt;/RTI&gt; fusions and primers &lt;RTI ID=0.0&gt;7&lt;/RTI&gt; through &lt;RTI ID=0.0&gt;13&lt;/RTI&gt; are for the &lt;RTI ID=0.0&gt;S&lt;/RTI&gt; to &lt;RTI ID=0.0&gt;L&lt;/RTI&gt; or TL fusions. </p><p> EXAMPLES Example &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; : Cloning Strategy for Obtaining the &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; Gene 
Gene specific primers, which incorporated restriction site &lt;RTI ID=0.0&gt;linkers,&lt;/RTI&gt; were designed based on the sequence for &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; putative ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; from Bacillus stearothermophilus in </p><p>&lt;Desc/Clms Page number 57&gt;</p><p> ERGO, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; curated &lt;RTI ID=0.0&gt;database&lt;/RTI&gt; &lt;RTI ID=0.0&gt;of genomic&lt;/RTI&gt; DNA made available on the World Wide Web by Integrated &lt;RTI ID=0.0&gt;Genomics&lt;/RTI&gt; which included the Bacillus stearothermophilus Genome &lt;RTI ID=0.0&gt;Sequencing&lt;/RTI&gt; Project at the University of Oklahoma &lt;RTI ID=0.0&gt;(NSF&lt;/RTI&gt; Grant &lt;RTI ID=0.0&gt;&amp;num;EPS-9550478).&lt;/RTI&gt; The forward primer utilized was &lt;RTI ID=0.0&gt;5'-CCC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;TTC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;TGC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;AGC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ATG&lt;/RTI&gt; &lt;RTI ID=0.0&gt;AGC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;GTA&lt;/RTI&gt; &lt;RTI ID=0.0&gt;AGC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ATC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;CCG&lt;/RTI&gt; CAT &lt;RTI ID=0.0&gt;GGC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;GGC&lt;/RTI&gt; ACA &lt;RTI ID=0.0&gt;TTG-3'&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;7)&lt;/RTI&gt; and the reverse primer used was &lt;RTI ID=0.0&gt;5'-CCC&lt;/RTI&gt; GTA AGC TTT TAG &lt;RTI ID=0.0&gt;CGC&lt;/RTI&gt; GCT &lt;RTI ID=0.0&gt;GAC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;GGG&lt;/RTI&gt; &lt;RTI ID=0.0&gt;GCG&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ACC&lt;/RTI&gt; &lt;RTI ID=0.0&gt;GTT&lt;/RTI&gt; &lt;RTI ID=0.0&gt;TCG&lt;/RTI&gt; &lt;RTI ID=0.0&gt;CGT&lt;/RTI&gt; &lt;RTI ID=0.0&gt;TCT&lt;/RTI&gt; &lt;RTI ID=0.0&gt;TG-3'&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(SEQ&lt;/RTI&gt; ID NO : &lt;RTI ID=0.0&gt;8).&lt;/RTI&gt; The reaction mix for PCR amplification contained &lt;RTI ID=0.0&gt;5.&lt;/RTI&gt; 0 &lt;RTI ID=0.0&gt;uL&lt;/RTI&gt; &lt;RTI ID=0.0&gt;10X&lt;/RTI&gt; polymerase buffer (Clontech, Cat. &lt;RTI ID=0.0&gt;&amp;num;8714),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;2.&lt;/RTI&gt; 0 &lt;RTI ID=0.0&gt;uL&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5&lt;/RTI&gt; &lt;RTI ID=0.0&gt;M&lt;/RTI&gt; betaine (Sigma, Cat. &lt;RTI ID=0.0&gt;&amp;num;B0300),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1.&lt;/RTI&gt; 0 &lt;RTI ID=0.0&gt;uL&lt;/RTI&gt; dNTP mix &lt;RTI ID=0.0&gt;(10&lt;/RTI&gt; mM each &lt;RTI ID=0.0&gt;dATP,&lt;/RTI&gt; dCTP, &lt;RTI ID=0.0&gt;dGTP,&lt;/RTI&gt; dTTP), &lt;RTI ID=0.0&gt;0.&lt;/RTI&gt; 8 &lt;RTI ID=0.0&gt;uL&lt;/RTI&gt; Advantage &lt;RTI ID=0.0&gt;2&lt;/RTI&gt; polymerase (Clontech, Cat. &lt;RTI ID=0.0&gt;&amp;num;8714),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;0.&lt;/RTI&gt; 2 &lt;RTI ID=0.0&gt;uL&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Advantage-HF&lt;/RTI&gt; &lt;RTI ID=0.0&gt;2&lt;/RTI&gt; polymerase (Clontech, Cat. &lt;RTI ID=0.0&gt;&amp;num;K1914),&lt;/RTI&gt; 10 &lt;RTI ID=0.0&gt;pmol&lt;/RTI&gt; forward primer, 10 &lt;RTI ID=0.0&gt;pmol&lt;/RTI&gt; reverse primer, 100 &lt;RTI ID=0.0&gt;ng&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(or&lt;/RTI&gt; less) &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; genomic DNA (ATCC, Cat. &lt;RTI ID=0.0&gt;&amp;num;12980D),&lt;/RTI&gt; and enough distilled water to make total volume of &lt;RTI ID=0.0&gt;50&lt;/RTI&gt; &lt;RTI ID=0.0&gt;uL.&lt;/RTI&gt; As little as &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ng&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; genomic DNA was sufficient to yield PCR product. The PCR &lt;RTI ID=0.0&gt;amplif cation of Bst&lt;/RTI&gt; ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; gene from genomic DNA consisted of an initial step at &lt;RTI ID=0.0&gt;96 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;3&lt;/RTI&gt; min, then &lt;RTI ID=0.0&gt;35&lt;/RTI&gt; cycles &lt;RTI ID=0.0&gt;of 96 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;15&lt;/RTI&gt; sec, &lt;RTI ID=0.0&gt;60 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;30&lt;/RTI&gt; sec, &lt;RTI ID=0.0&gt;72 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; min, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; finishing step at &lt;RTI ID=0.0&gt;72 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;10&lt;/RTI&gt; min and finally &lt;RTI ID=0.0&gt;14 C&lt;/RTI&gt; until removal. The PCR product was cleaned using &lt;RTI ID=0.0&gt;QIAquick&lt;/RTI&gt; PCR Purification Kit (QIAGEN). </p><p> Example &lt;RTI ID=0.0&gt;2&lt;/RTI&gt; : Cloning Strategy for Obtaining the &lt;RTI ID=0.0&gt;Sulfurylase-Luciferase&lt;/RTI&gt; Fusion Protein 
All chemicals were purchased from Sigma unless noted otherwise. &lt;RTI ID=0.0&gt;Racemically&lt;/RTI&gt; pure &lt;RTI ID=0.0&gt;D-luciferin&lt;/RTI&gt; was ordered from Pierce. The assay buffer for measuring ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; activities contained &lt;RTI ID=0.0&gt;Taq&lt;/RTI&gt; polymerase. &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; polymerase chain reaction &lt;RTI ID=0.0&gt;(PCR)-mediated&lt;/RTI&gt; approach was utilized to link the open reading frames &lt;RTI ID=0.0&gt;(ORFs)&lt;/RTI&gt; of &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;sulfurylase.&lt;/RTI&gt; </p><p>The cloning strategy is outlined in Fig. &lt;RTI ID=0.0&gt;1.&lt;/RTI&gt; Briefly, it involved the amplification of &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ORFs&lt;/RTI&gt; by &lt;RTI ID=0.0&gt;PCR,&lt;/RTI&gt; using primers that contain convenient restriction sites &lt;RTI ID=0.0&gt;(XhoI&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;HindIII)&lt;/RTI&gt; to clone the fusion gene into an expression vector, in-frame and, the design of &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; rare restriction site (Not &lt;RTI ID=0.0&gt;I)&lt;/RTI&gt; at the junction of the two polypeptides so that other versions of &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; such as thermostable &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(TL),&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; can be conveniently swapped to obtain either &lt;RTI ID=0.0&gt;sulfurlyase-luciferase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(S-L)&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;luciferase-sulfurlyase&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(L-S)&lt;/RTI&gt; fusion proteins. &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; Not &lt;RTI ID=0.0&gt;I&lt;/RTI&gt; site was used to fuse the variable heavy chain of antibodies to &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; to generate &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; viable fusion protein. These primers were also designed in such &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; way that the primers that form part of the junction of the two &lt;RTI ID=0.0&gt;ORFs&lt;/RTI&gt; contain &lt;RTI ID=0.0&gt;sufficient&lt;/RTI&gt; overlapping regions of </p><p>&lt;Desc/Clms Page number 58&gt;</p><p> nucleotides. For example, the &lt;RTI ID=0.0&gt;5'end&lt;/RTI&gt; &lt;RTI ID=0.0&gt;of FUS-L/S&lt;/RTI&gt; Not &lt;RTI ID=0.0&gt;R&lt;/RTI&gt; contains &lt;RTI ID=0.0&gt;deoxynucleotides&lt;/RTI&gt; in an anti- parallel orientation that encode the N-terminal &lt;RTI ID=0.0&gt;10&lt;/RTI&gt; amino acids of yeast &lt;RTI ID=0.0&gt;sulfurylase.&lt;/RTI&gt; Thus, &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; PCR product generated using this primer would anneal to the &lt;RTI ID=0.0&gt;5'end&lt;/RTI&gt; of yeast &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; ORF and would generate the fusion protein, L-S. </p><p> The products in boxes were obtained by PCR as elaborated in Fig. &lt;RTI ID=0.0&gt;2.&lt;/RTI&gt; As shown in Fig. </p><p>3, the PCR products were subjected to &lt;RTI ID=0.0&gt;electrophoresis.&lt;/RTI&gt; The PCR products were then purified, digested with Xho &lt;RTI ID=0.0&gt;I&lt;/RTI&gt; and Hind III and &lt;RTI ID=0.0&gt;subcloned&lt;/RTI&gt; into Xho &lt;RTI ID=0.0&gt;I/Hind&lt;/RTI&gt; III digested &lt;RTI ID=0.0&gt;pRSETA-BCCP.&lt;/RTI&gt; pRSETA-BCCP is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; derivative &lt;RTI ID=0.0&gt;of pRSET&lt;/RTI&gt; &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(Invitrogen)&lt;/RTI&gt; in which the sequence between &lt;RTI ID=0.0&gt;NheI and BamHI&lt;/RTI&gt; restriction sites has been replaced by the portion of the &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; carboxyl carrier protein &lt;RTI ID=0.0&gt;(BCCP)&lt;/RTI&gt; gene from &lt;RTI ID=0.0&gt;E.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;coli&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(GenBank&lt;/RTI&gt; accession &lt;RTI ID=0.0&gt;&amp;num;M80458)&lt;/RTI&gt; that codes for residue &lt;RTI ID=0.0&gt;87-165.&lt;/RTI&gt; The &lt;RTI ID=0.0&gt;87-amino&lt;/RTI&gt; acid BCCP domain was obtained by PCR and cloned into the &lt;RTI ID=0.0&gt;NheI&lt;/RTI&gt; and Bam HI sites &lt;RTI ID=0.0&gt;of pRSETA&lt;/RTI&gt; to obtain &lt;RTI ID=0.0&gt;pRSETA-BCCP.&lt;/RTI&gt; The &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; fusion protein and pRSETA-BCCP were transformed into &lt;RTI ID=0.0&gt;BL21DE3&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;TOP10&lt;/RTI&gt; cells. &lt;RTI ID=0.0&gt;BL21DE3&lt;/RTI&gt; cells yielded colonies for &lt;RTI ID=0.0&gt;L-S&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;TOPIC&lt;/RTI&gt; cells yielded colonies for &lt;RTI ID=0.0&gt;TL-S.&lt;/RTI&gt; </p><p>The following list of primers was used to construct the fusion proteins : 
EMI58.1
 PRIMER TITLE NUCLEIC ACID SEQUENCE SEQ 
NO ID 
NO 
1 FUS-L/S X F CCCC CTC GAG ATC CAA ATG GAA GAC GCC AAA 9 
AAC ATA AAG AAA GGC CC 
2 FUS-TL/SX CCCCCTCGAGATCCAAATGGCTGACAAAAAC 10 
F ATC CTG TAT GGC CC 
FUS-L/S Not TTG TAG AAT ACC ACC GTG AGG AGC AGG CAT 11 
R AGC GGC CGC CAA TTT GGA CTT TCC GCC CTT CTT 
GGC C 
4 FUS-TL/S TTG TAG AAT ACC ACC GTG AGG AGC AGG CAT 12 
Not R AGC GGC CGC ACC GTT GGT GTG TTT CTC GAA CAT 
C 
5 FUS-S-NotF GCGGCCGCTATGCCTGCTCCTCACGGTGGTATT 13 
CTAC 
FUS-S-Hind CCCC AAG CTT TTA AAA TAC AAA AAA GCC ATT 14 
III R GTC TTC CAA GAA TAG GAC 
7 FUS-S/LBF CCCCGGATCCATCCAAATGCCTGCTCCTCAC 15 
GGT GGT ATT CTA CAA GAC 
8 FUS-S/L R GGGCCTTTCTTTATGTTTTTGGCGTCTTCCAT AGC 16 
GGC CGC AAA TAC AAA AAA GCC ATT GTC 
9 FUS-L-F GCG GCC GCT ATG GAA GAC GCC AAA AAC ATA 17 
AAG AAA GGC CC 
10FUS-L-N-R CCCCCCATGGTTACAATTTGGACTTTCCGCC 18 
CTT CTT GGC C 
11 FUS-S/TL R GG GCC ATA CAG GAT GTT TTT GTC AGC CAT AGC 19 
GGC CGC AAA TAC AAA AAA GCC ATT GTC </p><p>&lt;Desc/Clms Page number 59&gt;</p><p> 
EMI59.1
 12 FUS-TL-F GCG GCC GGT ATG GCT GAC AAA AAC ATC CTG 20 
TAT GGC CC 13 FUS-TL-H-R CCCC AAG CTT CTA ACC GTT GGT GTG TTT CTC 21 
GAA CAT CTG ACG C These primers were utilized to perform &lt;RTI ID=0.0&gt;PCR.&lt;/RTI&gt; The following PCR condition was used. </p><p>PCR condition &lt;RTI ID=0.0&gt;96 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;3&lt;/RTI&gt; : 00 ; &lt;RTI ID=0.0&gt;96 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;0&lt;/RTI&gt; : 15 ; &lt;RTI ID=0.0&gt;76 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;0&lt;/RTI&gt; : 30 ;-1 C per cycle ; &lt;RTI ID=0.0&gt;72 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; : 00 ; For &lt;RTI ID=0.0&gt;15&lt;/RTI&gt; cycles &lt;RTI ID=0.0&gt;;&lt;/RTI&gt; &lt;RTI ID=0.0&gt;96 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;0&lt;/RTI&gt; : 15 ; &lt;RTI ID=0.0&gt;60 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;0 : 30&lt;/RTI&gt; ; &lt;RTI ID=0.0&gt;72 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;6&lt;/RTI&gt; : 00 ; For &lt;RTI ID=0.0&gt;29&lt;/RTI&gt; cycles ; &lt;RTI ID=0.0&gt;72 C&lt;/RTI&gt; for &lt;RTI ID=0.0&gt;10&lt;/RTI&gt; : 00 ; 14 C forever Example &lt;RTI ID=0.0&gt;3&lt;/RTI&gt; : Cloning of the &lt;RTI ID=0.0&gt;His6-BCCP&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Bst&lt;/RTI&gt; ATP &lt;RTI ID=0.0&gt;Sulfurylase&lt;/RTI&gt; Fusion Protein 
The Bst-affinity tagged fusion construct is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; derivative &lt;RTI ID=0.0&gt;of pRSETA&lt;/RTI&gt; in which the &lt;RTI ID=0.0&gt;NheI-&lt;/RTI&gt; XhoI fragment has been replaced by the BCCP domain and the ATP &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; is inserted after the BCCP domain. </p><p> Briefly, the &lt;RTI ID=0.0&gt;BstSulf&lt;/RTI&gt; PCR product, as described in Example &lt;RTI ID=0.0&gt;1,&lt;/RTI&gt; was double-digested with pstI and HindIII, isolated on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1%&lt;/RTI&gt; &lt;RTI ID=0.0&gt;agarose/TAE&lt;/RTI&gt; gel, purified using QIAEXII &lt;RTI ID=0.0&gt;(QIAGEN)&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;ligated&lt;/RTI&gt; into the large PstI/HindIII fragment of pRSETA-BCCP using the Quick &lt;RTI ID=0.0&gt;Ligation&lt;/RTI&gt; Kit from NEB according to manufacturer's instructions. As mentioned in Example 2, pRSETA-BCCP is &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; derivative &lt;RTI ID=0.0&gt;of pRSET&lt;/RTI&gt; &lt;RTI ID=0.0&gt;A&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(Invitrogen)&lt;/RTI&gt; in which the sequence between &lt;RTI ID=0.0&gt;NheI&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;BamHI&lt;/RTI&gt; restriction sites has been replaced by the portion of the &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; carboxyl carrier protein &lt;RTI ID=0.0&gt;(BCCP)&lt;/RTI&gt; gene from &lt;RTI ID=0.0&gt;E.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;coli&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(GenBank&lt;/RTI&gt; accession &lt;RTI ID=0.0&gt;&amp;num;M80458)&lt;/RTI&gt; that codes for residue &lt;RTI ID=0.0&gt;87-&lt;/RTI&gt; &lt;RTI ID=0.0&gt;165.&lt;/RTI&gt; 2 &lt;RTI ID=0.0&gt;uL&lt;/RTI&gt; &lt;RTI ID=0.0&gt;ligation&lt;/RTI&gt; reaction was used to transform &lt;RTI ID=0.0&gt;50&lt;/RTI&gt; &lt;RTI ID=0.0&gt;uL&lt;/RTI&gt; &lt;RTI ID=0.0&gt;TOP10&lt;/RTI&gt; competent cells &lt;RTI ID=0.0&gt;(Invitrogen)&lt;/RTI&gt; and plated on &lt;RTI ID=0.0&gt;LB-Ap&lt;/RTI&gt; plates. &lt;RTI ID=0.0&gt;Sequencing&lt;/RTI&gt; of plasmid insert from ten clones was used to determine the consensus sequence for the ATP sulfurylase gene from ATCC &lt;RTI ID=0.0&gt;12980.&lt;/RTI&gt; </p><p> The plasmid pRSETA-BCCP-BstSulf was transformed into the &lt;RTI ID=0.0&gt;E. coli&lt;/RTI&gt; expression host &lt;RTI ID=0.0&gt;BL21&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(DE3)&lt;/RTI&gt; &lt;RTI ID=0.0&gt;pLysS&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(Novagen)&lt;/RTI&gt; and the induction expression &lt;RTI ID=0.0&gt;of BstHBSulf was&lt;/RTI&gt; carried out according to the &lt;RTI ID=0.0&gt;maufacturer's&lt;/RTI&gt; instructions. The cells were harvested and stored as frozen pellets. The pellets were lysed using &lt;RTI ID=0.0&gt;BugBuster&lt;/RTI&gt; plus Benzonase according to manufacturer's instructions and protein was purified on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;20&lt;/RTI&gt; &lt;RTI ID=0.0&gt;mL&lt;/RTI&gt; column packed with Cheating Sepharose Fast Flow (Amersham, Cat. &lt;RTI ID=0.0&gt;&amp;num;17-0575-02)&lt;/RTI&gt; and charged with nickel &lt;RTI ID=0.0&gt;(in).&lt;/RTI&gt; Protein was &lt;RTI ID=0.0&gt;eluted&lt;/RTI&gt; </p><p>&lt;Desc/Clms Page number 60&gt;</p><p> using &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;0-500&lt;/RTI&gt; mM imidazole gradient. Analysis by &lt;RTI ID=0.0&gt;SDS-PAGE&lt;/RTI&gt; showed &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single band of the correct size. </p><p>Example &lt;RTI ID=0.0&gt;4&lt;/RTI&gt; : Binding enzymes to beads 
The BCCP domain enables the &lt;RTI ID=0.0&gt;E.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;coli&lt;/RTI&gt; to add &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; single &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; molecule onto &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; specific lysine residue. Hence these fusion proteins can be bound to solid supports that contain &lt;RTI ID=0.0&gt;streptavidin.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;TL-S&lt;/RTI&gt; was successfully cloned into &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; TA vector. 25 &lt;RTI ID=0.0&gt;1ll of MPG-Streptavidin&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(CPG,&lt;/RTI&gt; Inc.) or &lt;RTI ID=0.0&gt;Nickel-agarose&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(Qiagen)&lt;/RTI&gt; were taken in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1.&lt;/RTI&gt; 5 &lt;RTI ID=0.0&gt;ml&lt;/RTI&gt; tube and placed on &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; magnet. </p><p>The &lt;RTI ID=0.0&gt;supernatant&lt;/RTI&gt; was removed and the beads were &lt;RTI ID=0.0&gt;resuspended&lt;/RTI&gt; in &lt;RTI ID=0.0&gt;25&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Fg of His6-BCCP-&lt;/RTI&gt; &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;75&lt;/RTI&gt; &lt;RTI ID=0.0&gt;llg of His6-BCCP-luciferase.&lt;/RTI&gt; To test the fusion protein, 100 &lt;RTI ID=0.0&gt;pl of dialyzed&lt;/RTI&gt; fusion protein was bound to the 25  l of beads. The beads were allowed to mix at room temperature for Ihr, washed with assay buffer &lt;RTI ID=0.0&gt;(25mM&lt;/RTI&gt; &lt;RTI ID=0.0&gt;Tricine&lt;/RTI&gt; &lt;RTI ID=0.0&gt;(pH&lt;/RTI&gt; &lt;RTI ID=0.0&gt;7.&lt;/RTI&gt; &lt;RTI ID=0.0&gt;8),&lt;/RTI&gt; &lt;RTI ID=0.0&gt;5mM&lt;/RTI&gt; MgAcetate, &lt;RTI ID=0.0&gt;1mM&lt;/RTI&gt; DTT, &lt;RTI ID=0.0&gt;1mM&lt;/RTI&gt; &lt;RTI ID=0.0&gt;EDTA,&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; &lt;RTI ID=0.0&gt;mg/ml&lt;/RTI&gt; &lt;RTI ID=0.0&gt;BSA)&lt;/RTI&gt; and assayed for enzyme activities with 1mM PPi, &lt;RTI ID=0.0&gt;4mM&lt;/RTI&gt; APS and &lt;RTI ID=0.0&gt;300&lt;/RTI&gt; mM &lt;RTI ID=0.0&gt;D-luciferin.&lt;/RTI&gt; With the nickel-agarose beads, the EDTA was omitted from the assay buffer. </p><p> As shown in Fig. &lt;RTI ID=0.0&gt;4,&lt;/RTI&gt; these fusion proteins displayed activity on both the &lt;RTI ID=0.0&gt;NTA-Agarose&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;MPG-SA&lt;/RTI&gt; beads. &lt;RTI ID=0.0&gt;S&lt;/RTI&gt; : L &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; : 3 represents &lt;RTI ID=0.0&gt;sulfurylase&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;luciferase&lt;/RTI&gt; bound individually to beads in &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;1&lt;/RTI&gt; : 3 ratio. Ni-Ag and &lt;RTI ID=0.0&gt;MPG-SA&lt;/RTI&gt; are &lt;RTI ID=0.0&gt;nickel-agarose&lt;/RTI&gt; and &lt;RTI ID=0.0&gt;MPG-Streptavidin&lt;/RTI&gt; beads, respectively. PL is &lt;RTI ID=0.0&gt;Promega&lt;/RTI&gt; &lt;RTI ID=0.0&gt;luciferase,&lt;/RTI&gt; which does not have &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;polyhistidine&lt;/RTI&gt; or &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; tag on it and hence serves as &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; negative control. Fraction &lt;RTI ID=0.0&gt;19&lt;/RTI&gt; contains the fusion protein and is active on both kinds of beads. This suggests that the fusion protein was synthesized with &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; poly- histidine tag and &lt;RTI ID=0.0&gt;a&lt;/RTI&gt; &lt;RTI ID=0.0&gt;biotin&lt;/RTI&gt; molecule on the BCCP domain of the fusion protein.</p></description></fulltext-document>